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1 General introduction
Chapter 1
1.1 General remarks
TčĎĘ thesis is entitled ‘Digital Twin of Analogue Man: Development of aComputational Modelling Platform to Assess Heart-Vessel Interaction inHumans’. The concept of using ‘twins’ is not new. For many years, plastic
replicas of skeletons (i.e. ‘physical twins’) have been used in the classroom as
well as in the general practitioner’s ofϐice to explain aspects of the human skeletal
anatomy. Physical twins were also used during NASA’s Project Apollo in which
two identical spacecraft were built, one to remain on the basis, which allowed
engineers to recreate the conditions of the spacecraft during missions [11].
Digital twin technology is a novel concept originating from manufacturing
industry [17]. A digital twin refers to a virtual or computational model containing
a comprehensive physical and functional description of a component, product or
system [11].
In this thesis, we apply the digital twin concept to cardiovascular research on the
haemodynamic interaction between the heart and blood vessels. To emphasise
the role of computational modelling, we ϐirst provide a timeline that outlines
the technological developments that drive clinical data integration for improved
interpretation.
1.2 History of cardiovascular haemodynamics and
imaging studies
Already in ancient times, palpation of blood vessels has been performed as a
method to diagnose disease. Ancient physicians and priests used the concept of
measuring the ‘state’ of the heart through pulsating ‘canals’ in the head, hand and
ϐingers [12]. It was the Greek physician Galen (129 – c. 210 ), who extensively char-
acterised the cardiovascular system as being comprised of networks of arteries
and veins. At that time, there was still no notion of the circular blood ϐlow. Much
later, William Harvey (1578–1657) was ϐirst to mention the blood circulation in
his book De Motu Cordis, published in 1628. In contrast to Galen’s understanding,
Harvey discovered that 1) the arterial pulse is the result of an actively contracting
heart and is not caused by intrinsic contraction of the arterial wall itself, 2) there
exists a pulmonary circulation in which the right ventricle pumps blood through
the lungs to the left ventricle, instead of venous blood passing through invisible
pores in the interventricular septum, and 3) blood is continuously cycled through
the body (i.e. the cardiovascular system is a closed-loop system), rather than being
produced in the liver, distributed to the body, and vanished subsequently [2].
The ϐirst direct blood pressuremeasurementswere performedby StephenHales
(1677–1761) in England [30]. Hales performed arterial pressure measurements
by inserting a brass cannula into a horse’s carotid artery, which was connected
to a glass tube to read out the height of the column of blood (Fig. 1.1). Hales’s
work spawned further developments for recording the arterial pressurewaveform
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into the 1800s, which resulted in Scipione Riva-Rocci’s method using an upper
arm cuff to non-invasively measure the actual blood pressure in humans (ϐirst
described in 1896). The early version of this device was capable of measuring
peak (i.e. systolic) blood pressure. A few years later, following the discovery of
the Korotkoff sounds in Russia, Riva-Rocci’s method was improved to also include
diastolic blood pressure measurements, based on simultaneous auscultation of
the artery distally to the blood pressure cuff [10].
Figure 1.1: Reconstruction of Stephen Hales’s method of in vivo blood pressure measure-
ment, as performed in the carotid artery of a sedated horse. Reproduced with
permission fromSpecial Collections, University of Otago, Dunedin, NewZealand.
Other advances in cardiovascular research that took place around the 1900s
include the invention of X-ray imaging. X-ray now allowed to obtain structural in-
formation of the heart andmajor blood vessels. An even greater breakthroughwas
the introduction of the electrocardiogram that provides functional information
and is still used as the ground truth modality in emergency rooms and doctor’s
ofϐices all over the world [3]. Cardiac ultrasound was invented in the 1950s and
was at that time limited to describing the position of a cardiac structure over time
(i.e. a so-called M–mode image). It took until the 1970s for ultrasound scanners
to appear to acquire two-dimensional images (i.e. B–mode) of the heart [44].
Vascular ultrasound emerged around the same time as cardiac ultrasound.
Vascular research topics using ultrasound include assessment of the mechan-
ical properties of arteries by studying arterial wall deformation under blood
pressure pulsations [16, 19]. Although most vascular ultrasound applications
9
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are non-invasive, intra-vascular methods using a transducer-mounted catheter
are available to accurately evaluate the extent of atherosclerosis in arteries [46].
Among important clinical applications of vascular ultrasound is duplex ultrasound
which provides two-dimensional greyscale images of blood vessels combinedwith
a colour-coded map of the local blood ϐlow velocity [13]. Currently, duplex ultra-
sound is a ϐirst-line imaging modality to assess amongst others carotid stenosis
severity [28].
A more detailed assessment of signiϐicant stenoses can be obtained using com-
puted tomography (CT) imaging [28]. CT is a minimally-invasive imaging tech-
nique based on acquiring multiple X-ray images at different angles and focal
planes of a tissue [49]. Using a ϐiltered back-projection algorithm, pioneered by
the Austrian mathematician Johann Radon in 1917, the series of one-dimensional
projections can be reconstructed into a two-dimensional image of the tissue
[49]. In contrast to using duplex ultrasound for carotid stenosis assessment, CT
additionally renders the three-dimensional structure of stenotic lesions, as re-
constructed frommultiple two-dimensional images. Furthermore, CT allows for
characterisation of vessel wall composition (e.g. assessment of coronary calcium
content).
Magnetic resonance imaging (MRI), based on the tissue-speciϐic response of
hydrogen nuclei to a magnetic ϐield disturbance is a non-invasive imaging mo-
dality offering an anatomically detailed overview of the heart and blood vessels
[49]. Furthermore, phase-contrast MRI is now widely used in cardiovascular MRI,
providing a time-resolved quantitative assessment of blood ϐlow in blood vessels
as well as within the heart [23, 31].
Today, the variety of measurement devices (ultrasound machines, MRI scan-
ners and blood pressure measurement devices) allow for a comprehensive and
multi–faceted collection of clinical data. In theory, the multitude of clinical data
enables researchers and clinicians to better understand and exploit the mechan-
isms of cardiovascular disease. However, interpretation of data is hindered by
issues around mutual dependencies in the data, reliability, and accuracy, which
makes correct diagnosis-making difϐicult [21]. Below, three illustrative examples
of studies that are confronted with challenges regarding data interpretation are
presented.
1. Cardiac diastolic function studies: In non-invasive settings, cardiac ultra-
sound is used for estimation of left ventricular (LV) ϐilling pressure and
diagnosis of diastolic dysfunction [34]. The E/e’ ratio, based on Doppler
ultrasound measurements of early mitral inϐlow velocity (E) and mitral
annular early diastolic velocity (e’), has been proposed as index for ϐilling
pressure [34]. However, meta-analysis of studies performing both cardiac
ultrasound and cardiac catheterisation (i.e. considered gold standard) sug-
gested that the E/e’ ratio alone has limited value for assessment of LV ϐilling
pressure [42].
2. Arterial stiffness studies: Various arterial stiffness parameters (e.g. pulse
pressure, regional pulse wave velocity or local distensibility) have been
10
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proposed as risk factors for cardiovascular diseases [45]. However, arterial
stiffnessmeasures as suchdonot discriminate underlying changes in arterial
wall constituent properties (e.g. in collagen, elastin, or smooth muscle) [39].
Therefore, evaluation of changes in constituent properties is highly relevant
for the development and monitoring of treatment [18].
3. Heart-vessel interaction studies: Presence of left ventricular hypertrophy
(LVH) is an important risk factor for cardiovascular disease and mortality
[29]. Concentric left ventricular remodelling and LVH are common ϐindings
in hypertensive patients [15]. Therefore, consideration of LV afterload in
relation to LV structure and function— as governed by heart-vessel inter-
action — is important for research regarding LVH. Despite the multitude
of clinical data, it is controversial to what extent (ageing-induced) changes
in afterload are resulting from earlier arrival of reϐlected waves or from re-
duced arterial compliance [7, 32, 37]. Hence, the afterload aspects striking
‘the killing blow’ to the LV remain unclear.
A solution to these challenges may be the development of elaborate statistical
models that consider many variables and include interactions between variables.
However, statistical modelling alone offers only a limited interpretation of causal-
ity, because thesemodels are dependent on the population and circumstances they
are based on [1, 21]. In the ϐield of biomedical engineering, computational models
to capture physical and physiological relations, are being developed and applied
[21, 36, 41]. In this thesis, we develop and assess physics-based computational
models to interpret and estimate characteristics of heart-vessel interaction.
1.3 Computational models of cardiovascular
haemodynamics and their clinical applications
1.3.1 Models of the circulation
Many physiological relationships related to cell, tissue, organ or the whole system
can be approached by a mathematical relation. A computer model, composed of a
network of applied physiological relationships, may simulate the cardiovascular
system. As such, cardiovascular models are well-suited to test new hypotheses
about mechanisms of cardiovascular diseases. Most cardiovascular models can
roughly be assigned to three categories [43]. The ϐirst category consists of com-
putationally expensive three-dimensional (3D) solid mechanics models, computa-
tional ϐluid dynamics models and ϐluid-structure interaction models, describing
local stresses and strains, pressures and ϐlow velocity ϐields, or all of the aforemen-
tioned physical quantities, respectively (Fig. 1.2) [9, 14, 25]. The second category
is formed by computationally inexpensive zero-dimensional (0D) lumped para-
meter models, assuming uniform distributions of pressure and ϐlow within entire
compartments, e.g. the pulmonary circulation (Fig. 1.2). As such, lumped para-
meter models fail to take into account spatial variation of pressure and ϐlow. The
third is an intermediate category of the computationally expensive 3Dmodels and
11
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Figure 1.2: Dimensionality in cardiovascular modelling. Zero-dimensional (0D) or ‘lumped’
models consisting of a limited number of model parameters, (e.g. describing
vascular resistance (R) and compliance (C)), consider uniform distributions of
physical quantities (e.g. pressure or ϐlow), have a low computational demand
(e.g. run faster than real-time), but lack spatial detail. One-dimensional (1D)
or ‘distributed’ models allow calculation of physical quantities along a single
spatial direction at the cost of a moderate increase in computational demand.
Three-dimensional (3D) models offer the highest spatial resolution, capable of
calculating complex patterns of physical quantities.
simpliϐied 0D models, comprising of one-dimensional (1D) distributed models
that simulate wave transmission in networks of blood vessels (Fig. 1.2) [26, 40].
As a general rule, the choice of model dimensionality is determined by the
required spatial and temporal resolution, which in turn is determined by the
research question or clinical application [43].
In this thesis, we consistently use 0Dmodels of cardiac mechanics and distributed
models of wave transmission. The CircAdapt platform, an in-house developed
cardiovascular model, has been successfully applied so far for simulating haemo-
dynamics and LV adaptation processes during valvular pathologies and cardiac
conductance disorders [27, 38, 48]. Its cardiac model describes a simpliϐied car-
diac geometry and assumes the cardiac chambers to be surrounded by contractile
cardiac walls consisting of myoϐibres [48]. The myoϐibres are described using
the one-ϐibre model [5], which relates myoϐibre stress to cavity pressure using
the assumption that myoϐibre stress is homogeneously distributed within the
myocardial wall. Furthermore, instead of relying on input from imaging tech-
niques such as ultrasound or MRI, cardiac geometry (i.e. wall thicknesses and
cavity volumes) is determined using cardiac adaptation rules [6]. A current limita-
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tion of the CircAdapt model is that it does not yet contain a description of vascular
wave transmission, which is believed to be important in studies on heart-vessel
interaction (Section 1.2).
1.3.2 Patient-specific model-based characterisation of
cardiovascular structure and function
In daily clinical practice, treatments are often based on the ‘one-size-ϐits-all’ par-
adigm in which results from clinical trials are used to deϐine cut-off values for
risk-stratiϐication and clinical decision-making. Often, cut-off values are based on
statistical associations between a clinical measure (e.g. systolic blood pressure by
arm cuff) on the one hand, and a clinical end-point (e.g. heart failure or stroke)
on the other. For some diseases like acute myocardial infarction, cut-off values
exist that are useful for clinical decision-making [4, 47]. However, for complex
diseases such as heart failure, cut-off values may lack precision because of the
multi-factorial nature of the disease or the indirect description of a cut-off value
as a marker for disease. Imputation or tuning computational models with or to
a (subset of) clinical data could improve clinical decision-making. To this end,
roughly two modelling approaches can be distinguished.
Forward approach
Personalised modelling can be performed using a forward approach [24, 33, 39],
by substituting generic or population-averaged model parameters with their
patient-speciϐic counterparts, obtained or derived using measurements. Such
a personalised model provides additional direct information on the state of the
cardiovascular system by simulating variables (e.g. pressures, ϐlows and material
stresses) that cannot be routinely measured.
Inverse approach
An inverse approach [8, 24, 39] may be employed in which model parameters are
tuned so that model simulations and patient measurements agree. In case the
model parameters represent e.g. passive or active properties of tissue, such ϐitting
procedure provides model-based estimates of those properties based on patient
measurements. In previous works, the inverse approach has been proposed to
facilitate a constitutive interpretation of clinical arterial stiffness measurements
[39].
Limitations of patient-specific modelling
Difϐiculties with respect to patient-speciϐic modelling are 1) a lack of clinical data
available for model parametrisation, 2) measurement uncertainty associated with
the clinical data, and 3) a mismatch between available clinical data and required
clinical data to unambiguously estimate the unknown model parameters.
13
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1.4 Aim and outline of this thesis
The aim of this thesis is to develop and evaluate a computational modelling plat-
form to assess heart-vessel interaction. The developed models were employed
in two use-cases concerning patient-speciϐic modelling: 1) non-invasive compu-
tational methods to allow screening for LV diastolic abnormalities and 2) non-
invasive identiϐication of arterial wall mechanical properties to assess the effect
of (novel) vascular drugs on cardiovascular system dynamics. The structure of
this thesis is as follows.
In Chapter 2, we perform a meta-analysis of clinical intervention studies with
arterial and LV structure/function as (primary) outcomes. This study serves as an
important starting point to investigate heart-vessel interaction. In this review, we
aim to evaluate, using clinical evidence, the current pathophysiological paradigm
that links arterial stiffening and LV hypertrophy/failure [50].
In Chapter 3, we extend the existing CircAdapt computational model with a
module describing arterial and venous wave transmission. The extended model
is subjected to a relevant test-case, simulating the effect of systemic arterial hy-
pertension on 1) global arterial and venous haemodynamics, and 2) changes in
local wave dynamics at the level of the aorta. In Chapter 4, we use the newly
extended circulatory model to critically evaluate the augmentation index (AIx).
The AIx is a well-known and widely reported metric, deemed to capture the effect
of increased cardiac workload due to wave reϐlections. However, its validity as a
proxy for wave reϐlection magnitude has been questioned [22].
In Chapter 5, we model the adaptive capacity of blood vessels, making them
respond to ϐlow and pressure stimuli by changes in radius and wall thickness of
blood vessels. We integrate the adaptation rules into a previously developed pulse
wave propagationmodel [26], and assesswhether the PWP-adaptation framework
could be utilised to extrapolate incomplete patient-speciϐic data sets. Model-
based estimates are compared to dedicated ultrasound and MRI measurements,
as obtained in ten healthy volunteers.
In Chapter 6, we employ the extended CircAdaptmodel to non-invasively estim-
ate LV end-diastolic pressure (ped) and compliance (Ced) from routine measure-
ments of blood pressure and echocardiographic recordings. This approach could
improve the currently used method of assessing increased LV ϐilling pressure,
which reportedly lacks speciϐicity, i.e. echocardiographic E/e’ 6= ped 6= Ced [42].
In Chapter 7, we model carotid arterial wall mechanics using a constitutive
model that simulates stress-strain behaviour of the arterial collagen and elastin
[20]. For constitutive interpretation of clinical arterial stiffness data, an inverse ap-
proach is utilised which enables estimation of constitutive properties. According
to modelling standards [35], we perform uncertainty quantiϐication to determine
uncertainty in model-estimated constitutive property estimation.
This thesis concludes with a general discussion in Chapter 8, where we put the
developments in the context of a multi-scale modelling platform and its utility for
further mechanistic studies into heart-vessel interaction.
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2.1 Abstract
Vascular research demonstrated that pulse wave velocity (PWV), a measure of
arterial stiffness, is inherently blood pressure-dependent. Considering the hy-
pothesised pathophysiological chain of increased arterial stiffness leading to
increased blood pressure load with consequent left ventricle hypertrophy (LVH)
development, we conducted a systematic review of antihypertensive and life-
style intervention studies to determine the association between on the one hand
changes in arterial stiffness and blood pressure, and on the other hand changes in
LV mass (LVM).
Using PubMed, EMBASE, Cochrane andWeb of Science, we identiϐied 23 studies,
containing 2573 patients. Studies reported changes in arterial stiffness (assessed
by means of PWV), systolic- and diastolic blood pressure (SBP, DBP), and LVM
index (LVMI), respectively.
Statistically signiϐicant reductions in SBP, PWVandLVMIwere reported in 16, 14,
and 20 studies, respectively. Pooled analysis of studies showed that the proportion
in SBP reduction did not correlate signiϐicantly to the proportion in reductions
of the other two variables. On the other hand, we found a signiϐicant positive
correlation (r=0.61, p=0.003) between arterial stiffness and LVM, expressed as a
relevant reduction in LVMI of 6.9 g/m2 per 1.0 m/s reduction in PWV.
Our ϐindings provide evidence that a decrease in arterial stiffness is associ-
ated with reduction of LVM. To investigate whether there exists a causal relation
between LVH due to arterial stiffness increases and in turn blood pressure load
increases, future studies should strive for a multiple follow-up design and use of
blood pressure-independent or corrected stiffness indices.
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2.2 Introduction
CĚėėĊēęđĞ, cardiovascular disease (CVD) is the number one killer of humansworldwide, responsible for 17.9 million deaths (approximately 30% ofall deaths) each year [49]. In the elderly, CVD accounts for even more
than 80% of all deaths [50]. High arterial blood pressure is a key determinant of
CVD [24] and is the leading attributable factor for developing heart failure [39].
Elevated isolated systolic blood pressure (SBP) is becoming increasingly relevant
in the ageing population as 60% of people aged 60 years or older have elevated
SBP (i.e. SBP>140 mmHg) [34].
The (age-related) stiffening of arteries has been identiϐied as a key determinant
and precursor of elevated SBP [18, 21, 28]. The main contributors to elevated SBP
are believed to be decreased (central) arterial compliance and increased systolic
wave reϐlection (i.e. earlier arrival of reϐlected pressure wave) [28]. Increased
myocardial afterload due to elevated SBP affects the way the left ventricle (LV)
adapts and becomes hypertrophic [12]. Recently, the ESH/ESC guidelines for
the management of hypertension have emphasised the importance of increased
arterial stiffness (assessed as pulse wave velocity (PWV)) and LV hypertrophy
(LVH) (assessed as LV mass index (LVMI)) in determining overall cardiovascular
risk [26].
A pattern of increased arterial stiffness, high blood pressure, and LVH is fre-
quently observed in smaller observational, cross-sectional studies [5, 30, 44].
Due to design and study size, such studies are seriously limited in identifying
causality. Furthermore, arterial stiffness measurements are inherently blood
pressure-dependent [36], complicating the causative interpretation of observed
changes in both arterial stiffness and LV structure and function.
Considering the current pathophysiological paradigm linking arterial stiffening,
elevation of SBP, and development of LVH/LV failure [47], our aim was to review
the available randomised controlled trials (RCTs) and cohort studies, reporting
intervention-induced changes in blood pressure, arterial stiffness and LV struc-
ture/function as primary outcomes. We evaluated whether intervention–induced
changes in arterial stiffness correlated with improvement in LV structure and
function. In our meta-analysis, we included the orders of magnitude of changes in
PWV and of changes in LVM, in relation to changes in SBP and DBP.
2.3 Methods
2.3.1 Protocol and registration
In this study, we applied the Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) statement for studies evaluating medical interventions
[23].
21
Chapter 2
2.3.2 Search strategy and study selection
We extensively searched the PubMed, EMBASE, Cochrane and Web of Science
databases using the following search strategy: (((((((((((Heart Failure, Diastolic)
OR Heart Failure, Diastolic) OR diastolic dysfunction) OR isolated systolic hyper-
tension) OR pulse pressure) OR Blood pressure)) AND ((((((((Hypertrophy, Left
Ventricular) OR Hypertrophy, Left Ventricular) OR left ventricle hypertrophy)
OR cardiac hypertrophy) OR cardiomegaly) OR cardiomegaly)) AND (((((((blood
pressure) OR blood pressure) OR hypertension) OR high blood pressure) OR
hypertension)) AND (((((((arterial stiffness) OR vascular stiffness) OR vascular
stiffness) OR pulsewave velocity) OR pulsewave analysis) OR pulsewave analysis)
OR distensibility))))) AND ((((physical activity*) OR motor activity) OR Motor
activity) OR (((((((((revalidation) OR Exercise) OR Exercise) OR Life Style) OR
Life Style) OR Therapeutics) OR Therapeutics) OR medical treatment) OR medi-
cation)))). The starting date was determined as 1 January 1990 and the search
was updated till 20 April 2017. The reference lists and citations of the obtained
articles were handsearched for additional searches. Articles were included in this
systematic review if they fulϐilled the criteria described below (Fig. 2.1):
1. English-written randomised controlled trials (RCTs), prospective observa-
tional studies or case-control studies, investigating both an intervention-
and control group, examining i) the relationship between arterial stiffness
and (diastolic) heart failure in isolated systolic hypertension, or ii) the ef-
fects of medication, several compounds and lifestyle (diet or exercise) on
blood pressure, arterial stiffness and cardiac structure/function, in human
follow-up studies (subjects acting as their own controls).
2. Individuals with isolated systolic hypertension and/or heart failure. No
restrictions on age were enforced. Both sexes were included.
3. Studies investigating (primary) outcome measures (see summary meas-
ures) Studies were excluded a) if populations with kidney haemodialysis/
peritoneal dialysis were examined, b) if the estimated glomerular ϐiltra-
tion rate (eGFR) was lower than 30 ml/min/1.73 m2, c) if there were no
ventricular or vascular changes reported, or d) if the studies were classiϐied
as retrospective cohort- and/or cross-sectional studies. Additionally, review
articles and case reports were not eligible for inclusion.
2.3.3 Study selection and data extraction
When eligibility criteria and the search strategy were realised by three investiga-
tors (K.M.W, A.A.K. and K.D.R.), selection screening, based on title and abstract
according to the a priori retrieved inclusion- and exclusion criteria, was conducted.
In case of mismatch between the investigators, inclusion of an article was based
on agreement by consensus during the selection screening.
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Retrieved from PubMed, EMBASE,
Cochrane and Web of Science, 
date: January 1990 - April 2017
Full-text articles assessed 
for eligibility 
(n=24)
Studies included in qualitative
analysis
(n=23)
Inclusion criteria:
- English-written RCTs, prospective-
or case-control studies 
- Reporting arterial stiffness and 
(diastolic) heart failure indices
in ISH or effects of medication, 
compounds, lifestyle (diet/exercise) 
-  
Exclusion criteria:
- Kidney peritoneal / haemodialysis
populations 
- eGFR < 30 ml/min/1.73m2
- No ventricular/vascular changes
reported following intervention
- Retrospective cohort/cross-sectio- 
nal studies/reviews/case reports 
Full-text articles excluded (n=1) 
due to high similarity to a prior 
study by the same authors with a 
slightly different study design
Relevant articles from 
reference lists and 
citations (n=0)
386 studies
ISH/HF investigating primary 
outcomes
Figure 2.1: Search and selection of studies.
Full-text publications were reviewed by two investigators (K.M.W. andM.H.G.H.)
if eligibility criteriawere satisϐied. Study characteristics, risk of biaswithin studies
and results/conclusions of individual studies were reviewed independently of
each other.
From the selected studies, when available, the following data were extracted: i)
studymethods (design, data collection, time period), ii) participant characteristics
(inclusion/exclusion, size, origin, setting), iii) intervention/placebo treatment
(type, dose, duration), and iv) outcome measures. In case of a mismatch between
ϐirst and second reviewer, agreement was achieved by consensus.
2.3.4 Risk of bias
Two reviewers (K.M.W. and M.H.G.H.) independently assessed risk of bias to ascer-
tain the validity of the included studies. If present, discrepancies were resolved
by agreement based on consensus. Using the online Cochrane handbook for
writing systematic reviews [15], sequence generation, allocation concealment,
randomisation, blinding of participants and personnel, proportion of drop-outs,
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Table 2.1: Overview of arterial stiffness measured.
Name Abbreviation Regional or single-point PWV Studies [ref. no.]
Carotid-femoral pulse wave velocity cfPWV regional [2, 4, 13, 14, 31, 42]
Brachial-ankle pulse wave velocity baPWV regional [1, 38, 41, 45]
Aortic pulse wave velocity aoPWV single-point [8, 19, 32, 43]
similarity between therapies, selective outcome reporting and sponsors inϐluence
were assessed for RCTs. Prospective observational studies were assessed by the
Newcastle Ottawa Scale [46], in which selection-, comparability- and exposure
parameters were rated.
2.3.5 Summary measures
Primary outcome measures were changes in i) arterial stiffness and compliance,
ii) blood pressure, iii) pulse pressure, iv) LV hypertrophy, LV mass (LVM) and LV
mass index (LVMI), (v) diastolic heart failure, and particularly relations between
those variables. The included studies report on the one hand regional pulse wave
velocities (i.e. cfPWV and baPWV, based on transit time) and on the other hand
single-point aortic stiffness. These studies did not utilise carotid measurements.
Subsequently, from aortic stiffness estimates, we obtained estimates of aoPWV
using the Bramwell-Hill equation [6]. In case compliance (CC) was reported we
used PWV = (A0/ρCC)
1/2, whereas if distensibility (DC) was reported, we used
PWV = (1/ρDC)1/2 (see *, Table 2.A1). Here, A0 is the diastolic cross-sectional
area, deϐined A0= 0.25 pi diameter
2 and ρ blood density, assumed 1050 kg/m3.
In total, six studies reported cfPWV, four studies reported baPWV and ϐive
studies reported aortic distensibility or compliance as arterial stiffness outcome,
respectively (Table 2.1). Although pulse pressure was included in our search
strategy, we did not include these results in our analysis to avoid it being inter-
preted as arterial stiffness measure.
2.3.6 Outcome of interest and statistical analysis
For each study, we extracted average primary outcomes measures per treatment
arm. The outcomes were analysed for homogeneity via statistical analyses. Data
were visualised using scatter plots, whereas weighted Pearson’s correlation coefϐi-
cients and linear regression coefϐicients were calculated to explore between-study
associations between changes in PWV and SBP, LVMI and SBP, and LVMI and PWV,
respectively.
To internally validate our ϐindings, we performed a sensitivity analysis of the
correlation and regression parameters by repeating the statistical analyses after
omission of studies not speciϐically reporting the effect of antihypertensive med-
ication. Additionally, we repeated the statistical analyses using only the data
from RCTs. A p-value < 0.05 was considered statistically signiϐicant. All statistical
analyses were performed using SPSS version 24 (IBM Corp, Armonk, NY, USA).
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2.4 Results
2.4.1 Study selection
Using our search strategy, we identiϐied 386 potentially relevant articles from
PubMed (n=221), EMBASE (n=1), Cochrane (n=50) andWeb of Science (n=114).
A ϐlow diagram of the study selection process is shown in Fig. 2.1. Eventually, 23
articles with a total of 2573 subjects met the inclusion- and eligibility criteria and
were included in this systematic review.
2.4.2 Risk of bias
The quality of the different included studies varied. For RCT-studies (Table A1),
the domains ‘allocation concealment’, ‘blinding of participants and personnel’
and ‘blinding of outcome assessment’ constitute a plausible risk of bias for most
studies, which negatively inϐluenced the outcome for these individual studies, and
could lead to high risks of performance bias. On the other hand, most studies
demonstrated adequate ‘sequence generation’, ‘follow-up of patients’ and ‘sim-
ilarity of therapies’. In addition, low chance of publication bias was indicated,
via adequate exclusion of ‘undesirable inϐluences of sponsors’ and ‘selective-free
outcome reporting’.
For cohort studies (Table A2), the domains ‘selection’, ‘comparability’ and ‘ex-
posure’ were adequate indicating low risk of bias. Two studies [33, 40] constituted
overall a signiϐicantly higher risk of bias, and therefore, extra attention is needed
when interpreting those results.
2.4.3 Study characteristics
The characteristics of included studies are summarised in Table 2.2 and Table 2.3 .
Fourteen studies were qualiϐied as RCTs, while the other nine were prospective
observational cohort studies. The follow-up period ranged from three months to
4.8 years for all English-written studies. The number of participants ranged from
n=20 to n=873. Mainly, essential hypertensive patients with or without cardiac
and/or vascular alterations were included in studies in single-centre tertiary care
centres in European and East Asian countries. The main exclusion criteria were
cerebrovascular- and/or renal disorders.
The majority of the trials used antihypertensive drugs, such as angiotensin
II receptor blockers (ARBs), angiotensin converting enzyme inhibitors (ACEIs),
calcium channel blockers (CCBs), diuretics, and beta-blockers (BBs), while other
trials examined the effects of either weight loss, physical training, surgery, treat-
ment with agalsidase beta or high doses of allopurinol. Outcome measures in-
cluded changes in vascular stiffness, pulse pressure, LVM and LV diastolic function
parameters, and correlations between those variables.
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2.4.4 Studies with vascular and ventricular outcome variables
A total of 13 studies reported values on changes in SBP, PWV and LVMI after
intervention (Fig. 2.2).
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Figure 2.2: Effect of intervention onmean changes in systolic blood pressure (∆SBP), pulse
wave velocity (∆PWV) and left ventricular mass index (∆LVMI). Studies are
listed according to magnitude of ∆PWV, from largest (top-left) to smallest
(bottom-right). Ten of the thirteen studies had antihypertensive medication as
intervention (circles, triangles), while three (squares) had other interventions,
as indicated. Symbols indicate treatment arms (i.e. closed circle= arm 1, open
circle= arm 2, triangle= arm 3). Abbreviations: ACEI: angiotensin converting
enzyme inhibitor, ARB: angiotensin-receptor blockers, BB: beta-blockers, CCB:
calcium channel blockers. *No quantitative change in SBP reported but narrat-
ively reported as ‘(Central) systolic blood pressure and pulse pressure were not
reduced,…’.
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The remaining 10 studies, reporting only one or two of the outcome variables,
are not displayed in Fig. 2.2 (data given in Table 2.A1). At study level, changes
in SBP seemingly correlated with reductions in both PWV and LVMI. Ripley et al.
[32] reported no substantial differences between the change in SBP, PWV and
LVMI among treatment arms (Fig. 2.2). Conversely, three studies [1, 38, 41] re-
ported considerably different PWV reductions within treatment arms, despite a
similar reduction in SBP. Takami and Saito [38] consisted of two treatment arms
comparing two types of ARB, CCB combination treatment, whereas Anan et al. [1]
consisted of three treatment arms comparing between ARB and ACEI treatment
as well as ARB, ACEI combination treatment. Tomiyama et al. [41] consisted of
an ARB treatment arm and a CCB treatment arm, respectively. Furthermore, in
studies consisting of two or more treatment arms it appeared that the study arm
with the highest reduction in PWV and SBP, consistently corresponded to the
treatment arm with the highest reduction in LVMI.
2.4.5 Blood pressure in relation to vascular- and ventricular
changes
Table 2.4 shows changes in PWV and LVMI stratiϐied by mean changes (∆) in SBP
and DBP, deϐined by pressure ranges∆DBP≥ –7 mmHg versus∆DBP < –7mmHg,
and∆SBP ≥ –13 mmHg versus∆SBP < –13 mmHg, respectively. The choice of
the pressure ranges was based on twice the intra-session standard deviation for
DBP and SBP, as reported earlier [36]. We found that greater reductions in blood
pressure (both SBP as DBP) were indicative for greater PWV reductions, whereas
for LVMI reductions this pattern only appear to hold for greater DBP-changes
(Table 2.4).
Table 2.4: Blood pressure changes and associated changes in arterial stiffness and ventricu-
lar mass index.
BP change [mmHg] ∆ PWV [m/s] ∆ LVMI [g/m2]
∆ DBP≥–7 –0.9 (–3.2, –0.14) –7.3 (–22, –2.8)
∆ DBP < –7 –2.0 (–3.7, –0.6) –11.0 (–35, –3.9)
∆ SBP≥–13 –0.8 (–2.4, –0.14) –13.0 (–24,+4.5)
∆ SBP < 13 –2.0 (–3.7, –0.7) –8.0 (–35, –2.8)
Changes are presented as median (minimum, maximum). Abbreviations: ∆DBP and∆SBP
denote changes in diastolic and systolic blood pressure, whereas∆LVMI and∆PWV denote
changes in left ventricular mass index and pulse wave velocity, respectively.
2.4.6 Pooling of data and correlations between SBP, PWV
and LVMI within studies reporting all three variables
We pooled and plotted∆SBP,∆PWV and∆LVMI data to explore potential associ-
ations among these outcome measures (Fig. 2.3).
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Figure 2.3: Scatter plots of mean changes in left ventricular mass index (∆LVMI), pulse
wave velocity (∆PWV), and systolic blood pressure (∆SBP). Studies with two
or more treatment arms were plotted as separate data points. Markers indicate
treatment type, i.e. the prescribed antihypertensive drug class or combination
of classes, respectively. Abbreviations: ACEI: Angiotensin converting enzyme
inhibitor, ARB: Angiotensin-receptor blockers, BB: beta-blockers, CCB: Calcium-
channel blockers. Symbols: r: Pearson correlation coefϐicient. p: statistical
signiϐicance level.
Regarding SBP, the proportion in reduction did not correlate signiϐicantly to
the proportion in reductions of the other two outcome measures (i.e.∆PWV vs.
∆SBP: r=0.23, p=0.29;∆LVMI vs. ∆SBP: r=–0.05, p=0.81). However, we found a
signiϐicant positive correlation between changes in∆PWV and∆LVMI (Fig. 2.3,
r=0.61, p=0.003). Furthermore, linear regression of ∆PWV on ∆LVMI sugges-
ted a 6.9 g/m2 decrease in LVMI per 1 m/s decrease in PWV (95%CI=[1.9;11.8]
g/m2/m/s).
The analyses were repeated following omission of the non-antihypertensive
treatment studies [2, 8, 19, 25]. Brieϐly, this caused only minor changes in the
correlation and regression parameters (r=0.57, p=0.013, and B=6.5 g/m2/m/s,
95%CI=[1.6;11.4] g/m2/m/s, respectively). Similarly, we found minor changes
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in the correlation and regression parameters when using only data from RCTs
(r=0.62, p=0.010, and B=6.6 g/m2/m/s, 95%CI=[1.9;11.4] g/m2/m/s). Given the
limited amount of data points available for regression analysis (Fig. 2.3), we chose
not to evaluate quadratic instead of linear associations, since this would result in
overϐitting. We explored possible mutual relationships between types of∆PWV
(i.e. as assessed by cfPWV, baPWV and aoPWV) with both∆SBP and∆LVMI (Fig.
A1).
Our analysis did not demonstrate statistically signiϐicant associations. Never-
theless, in particular∆baPWV and∆aoPWV, but not∆cfPWV, showed trendswith
∆LVMI (r=0.62, p=0.10; r=0.83, p=0.08; r=0.26, p=0.54, respectively). Further-
more,∆cfPWV and∆aoPWV, but not∆baPWV showed trends with∆SBP (r=0.59,
p=0.07; r=–0.85, p=0.07; r=0.14, p=0.74, respectively), indicating that a larger
power (in future studies) might possibly lead to signiϐicant correlations. In the
above analyses a limited amount of data points was available (Fig. A1).
2.5 Discussion
2.5.1 Key findings
Our systematic review of well-controlled clinical intervention studies provides
evidence that a decrease in arterial stiffness could contribute to the reduction of
LVM in (hypertensive) patients. However, we could not obtain convincing evidence
supporting the causative pathophysiological [arterial stiffening— elevated SBP
— LV hypertrophy/ failure]-chain.
A major complication is that arterial stiffness measurements such as PWV are
inherently blood pressure-dependent [36, 37]. In the present review, we found
studies showing a signiϐicant decrease in PWV in excess of ≈0.5 m/s, which is
typically the measurement variability order of magnitude, and in excess of 1
m/s, which our group identiϐied as the change in PWV expected for a change
in diastolic blood pressure of 10 mmHg [36]. As such, some of the observed
signiϐicant changes in PWVmay partially or fully be attributable to a change in
blood pressure, without a change in intrinsic arterial stiffness.
We did not ϐind a study thatwas appropriately designed to disentangle pressure-
independent arterial stiffness effects from plain blood pressure lowering, nor are
we aware of a study that extensively described SBP, PWV and LVMI changes over
many time-points. We expect that changes in PWV precede changes in LV mass.
There were several studies included reporting arterial stiffness and ventricular
structure at multiple time-points [8, 19, 38, 41]. However, only data from Collin
et al. [8] suggested that a change in PWV could precede a change in LV mass.
Despite the present analysis, therefore, it remains cumbersome to assess the
direct effect of antihypertensive treatment on LV structure and function as well
as test the hypothesised causal relation between increased arterial stiffness and
LVH.
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2.5.2 Clinical implications and future work
Our results indicate a signiϐicant positive correlation between changes in arterial
stiffness and LVM. Only two of the 23 included studies [22, 38] reported changes
in LV diastolic function indices (i.e. the outcome variables E/A and E/e’, respec-
tively). Those studies found independent statistical associations between on the
one hand reductions in PWV and pulse wave reϐlection magnitude (assessed by
means of augmentation index), and on the other hand improvements in LV di-
astolic function (via LVMI reduction and improvements in E/A and E/e’, Table
2.A1). Takami and Saito [38] hypothesised that the mechanism involved could be
a delay in arrival of the reϐlected pulse wave due to decreased PWV, which in turn
reduces left ventricular afterload [38]. However, it should be noted that using
augmentation index as proxy for wave reϐlection magnitude is deemed conten-
tious by some researchers in the ϐield [3, 17]. Hashimoto et al. [14] reported a
positive correlation between changes in LVM and reϐlection magnitude, calculated
using a ‘gold standard’ method of assessing pulse wave reϐlections (i.e. based on
solving the physical laws of mass conservation and momentum balance [47]. The
authors reported that reducing stiffness of peripheral muscular arteries, which
they considered to be the root cause of increased pulse wave reϐlection, was more
important than reducing central arterial stiffness, in the regression of LVM [14].
Tomiyama et al. [41] reported that candesartan leads to signiϐicantly greater re-
ductions in stiffness of muscular arteries (i.e. assessed by brachial-ankle PWV),
as compared to amlodipine [41], with similar decreases in LVMI of 7 g/m2 and 6
g/m2, respectively.
In summary, our results suggest that therapeutic agents that aim to lower
arterial stiffness may lead to greater reductions in LVM. However, further clinical
trials withmultiple follow-upmeasurements, using pressure-independent arterial
stiffness indices, are required to establish the causative role of arterial stiffness-
lowering in reduction of LVM. To achieve the latter, a stiffness index such as CAVI0
could be a promising candidate [37]. Additionally, directing more attention to
pulse wave reϐlection indices may further advance insight into LVM reduction
[14, 38]. Of particular interest are (lifestyle or surgical) interventions improving
physical activity and diet, since these kinds of trials provided promising results in
terms of arterial stiffness and LV diastolic function improvements [2, 8, 19, 25, 31],
without invoking per se the effects of direct actions of antihypertensive drugs on
the cardiovascular system.
2.5.3 Limitations
Our review is limited by its reliance on published data causing an inherent risk of
publication bias, as neutral studies (without changes in LVMI or PWV) are less
likely to be accepted by publishers.
A general conclusion about the effect size of lowering blood pressure and arteri-
al stiffness on LVH is difϐicult, since the quality of the studies was variable (quality
rating between 2 and 8 points out of 10 for RCTs and between 5 and 9 points
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for cohort studies, Table A1 and A2). Most studies quantiϐied arterial stiffness
using carotid-femoral PWV or brachial-ankle PWV (i.e. calculated using pulse
transit time and path length). For studies reporting either a change in compliance
or distensibility, we were limited to calculating an estimate of PWV using the
Bramwell-Hill equation. Regional (i.e. carotid-femoral and brachial-ankle) PWV
values are physically different compared to single-point (i.e. aortic) PWV values,
calculated using the Bramwell-Hill equation. However, previous work includ-
ing patient studies [10, 16] and mechanistic computational studies [48] showed
reasonable proportionality between regional PWV and single-point PWV. Also,
the study of Chow and Rabkin [7] showed appropriate proportionality between
baPWV and cfPWV. Therefore, we believe that pooling of changes in cfPWV, baPWV,
and aoPWV can be justiϐied. We, however, cannot exclude that pooling the various
methodologies of PWV assessment inϐluenced the associations we found.
Furthermore, considering the heterogeneity in antihypertensive treatment
and the limited number of studies included, we have not been able to conduct
antihypertensive drug class speciϐic analyses. Lack of correlation between changes
in SBP and LVMI could be related to the fact that most studies included in this
review performed ofϐice BP measurements instead of 24-hour ambulatory BP
measurements. Ofϐice blood pressure measurements contain more variable SBP
readings, e.g. due to inter-individual differences in white-coat effect. Previously, it
was reported that in hypertensive children 24-hour SBP relates with LVMI, but
not with ofϐice SBP [35].
Lastly, minor limitations of this review include our language restriction for
only English written articles, and our inclusion of non-RCT studies, which in the
hierarchy of evidence are inferior to RCT studies.
2.6 Conclusions
This systematic review demonstrates that there is evidence in well-controlled
clinical intervention studies that a decrease in arterial stiffness is associated with
reduction of LV mass. To eliminate blood pressure-dependent effects for the cor-
relation between arterial stiffness and LV structure, blood pressure-independent
markers should be used in future studies. In that way, better identiϐication of
potential targets for antihypertensive drug treatment may be facilitated. In addi-
tion, the potential of lifestyle interventions (e.g. physical activity and diet) in the
research ϐield remains to be emphasised.
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Figure A1: Top: Scatter plots displaying the relation between changes in left ventricular
mass index (∆LVMI), and changes in carotid-femoral, brachial-ankle, and aor-
tic pulse wave velocity (∆cfPWV, ∆baPWV, ∆aoPWV, respectively). Bottom:
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statistical signiϐicance level.
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Chapter 3
3.1 Abstract
We developed a whole-circulation computational model by integrating a transmis-
sion line (TL) model describing vascular wave transmission into the established
CircAdapt platform of whole-heart mechanics. In the present paper, we verify the
numerical framework of our TL model by benchmark comparison to a previously
validated pulse wave propagation (PWP) model. Additionally, we showcase the
integrated CircAdapt–TL model, which now includes the heart as well as extensive
arterial and venous trees with terminal impedances. We present CircAdapt–TL
haemodynamics simulations of 1) a systemic normotensive situation and 2) a
systemic hypertensive situation.
In the TL–PWP benchmark comparison we found good agreement regarding
pressure and ϐlow waveforms (relative errors≤2.9% for pressure, and≤5.6% for
ϐlow). CircAdapt–TL simulations reproduced the typically observed haemodynam-
ic changes with hypertension, expressed by increases in mean and pulsatile blood
pressures, and increased arterial pulse wave velocity. We observed a change in
the timing of pressure augmentation (deϐined as a late-systolic boost in aortic
pressure) from occurring after time of peak systolic pressure in the normotensive
situation, to occurring prior to time of peak pressure in the hypertensive situation.
The pressure augmentation could not be observed when the systemic circulation
was lumped into a (non-linear) three-element windkessel model, instead of using
our TL model. Wave intensity analysis at the proximal aorta indicated earlier
arrival and increased intensity of reϐlected waves with hypertension as compared
to normotension, in good qualitative agreement with ϐindings in patients.
In conclusion, we successfully embedded a TL model as a vascular module into
the CircAdapt platform. The integrated CircAdapt–TL model allows mechanistic
studies on heart-vessel interaction.
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3.2 Introduction
TčĊ CircAdapt platform, a zero-dimensional whole-heart model developed inour lab, historically focussed on cardiacmechanics. It has been successfullyused for simulating haemodynamics during cardiac conductance disorders,
valve pathologies, and changes in afterload [23, 26, 34, 43]. Lacking a distributed
model of the vascular system, the current CircAdaptmodel is yet unable to simulate
heart-vessel interaction at the level of arterial wave dynamics.
Arterial pulse waves, constituting a component of ventricular afterload, ap-
pear to have implications in age-related changes in left ventricular mass, and
left ventricular hypertrophy [12, 29]. So-called wave intensity analysis (WIA)
allows characterisation of both pulse wave magnitude and propagation direction,
thereby requiring synchronous and co-localised measurements of blood pressure
and blood ϐlow velocity signals [35]. WIA applied to patient measurement data
is sensitive to synchronisation errors and the signal processing characteristics
of the measurement devices [37], which hampers or limits detailed studies on
heart-vessel interaction, especially concerning causal relationships.
Computational models of whole-circulation mechanics, such as CircAdapt, al-
low for well-controlled simulations, facilitating comprehensive study of single-
and multi-factorial relationships between arterial system properties and cardiac
structure and function. In the present study we introduce and demonstrate the
CircAdapt–TL model (Fig. 3.1): a whole-circulation model with an integrated seg-
mental transmission line (TL) module, describing vascular wave propagation,
reϐlection and transmission. We verify the numerical implementation of the TL
model by a benchmark comparison of the model to the established pulse wave
propagation (PWP) model of Kroon et al. [21]. Additionally, we demonstrate op-
eration and output of the integrated CircAdapt–TL model, by simulating systemic
normotensive- and hypertensive conditions. We evaluate the implications of mod-
elling vascular wave transmission on aortic haemodynamics by comparing simu-
lated left ventricular- and aortic pressure tracings of the integrated CircAdapt–TL
model with the tracings obtained with the systemic circulation lumped into the
existing CircAdapt non-linear three-element windkessel (3WK) model (i.e. neg-
lecting wave transmission effects). Further evaluation includes WIA applied to
simulated carotid arterial pressure and ϐlow waveforms in semi-quantitative com-
parison with WIA applied to patient measurements.
3.3 Models
3.3.1 Overview of complete model
Our vascular module describing wave transmission in vascular networks will
be integrated into the existing CircAdapt platform (www.circadapt.org). This
model platform has a modular setup, currently consisting of a 0D whole-heart
mechanics model, valve haemodynamics model, and non-linear three-element
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Figure 3.1: The new vascular module interfaces the existing whole heart-heart mechanics
and arterio-venous impedance modules. The CircAdapt–TL model contains the
cardiac modules describing whole-heart mechanics, including interventricular
interactions, and the systemic and pulmonary circulations [25]. Cardiac valves
are modelled as described in Palau-Caballero et al. [34]. The vascular mod-
ule is described in section ‘Vascular module’. The arterio-venous impedance
module, modelling the peripheral circulation using a non-linear three-element
windkessel (3WK) was previously developed by Arts et al. [3]. Abbreviations:
RA: right atrium, LA: left atrium, TV: tricuspid valve, PV: pulmonary valve, AV:
aortic valve, RV: right ventricle, LV: left ventricle, MV: mitral valve, art: arterial,
ven: venous, 3WK: non-linear three-element windkessel model. Symbols: Rp:
peripheral resistance, Zwave: wave impedance, C : compliance.
windkessel models of the pulmonary and peripheral circulations (Fig. 3.1). In the
next section, we introduce the governing equations, modelling assumptions and
implementation of our new vascular module in detail.
3.3.2 New vascular TL–module
To model pressure-ϐlow waves within segments of blood vessels, we assume 1)
blood vessels to be thick-walled, longitudinally constrained non-linear elastic
tubes, 2) blood to be incompressible and Newtonian and 3) that gravity forces
can be neglected. Furthermore, we assume 4) no leakage of blood to small side-
branches that are not explicitly modelled. Application of the laws of balance of
mass and momentum, and subsequent integration over the tube’s cross-sectional
area yield the governing equations [16]:
C
∂ p
∂ t
+
∂ q
∂ z
= 0 , (3.1)
L

∂ q
∂ t
+
∂
∂ z
∫
A
v2z dA

+
∂ p
∂ z
= f , (3.2)
where p = p(z, t) is the pressure at the axial vessel coordinate z, and q = q(z, t) the
ϐlow rate at that coordinate. Furthermore, A denotes cross-sectional lumen area,
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and L and C are the tube inertance and compliance per unit length, respectively.
Term L ∂∂ z
∫
A v
2
z dA represents the convective acceleration term, with vz the axial
blood velocity. Term f represents friction force per unit volume caused by viscous
properties of the blood, deϐined f = 2pir0τw/A0 [6]. Here, symbol τw denotes
wall shear stress, r0 reference radius, and A0 reference cross-sectional lumen area,
respectively. After neglecting the convective acceleration term and assuming an
approximate velocity proϐile to estimate τw [6], the governing equations can be
rewritten to the telegrapher’s equations:
− ∂ q
∂ z
= C
∂ p
∂ t
, (3.3)
− ∂ p
∂ z
= L(α0)
∂ q
∂ t
+ R(α0)q, (3.4)
with L(α0) and R(α0) a characteristic Womersley number-dependent inertance
and resistance term, deϐined by
L(α0) = g(α0)
ρ
A0
, (3.5)
R(α0) = h(α0)
8piη
A20
,with (3.6)
α0 = r0
Æ
ρω0/η . (3.7)
The functions g(α0) and h(α0)were derived by Bessems et al. [6] and are detailed
in Appendix 3.A1.2. The characteristicWomersley number (α0) describes the ratio
of instationary inertia forces and viscous forces, governed by vessel radius (r0),
characteristic angular frequency (ω0 = 2pi/T , with T the cardiac cycle duration),
blood dynamic viscosity (η) and blood density (ρ), respectively (Table 3.1).
Table 3.1: Parameters relevant for the transmission line model.
Symbol Value or expression Unit Meaning Reference
A0, r0 See Table A2 and A3 m
2 or m Reference lumen area or vessel radius [30, 39]
α0 α0 = r0
p
ρω0/η - Characteristic Womersley number [6]
b 0.02 - Collapsible tube fraction Assumed
∆t 0.001 s Time step Assumed
∆z 0.02 m Element size Assumed
lAV 6q
1/3
AV m Characteristic vessel bed length Assumed
k See Tables A2 and A3 - Vessel stiffness coefϐicient [13], Assumed
l See Tables A2 and A3 m Vessel length [30, 39]
η 0.003 Pa s Blood dynamic viscosity [47]
p0,a 105 (REF), 135 (HYP) mmHg Reference pressure for arteries Assumed
p0,v 1.1 (REF), 1.1 (HYP) mmHg Reference pressure for veins Assumed
qAV See Table A2 ml s
–1 Mean ϐlow through terminal tube [11, 14], Assumed
q0 85 ml s
–1 Mean systemic ϐlow [43]
ρ 1050 kg m–3 Blood density [47]
T 0.85 s Cardiac cycle duration [43]
ω0 7.39 rad s
–1 Characteristic angular frequency [6]
REF: Reference simulation. HYP: Hypertension simulation.
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The rationale of this method is to calculate R and L based on an approximated
velocity proϐile forwhich the viscous boundary layer thickness is approximated for
the characteristic frequency [6]. To solve the governing equations, we also need a
constitutive law to relate (changes in) transmural pressure (ptrans) to (changes
in) current cross-sectional area (A). We formulated a non-linear power-law to
phenomenologically capture the experimentally observed non-linear pressure-
area relation of arteries and veins [4, 13]:
ptrans(A) = −pext + p0

(1+ b)

A
A0
1+ k/3−21+b − bA0
A

,
and
C =
dA
dptrans
,
(3.8)
with p0 a reference pressure, A0 a reference cross-sectional area, and k the vessel
stiffness coefϐicient. Furthermore, b is a small fraction to simulate collapse of
the tube with negative transmural pressure (Table 3.1) and pext represents a pre-
scribed external pressure (if present). Now we can solve the resulting governing
equations in either the time domain or frequency domain [10]. We explicitly chose
a time-domain approach, since this permits using non-linear boundary conditions
as already present in the CircAdapt platform [43]. Our solving method uses a TL
model. A detailed overview of our solving method is provided in Appendix 3.A1.1.
3.3.3 Arterio-venous impedance module
The terminal end of a tube was coupled to a non-linear three-element windkes-
sel (3WK) element [3]. We assumed the windkessel compliance to be pressure-
dependent, and scaled by an estimate of the tissues’ vessel bed length [46]. As a
consequence, wave impedance also becomes pressure-dependent (Fig. 3.1):
CAV = lAV
dA
dpAV
and Zwave,AV =
√√ρ
A
dpAV
dA
, (3.9)
with AV, the subscript for the arterial and venous contributions, i.e. AV = [art,ven].
Such approach enables simulating large changes in haemodynamic load (e.g. exer-
cise or hypertension) without requiring to manually adjust the 3WK parameter
values. The derivatives in the aforementioned equations were calculated at the
connection point (i.e. a node) of a tube with a 3WK, using the constitutive relation
as given in Eq. 4.2. The parameter lAV represents the characteristic length of a
peripheral bed. We estimated the vessel bed length using the relation given by
lAV = 6q
1/3
AV , with qAV the mean peripheral ϐlow through any terminal tube. To
obtain ϐirst-order approximations of lAV among all peripheral beds, we utilised
this relation in conjunction with ϐlow distribution estimates as reported in Table
A2. Furthermore, using a physiology textbook [11], we estimated that in rest
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21% of the cardiac output is directed to the head, 47% to the abdomen, 18% to
the pelvis and lower extremities, and 14% to the upper extremities, respectively.
The peripheral resistance (Rp) was deϐined via a ϐlow source, controlled by the
instantaneous arterio-venous pressure difference (Fig. 3.1) [3]:
Rp =
part − pven
qAV
. (3.10)
3.3.4 Cardiac module
The atria and ventricles of the heart were modelled as contractile chambers.
The ventricles are surrounded by three cardiac walls: the left ventricle free wall,
interventricular septum and right ventricle free wall (Fig. 3.1). Ventricles are
mechanically coupled, based on force equilibrium in the junction of the ventricu-
lar walls [25]. The atria are surrounded by the left atrial wall and right atrial wall
(Fig. 3.1). The cardiac chambers are considered as contractile cavities formed by
the one-ϐibre model, relating myoϐibre stress to cavity pressure using the assump-
tion that myoϐibre stress is homogeneously distributed within the myocardial
wall [1]. The phenomenological model of myoϐibre mechanics was previously
described [43]. The one-ϐibre model is used to calculate myoϐibre stress from
myoϐibre strain. Total Cauchy myoϐibre stress experienced by cardiac tissue com-
prises of a summation of active stress, present in the actin ϐilaments and separate
microstructural contributions (i.e. titin and the extracellular matrix, assumed to
act in parallel). Transmural pressure is calculated fromwall tension, derived from
total Cauchy stress and wall curvature using Laplace’s law [43]. Cavity pressures
are calculated by adding the transmural pressures to the pericardial pressure
surrounding themyocardial walls. As commonly used in other cardiac models, the
pericardium was assumed a compliant bag, modelled using a non-linear relation
relating pericardial pressure and volume [19]. The pulmonary circulation was
modelled as 3WK (see Section ‘Arterio-venous impedance module’), connecting
the pulmonary artery with the pulmonary veins [33]. Full details of the cardiac
model can be retrieved fromWalmsley et al. [43] and Lumens et al. [25].
3.3.5 Valve module
Valve ϐlow (qvalve) was generated using the unsteady Bernoulli equation, assuming
incompressibility and inviscid, irrotational ϐlow:
ρlvalve
Avalve
∂ qvalve
∂ t
=∆p− 1
2
ρ qvalve|qvalve|

1
A2valve
− 1
A2p

, (3.11)
with the term on the left hand side the unsteady inertia, governed by blood density,
effective valve length (lvalve) and valve cross-sectional area (Avalve) [34]. The ϐirst
term on the right hand side denotes the pressure difference (∆p) and the second
term is the change in kinetic energy, with Avalve and Ap cross-sectional areas of
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the valve and proximal to the valve, respectively. For Avalve, a phenomenological
valve opening and closing function depending on the pressure gradient was used
[34]. In case∆p > 0, Avalve instantaneously increases towards an effective valve
area representing a completely opened valve. In case∆p < 0, on the other hand,
ϐlow gradually decreases due to inertia. Furthermore, Avalve gradually decreases
towards a quasi-closed state, with small leakage to avoid division by zero [34].
3.3.6 Simulations and analysis
Benchmark comparison
First, we evaluated the TL model’s numerical framework in a benchmark com-
parison, comparing arterial pressure and ϐlow waveforms generated by on the
one hand the TL model and those generated by the PWP model, developed by
Kroon et al. [21]. The numerical framework of this PWP model was previously
validated in Boileau et al. [8] against in vitro experiments, whereas Bessems et al.
[6] conϐirmed the validity of the approximate velocity proϐile against Womers-
ley theory. In the benchmark comparison, we considered large central arteries
(vessel diameters between 15 and 30 mm) as well as smaller arteries of the left
arm (vessel diameters between 2 and 11 mm, Table A2). Furthermore, the same
set of equations (i.e. the balance equations and the constitutive law) was solved
for the PWP- as well as for the TL model. We also kept boundary conditions (i.e.
constitutive law and 3WK parameters) equal between the PWP- and TL model. At
the proximal aorta we prescribed a periodical ϐlow wave (qinflow) with a period of
0.85 s. This ϐlow wave was composed of a half-sinusoidal wave with a duration
(tc) of 0.3 s and a peak ϐlow rate (qp) of 350 ml s
–1, whereas ϐlow was zero in the
rest of the period,
qinflow(t) =
¨
qp sin

pit
tc

if 0≤ t ≤ tc
0 if t > tc .
(3.12)
The PWPmodel used a simpliϐied trapezoidal scheme for spatial discretisation
and a second-order backward difference scheme for time discretisation. For each
tube in the domain, agreement between models in terms of pressure and ϐlow,
was quantiϐied by calculation of root mean square errors (ε) and relative errors
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(δ):
εp,n =
√√√∑Tt=0 (pTL(t)− pPWP(t))2
Nt
, (3.13)
εq,n =
√√√∑Tt=0 (qTL(t)− qPWP(t))2
Nt
,
δp,n =
1
Nt
T∑
t=0
 pTL(t)− pPWP(t)pPWP(t)
 · 100% ,and
δq,n =
1
Nt
T∑
t=0
qTL(t)− qPWP(t)maxn (qPWP(t))
 · 100% ,
with n the tube reference number, T the cardiac cycle duration and Nt the number
of time points for which a comparison is made. A complete overview of the
benchmark comparison setup is provided in Appendix 3.A2.
Simulation of arterial and venous haemodynamics using the CircAdapt–TL
model
We ϐirst show the applicability of the CircAdapt–TL model in terms of simulation
of pressure and ϐlow waveforms throughout arteries and veins as well as changes
in wave dynamics when simulating systemic hypertension. Furthermore, we
compare LV and aortic pressure tracings of the CircAdapt–TL model with those
obtained when lumping the systemic arterial and venous blood vessels into a
single 3WK. For the ϐirst purpose, we implemented an arterial tree (Fig. 3.2 and
Table A2), for which the morphological and mechanical properties were based
on the work of Reymond et al. [39], and a venous tree (Fig. 3.3 and Table A3),
based on the work of Müller and Toro [30]. Since in the present study we were
not interested in simulating pressure and ϐlow in cerebral and coronary vessels,
we excluded these vessels from our model domain. Vessel stiffness coefϐicients (k)
for the aortic segments as well as arteries of the left and right arm were as used
in the benchmark comparison. Furthermore, for the arteries of the leg (i.e. the
iliac, femoral and tibial arteries), we chose k equal to 30, based on data of Hayashi
et al. [13]. Given the lack of human data on veins, a ϐixed k-value of 10 was chosen
for all veins in the model domain.
We performed the following sets of simulations.
1) Using the CircAdapt–TL model, we performed:
• A reference simulation (REF–TL) in which we model the case of normal
arterial stiffness. For this simulation, we kept reference pressure (p0) at
105 mmHg and vessel stiffness coefϐicient (k) as given in Tables A2 and
A3. According to clinical standards, we characterised arterial stiffness by
calculating the carotid-femoral pulse wave velocity (PWV). We obtained
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PWV by dividing the ϐixed path length between the terminal nodes of the
tubes thatmodelled the carotid artery and femoral artery by the pulse transit
time between these nodes. The pulse transit time was obtained as the foot-
to-foot time difference between the respective pressure waveforms. Foot
detection was performed using the maximum of the 2nd-order derivative of
the pressure waveform.
• A systemic hypertension simulation (HYP–TL), in which we model a hyper-
tensive situation. For this simulation, we increased p0. Such increase in
p0 can physiologically be interpreted as an increase in peripheral resist-
ance. Furthermore, vascular stiffness parameter k of all systemic arteri-
al segments was increased by a factor ∆k. The latter increases the non-
linearity of the pressure-area relation (Eq. 4.2), and models an increase
in material stiffness of the vessel wall. For the HYP simulation, we im-
posed [p0,∆k] = [135 mmHg,+6]. This resulted in a blood pressure ex-
ceeding 140/90mmHg, a situation deϐined as hypertension according to the
European Society of Hypertension/European Society of Cardiology guide-
lines [49].
2) Using the CircAdapt–3WKmodel, we performed
• A reference and hypertension simulation. Now, the systemic circulation was
lumped into a 3WK (REF–3WK and HYP–3WK, see Appendix 3.A3).
For the REF–TL and HYP–TL simulations, we compared pressure and ϐlow wave-
forms for cardiac chambers, central arteries and veins, as well as trans-valvular
ϐlows. Furthermore, haemodynamic indices (i.e. diastolic, systolic blood pressures,
pulse wave velocity) were compared between the REF–TL and HYP–TL simulation.
Systolic and diastolic aortic blood pressures were calculated from the tube that
mimics the ascending aorta (i.e. tube #1, Fig. 3.2). The following analyses were
conducted to assess the implications of using the TL model on aortic haemody-
namics. First, we compared the morphology of pressure tracings of the LV and
aorta obtained using the CircAdapt–TLmodel with those from the CircAdapt–3WK
model. Second, wave intensity analysis was performed in the common carotid
artery. Wave intensity analysis provides an approach to determine the charac-
teristics of the primary wave originating from wave reϐlection, (i.e. termed the
backward compression wave (BCW)) [35]. Wave intensity may be deϐined as the
rate of energy transfer per unit area, often given in units of [Wm–2 s–2] [48]. Wave
intensity is positive (dI+) for a forward running wave, and negative (dI−) for a
backward running wave. Furthermore, net wave intensity (dI) is deϐined as the
sum of backward and forwardwave intensity, respectively. Using the derivedwave
intensity tracings, we qualitatively assessed changes in arrival time and intensity
of the BCW between the normotensive- and hypertensive situations. Finally, we
compared between simulated wave intensity tracings and those obtained in pa-
tients. Details regarding derivation of dI+, dI−, and dI are provided in Appendix
3.A5.
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Numerical implementation
All simulations were performed in MATLAB 2015a (The MathWorks, Natick, MA,
USA) on a standard personal computer running an Intel® Core i7™processor and
8.00 GB RAM. Blood viscosity was kept at 3 · 10−3 Pa s, blood density was kept
at 1050 kg m–3, and collapsible tube fraction b was kept at 0.02 (Table 3.1). We
chose a time step (∆t) of 1 ms. Furthermore, for the simulations performed using
the CircAdapt–TLmodel, we chose an element size (i.e.∆z, indicating the distance
between nodes) of 0.02 m. This value was chosen as a trade-off between on the
one hand being able to capture geometric tapering of arterial vessels, and on the
other hand to restrain simulation time. For both the benchmark evaluation and
the simulations that were performed using the CircAdapt–TL and CircAdapt–3WK
models, we ensured that numerical convergence was achieved (i.e. negligible
change in pressure and ϐlow waveforms when further decreasing∆t and∆z).
3.4 Results
3.4.1 Benchmark comparison
Agreement between pressure and ϐlow waves of the TL model and PWP model
for ϐive tubes in the model domain is graphically depicted in Fig. 3.4. Root mean
square errors (Eq. 3.13) for pressures and ϐlows for all tubes are given in Table
3.2.
Table 3.2: Benchmark comparison between pressure and ϐlow waveforms of the new trans-
mission line (TL) model and established pulse wave propagation (PWP) model.
tube # 1+2 4 15 19+27 3 16 20 21 22 23 24 26 25
εp [mmHg] 1.62 1.65 1.68 1.62 2.36 1.68 1.68 2.14 2.96 3.96 3.68 4.03 4.05
εq [ml s
–1] 2.53 21.20 4.41 5.71 3.02 0.87 1.63 0.32 0.92 0.22 0.48 0.30 0.27
δp [%] 0.8 0.8 0.8 0.9 1.2 0.8 0.8 1.5 1.5 2.7 2.2 2.8 2.9
δq [%] 0.6 5.6 1.1 1.9 4.5 2.2 3.3 2.8 3.5 3.2 3.1 3.7 5.3
Root mean square errors for pressure (εp) and for ϐlow (εq), as well as their
relative errors (δp and δq) describe agreement between both models. Agreement
was calculated for the element located at the centre of the tube.
Between models, we found good agreement in terms of pressure and ϐlow
waveforms for proximal arteries (e.g. aorta, carotid, subclavian and vertebral
arteries), expressed by relative errors δp ≤ 1.5% and δq ≤ 5.6% At the distally
located interosseous artery, the difference between bothmodels slightly increased,
expressed by δp,25 equal to 2.9% and δq,25 equal to 5.3%. Nevertheless, the shape
of the pressure and ϐlow waveforms as well as absolute systolic and diastolic
pressure and ϐlow values were highly similar (Fig. 3.4).
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Figure 3.2: Overview of the complete arterial model domain. Geometrical and mechanical
properties of modelled arteries are given in Table A2. Panels display pressure
and ϐlow waveforms for three regions (i.e. central, arm and leg, indicated using
symbol and colour coding). Grey curves display left ventricular (LV) pressures
and volumes, left atrial (LA) pressures and volumes as well as aortic valve ϐlow.
Line type indicates the distance from the heart within a region; proximal: solid
line, intermediate: dash-dotted line, distal: dotted line, respectively. Arrows
indicate the direction of mean blood ϐlow. Aortic valve closure is indicated by
the vertical blue dashed lines.
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Figure 3.3: Overview of the complete venous model domain. Geometrical and mechanical
properties of modelled veins are given in Table A3. Panels display pressure and
ϐlow waveforms for three regions; central, arm and leg, indicated using symbol
and colour coding. Line type indicates the distance from the heart within a
region; proximal: solid line, intermediate: dash-dotted line, distal: dotted line,
respectively. Grey curves display right ventricular (RV) pressures and volumes,
right atrial (RA) pressures and volumes. Arrows indicate the direction of mean
blood ϐlow. Aortic valve closure is indicated by the vertical blue dashed lines.
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Figure 3.4: Results of the benchmark comparison. Pressure (p) and ϐlow (q) waveforms
generated by the transmission line (TL) model and 1D pulse wave propagation
model (PWP) model are shown for various locations along the arterial domain.
Agreement between p and qwaveforms is expressed by rootmean square errors
εp and εq , as well as relative errors δp and δq .
3.4.2 Simulation of normotension and hypertension
In Figs 3.2 and 3.3, pressure and ϐlow waveforms in normotension are displayed
for arteries and veins at three regions (i.e. the central-, arm- and leg region).
Arterial pressure waveforms at distal locations are characterised by an increase
in pressure amplitude, as well as a reduction in peak width. The arterial pressure
waveforms at distal locations show a more prominent dicrotic notch compared to
the pressure waves at proximal locations. For veins, a biphasic pressure waveform
can be distinguished, with venous ϐlow and pressure in anti-phase (Fig. 3.3).
In theREF–TL simulation, pulsewave velocity (PWV)was5.5ms–1, representing
a PWV value commonly found in subjects aged <30 years [28]. For the HYP
simulation, pulse wave velocity (PWV) was 8.0 m s–1, representing a PWV value
clinically associated with early aortic stiffening, and commonly found in subjects
aged >50 years [28]. The blood pressure values in the REF–TL simulation were
within the normal range (Table 3.3). As shown in Fig. 3.5, simulating systemic
hypertension (HYP) caused arterial pressure to increase. This resulted in an
increase in left ventricular pressure and left atrial pressure, whereas pulmonary
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artery pressure and pulmonary venous pressure slightly increased (Fig. 3.5). The
HYP–TL simulation showed an increase in systolic blood pressure (psys) from 128
to 193mmHg and an increased diastolic blood pressure (pdia) from75 to 92mmHg
(Table 3.3).
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Table 3.3: Haemodynamic indices in the reference (REF) and hypertensive (HYP) simula-
tions.
Index REF HYP Unit Meaning
psys 128 193 mmHg Systolic pressure in the aorta
pdia 75 92 mmHg Diastolic pressure in the aorta
ppulse 53 101 mmHg Pulse pressure in the aorta
PWV 5.5 8.0 m s–1 Carotid–femoral pulse wave velocity
Fig. 3.6 shows LV and ascending aortic pressure tracings obtained using the
CircAdapt–3WK model and the CircAdapt–TL model, respectively. The aortic
pressure tracings of the REF–TL and HYP–TL simulation showed pressure aug-
mentation (i.e. a systolic pressure boost) as well as an dicrotic notch, whereas for
CircAdapt–3WKmodel simulations, these waveform characteristics were absent.
In the REF–TL simulation, systolic pressure augmentation occurred after time of
peak systolic pressure, whereas in the HYP–TL simulation this occurred prior to
the time of peak systolic pressure.
Wave intensity tracings (dI+, dI−, and dI , respectively) of the REF–TL and
HYP–TL simulation were calculated for the left common carotid artery (Fig. 3.7A).
The carotid arterial wave intensity tracings of the REF–TL simulation indicate a
forward compression wave (FCW) followed by a backward compression wave
(BCW). At end-systole, there is a forward expansion wave (FEW) associated with
the deceleration of the rate of myocardial contraction [36]. In the REF–TL simula-
tion, the onset of the BCW occurred 38 ms after onset of left ventricular ejection,
whereas for the HYP–TL simulation the delay was 28 ms (Fig. 3.7A). Peak wave in-
tensity of the BCWwas approximately equal for the HYP–TL simulation (4.19·105
W m–2 s–2) as compared to the REF–TL simulation (4.23 ·105 W m–2 s–2) (Fig.
3.7A). Overall, the pattern of the simulated wave intensity tracings was similar
to measured carotid arterial wave intensity tracings as reported by Hughes et al.
[15] (Fig. 3.7B).
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3.5 Discussion
We integrated a transmission line (TL) model into the existing CircAdapt platform
of whole-heart mechanics. The resulting benchmarked CircAdapt–TL model now
also describes vascular wave transmission. The presented model and simulation/
validation results bring the following innovative steps forward. First, our model
platform allows for computationally efϐicient simulation of cardiac mechanics and
vascular haemodynamics. CircAdapt–TL, as implemented in MATLAB, simulates
a single cardiac cycle in 6 s, whereas the CircAdapt–3WK model requires 4 s
but does not model wave transmission. We consider our TL implementation of a
distributedmodelwell-justiϐied based on the acceptable increase in computational
time. Second, the modular structure of CircAdapt–TL renders it easy to change
the model domain (e.g. through user-deϐined assembly of network connections of
the various modules). This versatility comes at hand when handling the model
in a non-engineering environment, for example in a classroom of cardiologists
in training. Third, the coupling of the extension of CircAdapt heart [25] with
our framework to capture large vessels, in conjunction with modest increase
in computational demand, facilitates extensive uncertainty quantiϐication and
sensitivity analysis of detailed haemodynamics mechanisms.
The ϐield of distributed modelling of vascular wave transmission considers
continuous pulse wave propagation (PWP) models that compute pressure and
ϐlow using numerical techniques such as ϐinite differences or the method of char-
acteristics [42], and models that use transmission line (TL) theory based on the
telegraph equations [18, 20, 47]. We chose the TL model for its reduced com-
putational cost as compared to models using the method of characteristics, its
capability of operating in the time-domain, and its compatibility with the existing
CircAdapt model [20, 43].
The validity of our TL model’s numerical implementation was assessed by com-
paring pressure and ϐlow waveforms generated with the TL model with those
generated by the validated model of Kroon et al. [21]. For adequate comparison,
an exact same model domain ranging from the large central arteries towards the
smaller arteries of the left arm was chosen. Moreover, for both models boundary
conditions deϐining proximal inϐlow, vessel wall mechanics, and outϐlow condi-
tions were kept identical. Remaining differences in pressure and ϐlow waveforms
between bothmodelsmay be attributed to the fact that in deriving the propagation
constant, our TL model neglects the higher order terms to render the attenuation
constant frequency-independent (Appendix 3.A1.2). This assumption is justi-
ϐied for high frequencies, but may become questionable for low frequencies. For
the PWP model of Kroon et al. [21], such assumption was not made, since the
attenuation in that model is incorporated by wall shear stress [21].
For the CircAdapt–TL model, pressure and ϐlow waveforms of the arteries
showed physiologically realistic behaviour in both time and position along the
modelled domain. The morphology of arterial pressure waveforms of the aorta
towards the radial and ulnar arteries resemble pressure waveforms measured
during pressure catheter withdrawal from the aorta to the radial artery in man
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[38]. Venous pressure and ϐlow waveform morphologies were similar to the ones
obtained in the computational model study of Müller and Toro [30]. We found a
similar venous pressure pulsatility (i.e. the maximum–minimum difference in ve-
nous pressure) as these investigations reported (i.e. between 1.2 and 2.3 mmHg in
the central veins and between 0.9 and 3.9 mmHg in veins of the arm, respectively).
In the reference (REF–TL) simulation, systolic and diastolic pressure in the aorta
as well as pulse wave velocity were within normal ranges. In the hypertension
(HYP–TL) simulation, blood pressure clearly increased indicated by the aortic
systolic and diastolic pressures of 193 and 92mmHg. The pulse pressure increase
in the systemic hypertension simulation to 101 mmHg is considered high given
the moderate increase in pulse wave velocity to 8.0 m s–1 [28]. In our model, such
large increase in pulse pressure could be caused by the fact that we did not incor-
porate the dilatation of arteries caused by vascular remodelling in hypertension
[17, 28].
For the hypertension simulation, wave intensity analysis revealed earlier arrival
of a backward compression wave (Fig. 3.7A), consistent with human measure-
ments [24]. The simulated ascending aortic blood pressure waveform changed
from a type Cwaveform in the REF–TL simulation, most often seen in young adults
under 30 years of age, to a type A waveform in the HYP–TL simulation, most
often seen in subjects aged 40 to 65 years [31]. Although the classiϐication of
pressure waveforms according to systolic pressure augmentation may appear
subtle, the clinical-epidemiological ϐield assesses indices derived from systolic
pressure augmentation for cardiovascular risk stratiϐication [45, 32]. Simulated
carotid arterial wave intensity tracings appeared similar to illustrative examples of
measured tracings (Fig. 3.7B). In the HYP–TL simulation, a so-called mid-systolic
forward expansion wave was present, similar to patient case 1 (around t=0.2 s)
as described in [15]. Though this illustrates the level of detail possible in model-
based haemodynamic studies, the mechanistic interpretation of e.g. a mid-systolic
forward expansion wave is beyond the scope of this method paper.
With lumping the systemic vessels into a 3WK, the aortic pressure tracings lost
the typical dynamics around the dicrotic notch, which were present in the REF–TL
and HYP–TL simulations. Moreover, the (early) systolic pressure augmentation in
the LV and aortic pressure tracings was absent for the pressure tracings of the
REF–3WK and HYP–3WK simulation (Fig. 3.6). Given the interest in parameters
such as systolic pressure augmentation, we believe that using distributed models
like ours, for studies on heart-vessel interaction, may be preferable over using
3WKmodels. However, future experimental studies and clinical comparisons are
needed to appraise the added value of distributed models over 3WKmodels in
testing heart-vessel interaction hypotheses.
3.5.1 Limitations
A simpliϐication in the TL model is that convective acceleration is neglected. How-
ever, the inϐluence of convective acceleration on arterial pressures and ϐlows is
believed to be small [41]. Moreover, it was found that inclusion of convective
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acceleration in an arterial model domain, similar to the one used in the present
study, changed pressure and ϐlow waveforms in the various arteries only slightly
(i.e. a root mean square error of 1.3 mmHg for thoracic aortic pressure waveform
and 11.3 ml s–1 for thoracic aortic ϐlow waveform, respectively [39]). We expect,
however, that the effect of convective acceleration will be more important when
simulating exercise conditions. Therefore, in such studies the modelling error
related to convective acceleration needs to be properly considered.
By excluding cerebral and coronary vessels from our model domain, we neglect
the presumed inϐluence that wave reϐlections and re-reϐlections from head and
neck vessels or vessels in the myocardiummay have on observed ascending aortic
and carotid waveforms [39, 44].
Our model neither contains a skeletal-muscle pumpmodel nor does it incorpor-
ate venous valves. Hence, the present vascular model will not account for these
functional aspects with postural changes. For studies with emphasis on venous
haemodynamics, the CircAdapt platform allows for a straightforward implemen-
tation of venous valves, using for instance the existing valve module as a starting
point.
Like all distributed models of 1D wave transmission, our model cannot capture
the complex pressure losses or local wall shear stresses when applied to disease
conditions (e.g. stenosis or aneurysm). This requires either use of calibrated
loss models or coupling of detailed 3D models of stenoses and aneurysms to 1D
models, respectively [5, 7].
Reymond et al. [40] reported for the case of an apparently healthy aorta, that
pressure and ϐlow waveforms from a 3D computational ϐluid dynamics model
and from a 1D PWP model are highly similar. The latter ϐinding supports our
notion that, in general, distributed models of wave transmission are well suited to
examine and quantify heart-vessel interaction at the level of pressure and ϐlow
waveform characteristics.
3.5.2 Perspectives
The utility of the CircAdapt–TL model should be further tested by direct com-
parisons against detailed haemodynamic data from humans. We consider the
concurrent use of in vivo as well as simulated data as most valuable, because both
arms bring complementary assets. The model allows error free assessment of
phase relationships between signals and in vivo data enables characterisation of
biological and pathological variability.
In the future, we aim to further extend the CircAdapt–TLmodel with the cardiac
adaptation module of Arts et al. [2]. This module contains a homeostatic control
loop that senses offsets in mechanical load (e.g. as present in chronic hyperten-
sion), and in response, imposes geometrical (i.e. cavity volume and wall volume)
adaptation of the heart. We believe that modelling cardiac adaptation is vital in
assessing candidate haemodynamic indices.
Key clinical studies in this ϐield include that of Hashimoto et al. [12]. They
found a positive association between left ventricular mass, and wave reϐlection
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magnitude derived from pressure and ϐlow velocity measurements, following
antihypertensive treatment in left ventricular hypertrophy patients. However, a
limitation of such clinical studies is that for non-invasive acquisition, pressure
signals are obtained at distal measurement sites (e.g. at the radial artery) and
therefore require a transfer function to obtain an estimate of the aortic pressure
signal. Moreover, for clinically-gathered data, correct synchronisation of pressure
and ϐlow velocity signals is crucial, because only a small (e.g. 5 ms) misalignment
can cause substantial changes in derived wave (intensity) quantities [35].
3.6 Conclusions
We validated and incorporated a one-dimensional vascular module into the Circ-
Adapt platform. The resulting CircAdapt–TL model enables fast simulation of
whole-heart mechanics, pressure and ϐlow waveforms at various locations along
the arterial and venous systems, and allows detailed haemodynamics studies. The
CircAdapt–TL model provides a valuable tool for testing hypotheses concerning
heart-vessel interaction and evaluating existing haemodynamics indices.
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3.A1 Appendix: Vascular module
3.A1.1 Solving strategy
Pressure and ϐlow in a tube constitutes of the summation of a backward (bw) and
a forward (fw) wave component [9]. Therefore, at any location in the tube, it holds
that
p(z, t) = pfw(z − c t) + pbw(z + c t) , (3.A1)
q(z, t) =
pfw(z − c t)
Z
− pbw(z + c t)
Z
,
with Z and c the characteristic Womersley number-dependent wave impedance
and wave speed deϐined Z =
p
L(α0)/C and c = 1/
p
L(α0)C , respectively (Sec-
tion ‘Derivation of the attenuation constant, wave speed and wave impedance’).
Considering the proximal inlet of a tube, we assume a linear relation between
pressure pin = p(0, t) and ϐlow qin = q(0, t), characterised by a zero-ϐlow pressure
ps and an input resistance Zin:
pin = ps + Zinqin . (3.A2)
We derive in Section ‘Derivation of source pressure’ that quantities ps and Zin can
be calculated from pbw and Z using the expressions given by
ps = 2pbw , (3.A3)
Zin = Z . (3.A4)
The proximal load relates pin to qin. Using Eq. 3.A2, pin and qin are calculated. Then,
for further calculations we need to determine the amplitude of reϐlected wave pfw
at the entrance. It holds
pfw =
1
2
ps + Zqin . (3.A5)
A tube, representing a blood vessel with length l, has a proximal and a distal side
(Fig. A1).
l
pprox pdistz
qprox qdist
pfw
pbw
proximal 
inlet
distal 
outlet
z=0 z=l
Figure A1: Overview of wave propagation in a tube segment, directed along the z-axis. See
text for description of symbols.
For each side Eqs. 3.A1 to 3.A5 may be applied with the remark, that ϐlow at
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the distal side is directed outward, implying that the terms with ϐlow qout = q(l, t)
have to change sign. At eachmoment in time, the amplitudes of thewaves entering
on both sides of the tube are calculated according to Eq. 3.A5. This wavewill arrive
with a delay τ later at the opposite ending. As derived by Boucher and Kitsios
[9] and applied by Krus et al. [22], the contribution of wave attenuation due to
friction may be lumped at the proximal and distal sides of the transmission line.
Thus, for the proximal side it holds
pbw,prox = pbw,dist(t −τ)exp(−ζl), with τ= lc . (3.A6)
Symbols ζ and τ represent the attenuation constant and wave delay time, re-
spectively. Attenuation constant ζ is assumed a function of the characteristic
Womersley number (see Section Derivation of the attenuation constant, wave
speed and wave impedance). Since pbw,dist is calculated before, and τ is assumed
to be known, pbw,prox can be calculated. Pressure pfw,dist is to be calculated simil-
arly. When knowing these wave amplitudes, zero-ϐlow pressure ps and an input
resistance Zin can be calculated on both sides of the tube, using Eqs. 3.A3 and
3.A4 and their equivalents at the distal side. Pressures and ϐlows related to wave
propagation are superimposed on DC-components of ϐlow qDC and pressure pDC
[9]. Furthermore, for small blood vessels, the Poiseuille resistance may become
important. For the DC-pressure difference over the tube, related to qDC it holds
∆pDC = qDC
8piηl
A2
. (3.A7)
Flow qDC, derived in the online supplement section ‘Derivation of the DC-ϐlow’, may
vary slowly, practically not inϐluencing the behaviour of the wave. Thus, besides
the wave, a tube may be subject to a (nearly) constant ϐlow qDC, not being subject
to wave attenuation. Since wave impedance Z is known, we may describe the
zero-ϐlow pressures p˜s,prox and p˜s,dist by adding a DC-component to the zero-ϐlow
wave pressures (ps,prox and ps,dist, respectively) as calculated using Eq. 3.A3:
p˜s,prox = ps,prox − qDCZ + ∆pDC2 , (3.A8)
p˜s,dist = ps,dist + qDCZ − ∆pDC2 .
For solving the differential equations, the solution inside is not needed; between
nodes just a phase-delay and damping are imposed. However, if needed, a solution
may be computed using the right- and left-ward traveling waves, attenuation
constant, wave velocity, and position in the segment. Practically, if pressure and
ϐlow waveforms half-way would be required as simulation output, then the tube
of interest may be subdivided into two separate tubes.
Around junctions and bifurcations, we assumed continuity of static pressure
and balance of mass.
66
Circulatory model
3.A1.2 Derivation of the attenuation constant, wave speed
and wave impedance
Previously, Huberts et al. [14] showed that for a time-domain analysis, the mo-
mentum balance equation can be represented by a lumped-parameter model con-
sisting of a characteristicWomersley number-dependent inertance per unit length
(L(α0)) element in series with a characteristic Womersley number-dependent
resistor per unit length (R(α0)) element. We deϐine the characteristic Womersley
number (α0) as α0 = r0
p
ρω0/η, withω0 the characteristic angular frequency,
r0 the reference lumen radius, and constants ρ and η the blood density and blood
dynamic viscosity, respectively. For our time-domain approach, we adopted the
method of Huberts et al. [14]. Expressions for R(α0) and L(α0) are given by
L(α0) =
g(α0)︷ ︸︸ ︷
1
2− cp(α0)

L0 , (3.A9)
R(α0) =
h(α0)︷ ︸︸ ︷
cq(α0)
2− cp(α0)

R0 . (3.A10)
Here, inertance per unit length (L0) and Poiseuille resistance per unit length (R0)
are deϐined L0 = ρ/A0 and R0 = 8piη/A20, respectively. The coefϐicients cp and cq
were derived by Bessems et al. [6]:
cp(α0) =
¨
1+
p
2
α0

1− p22α0

if α0 >
p
2
3
2 if α0 ≤
p
2 ,
(3.A11)
cq(α0) =
(
α0
4
p
2

1− p22α0
−1
if α0 >
p
2
1
2 if α0 ≤
p
2 .
In Fig. A2, g and h are depicted as a function of α0. The ranges chosen for α0, i.e.
[0,
p
2] and [
p
2,∞] render that for the limiting cases of α0 = 0 and α0 →∞,
the friction term coincides with Womersley theory [6].
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 Coefficients for calculating R(α0), L(α0) 
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Figure A2: Coefϐicients g and h as a function of the characteristic Womersley number (α0),
used for calculating the characteristicWomersley number dependent resistance
R(α0) and inertance L(α0), respectively.
Using the expressions for R(α0) and L(α0), attenuation constant ζ is obtained
by calculating propagation constant γ, evaluated for characteristic frequencyω0.
We approximated γ following Matick [27]:
γ= ζ+ jβ = jω
Æ
L(α0)C
√√√
1− jR(α0)
ωL(α0)
(3.A12)
≈ jωÆL(α0)C 1− jR(α0)2ωL(α0) +O

1
ω2

≈ R(α0)
2
p
L(α0)/C
+ jω
Æ
L(α0)C ,
with ζ the attenuation constant per unit length, β the phase constant per unit
length and C the compliance per unit length. The characteristic Womersley
number-dependent wave speed c was calculated using
c =
ω
β
=
1p
L(α0)C
. (3.A13)
Finally, Womersley number-dependent wave impedance was calculated using
Z =
√√ L(α0)
C
. (3.A14)
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3.A1.3 Derivation of source pressure
As previously described, it holds for pressure and ϐlow at any location that
p(z, t) = pfw(z − c t) + pbw(z + c t) , (3.A15)
q(z, t) =
pfw(z − c t)
Z
− pbw(z + c t)
Z
.
Pressure and ϐlow at the proximal side of the tube are given by
pprox = pfw,prox + pbw,prox , (3.A16)
qprox =
pfw,prox
Zprox
− pbw,prox
Zprox
.
If qprox = 0 and pbw,prox is known, then for proximal source pressure ps,prox = pprox
it follows after substitution of Eq. 3.A16:
ps,prox = 2pbw,prox . (3.A17)
For short circuit ϐlow qs,prox = qprox with pprox = 0, it follows after substitution of
Eq. 3.A16:
qs,prox =
2pbw,prox
Zprox
. (3.A18)
The source impedance of the proximal side of the tube is calculated using
Zprox =
ps,prox
qs,prox
= Z . (3.A19)
Finally, the applied equations for the distal side of the tube are given by
ps,dist = 2pfw,dist , (3.A20)
qs,dist =
2pfw,dist
Zdist
,
Zdist =
ps,dist
qs,dist
= Z .
3.A1.4 Derivation of the DC-flow
The DC-ϐlow (qDC), averaged over the tube length, changes due to contribution
of ϐlow waves entering and leaving from the proximal and distal side. In case no
wave enters, the waves inside the tube will disappear completely after wave delay
time τ. Using Eq. 3.A8, reaching of the DC-steady state (i.e. term B of Eq. 3.A21
becoming zero) was approximated by a ϐirst order differential equation with time
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constant equal to τ:
dqDC
d t
=
B︷ ︸︸ ︷ ps,dist − ps,prox
2Z
− qDC

1
τ
. (3.A21)
3.A2 Benchmark comparison between TL and
PWP model
For the benchmark comparison, we implemented a network of tubes describing
the central arteries (i.e. the aorta, carotid artery, and vertebral artery), as well as
the arteries of the left arm (Fig. A3).
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Figure A3: Benchmark comparison of the transmission line (TL) model with the previously
validated 1D pulse wave propagation (PWP)model. We implemented a network
of 13 tubes representing the large central arteries and the arteries of the left arm.
Geometrical and mechanical properties of arterial segments that were used
in the benchmark comparison are given in Table A2. A half-sinusoidal inϐlow
proϐile (qinflow) was prescribed to the ascending aorta. Boundary conditions;
proximal inϐlow, termination of distal vessels using a non-linear three element
winkessel model (3WK), vessel geometry and material properties were kept
the same for the TL model and PWPmodel. Evaluated agreement metrics were
root mean square errors εp and εq , as well as the relative errors δp and δq .
Furthermore, Nt denotes the number of time points for which a comparison was
made. A graphical comparison between pressure and ϐlow waveforms is given
for ϐive tubes (blue circles).
Geometrical andmechanical properties of all tubeswerebasedonReymondet al.
[39], (Table A2). Vessel stiffness coefϐicient (k) for the aortic segments, vertebral
artery and carotid artery was estimated by ϐitting the constitutive law to in vitro
data from Hayashi et al. [13]. For the radial, ulnar and interosseous arteries, stiff-
ness was assumed equal to vertebral artery stiffness. For the subclavian–axillary–
brachial arterial segment, stiffness was taken as the mean of aortic and carotid
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artery stiffness (Table A2). Flow fractions were based on previously published
patient measurements with duplex ultrasound and phase-contrast magnetic res-
onance imaging [14]. For the benchmark comparison, we deϐined a half-sinusoidal
inϐlow proϐile as a proximal inlet boundary condition (qinflow(t)):
qinflow(t) =
¨
qp sin

pit
tc

if 0≤ t ≤ tc
0 if t > tc .
(3.A22)
Distal tubes were terminated using 3WKs. For these simulations, time step (∆t)
was kept at 0.5 ms, duty cycle (tc) at 0.3 s, cardiac cycle duration (T) at 0.85 s,
and peak ϐlow rate (qp) at 350 ml s
–1, resulting in a physiological cardiac output.
Boundary conditionswere kept equal for the TLmodel and PWPmodel. Reference
pressure (p0) was kept at 105 mmHg, external pressure (pext) at 0 mmHg and
outϐlow pressure at 4 mmHg. We chose an element size of 0.01 m. Convergence
of the calculated haemodynamics was evaluated after each simulated cardiac
cycle. Hereto, the calculated nodal pressures, p(t), of the current cycle (icyc)
were compared to those of the previous cycle (icyc − 1). An expression for the
haemodynamics convergence norm (εnorm) is given as a relative root mean square:
εnorm =maxn

√√√√√∑Tt=0 ptn,icyc − ptn,icyc−12∑T
t=0

ptn,icyc−1
2
 , (3.A23)
with n referring to the tube number as given in Table A2. Throughout simulations,
the haemodynamics convergence criterion was kept at 10−2. Agreement between
p and q waveforms, expressed by root mean square errors εp and εq , as well as
relative errors δp and δq , was calculated for the centre element of each tube (Fig.
A3).
3.A2.1 Numerical implementation of the pulse wave
propagation model of Kroon et al. [21]
For the 1D vessels of the PWPmodel, we assumed the same constitutive law as
used for the TLmodel. Moreover for the periphery, we implemented the same non-
linear three-element windkessel as used for the TL model. Coupling and solving
of 1D mass conservation and momentum balance equations (after neglecting the
convective acceleration term) and the 0D equation for pressure and ϐlow in the
periphery was performed using the method previously published by Kroon et al.
[21]. We used a simpliϐied trapezoidal scheme for spatial discretisation. The
second-order backward difference scheme was used for time discretisation.
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3.A3 Simulations performed using the
CircAdapt–3WK model
As described in the main text of this article, we additionally performed reference-
and hypertension simulations using the CircAdapt model with the systemic circu-
lation lumped into the non-linear three-element windkessel model (REF–3WK
and HYP–3WK, respectively). For the REF–3WK simulation, reference pressure
was 105 mmHg and vessel stiffness coefϐicient (k) was kept equal to 8 for the
arterial side and 10 for the venous side, respectively. For the HYP–3WK simulation,
reference pressure was increased to 135 mmHg and the k-value of the systemic
arterial 3WK was set to 14. For both simulations, characteristic vessel bed length
(lAV) was chosen 0.8 m [46].
3.A4 Code availability and calculation loop of the
CircAdapt–TL model
The CircAdapt–TL model source code can be retrieved from https://github.
com/Mheu1991/CircAdaptTL/. Table A1 refers to speciϐic lines of MATLAB-code
providing programmatic logic of the aforementioned relations (i.e. Eq A#) that
were implemented to solve our TL model. Furthermore, Fig. A4 illustrates the
calculation loop in CircAdapt–TL.
Table A1: Index linking mathematical relations of the transmission line model to MATLAB-
scripts and underlying lines of code. Previous publications comprising existing
CircAdapt modules are indicated.
Equation MATLAB-script Line no.
A5 PNodeVDot.m 52
A6 TubeDelays.m 36, 37, 85, 86
A7 TubeV2p.m 51, 52
A8 TubeDelays.m 60 to 63
A9 CalcApproximateVelocityProfile.m 29
A10 CalcApproximateVelocityProfile.m 30
A11 CalcApproximateVelocityProfile.m 27, 28
A12 CalcApproximateVelocityProfile.m 36
A13 CalcApproximateVelocityProfile.m 37
A14 CalcApproximateVelocityProfile.m 38
A21 TubeDelays.m 57 to 59
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ArtVen
ArtVenV2p.m
Sarcomere Multipatch Chamber/TriSeg
Chamber/TriSeg
TriSeg
SarcomereCavity
pCavity.m
Node
pNodeVDot.m
Valve
ValveqDot.m
Update 
derivatives
SarcEf2Sf.m 
PatchWallA2T.m
PatchWallA2T.m ChamberV2p.m 
TriSegV2p.m
TriSegV2p.mCircAdapt.m
SarcEf2Sf.m 
Wall2Patch2Sarc.m
Tube
TubeV2p.m
ChamberV2p.m 
TriSegV2p.m
Wave attenuation
CalcApproximateVelocity.m
Wave delay
TubeDelays.m
Walmsley et al. 2015 PLoS Comput Biol 11(7), e1004284 
Arts et al. 2012 Mech Res 
Comm 11(7), 42:  
Palau-Caballero et al. 2016 
J Am Soc Echocardiography 
29(11):  
Figure A4: Calculation loop of the CircAdapt–TL model.
3.A5 Calculation of wave intensity
The fundamental basis of wave intensity analysis is described in Parker [35].
Brieϐly, at a ϐixed measurement location, waves are considered incremental fronts
for which the sum of successive forward- or backward travelling wavefronts form
the measured pressure- or ϐlow velocity waveform. Wave intensity analysis de-
termines the magnitude and direction of wavefronts from derivatives of local
pressure and ϐlow velocity [35]. Wave intensity (dI) is here calculated using the
time derivatives of pressure (dp/dt) and ϐlow velocity (dU/dt):
dI =
dp
dt
dU
dt
. (3.A24)
Wave intensity is positive when forward travelling waves are dominant, whereas
it is negative when backward travelling waves are dominant. Wave intensity
itself may also be calculated for forward- and backward waves. This requires
separation of the simulated pressure and ϐlow velocity waveforms into their re-
spective forward- and backward components. By assuming balance of mass and
momentum in elastic tubes and neglecting viscous friction, a simple relation
between the time derivatives of pressure and ϐlow velocity is given by [35]
dp
dt
= ρc
dU
dt
, (3.A25)
with c the local pulse wave velocity. Parker [35] showed that the relation as given
in Eq. 3.A25 may be written for forward- and backward components as
dp+
dt
= ρc
dU+
dt
, and (3.A26)
dp−
dt
= −ρc dU−
dt
,
with superscripts ”+”, and ”−” the forward- and backward wave components.
Because we assumed that summation of backward- and forward waves yields the
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measured pressure and ϐlow velocity waveforms, the aforementioned equation
may be expressed as [35]
dp+
dt
=

dp
dt
+ρc
dU
dt

/2 , (3.A27)
dp−
dt
=

dp
dt
−ρc dU
dt

/2 ,
dU+
dt
=

dU
dt
+
dp
dt
/ρc

/2 , and
dU−
dt
=

dU
dt
− dp
dt
/ρc

/2 ,
Using Eq. 3.A24, intensity for forward- and backward waves, and the net pressure
wave is expressed by
dI+ =
dp+
dt
dU+
dt
, (3.A28)
dI− = dp
−
dt
dU−
dt
, and
dI = dI+ + dI− .
For mathematical derivation of Eqs. 3.A27 and 3.A28, we refer to the work of
Parker [35]. It should be noted that whereas Parker [35] calculated wave intensity
based on instantaneous differences in pressure and ϐlow velocity (i.e. dp and dU),
we calculated time derivatives (i.e. dp/dt and dU/dt). As a result, wave intensity
is given in units of [Wm–2 s–2], instead of in [Wm–2].
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3.A6 Description of geometrical and mechanical
parameters of the implemented network of
arteries and veins
Table A2: Geometrical and mechanical properties of arterial segments, based on Reymond
et al. [39]. The italic qAV values represent the terminal ϐlow (here expressed as a
percentage of cardiac output) as used in the benchmark comparison. The italic
tube numbers (e.g. 3) refer to segments that were also used in the benchmark
comparison.
tube name [-] l [m] dprox [mm] ddist [mm] k [-] qAV [%]
1 ascending aorta 1 0.020 29.4 29.3 10
2 ascending aorta 2 0.020 29.3 28.8 10
3 brachiocephalic artery 0.040 20.2 18.0 10 20
4 aortic arch A 0.020 25.1 24.0 10
5 r. subclavian artery 0.040 11.5 9.0 10
6 r. common carotid artery 0.100 13.5 7.0 14
7 r. vertebral artery 0.150 3.7 2.8 16 5
8 r. subcl. B + axill. + brach. 0.430 8.1 4.7 12
9 r. radial artery 0.240 3.7 3.1 12 2.3
10 r. ulnar artery A 0.070 3.7 3.4 16
11 r. interosseous artery 0.080 2.1 1.8 16 0.14
12 r. ulnar artery B 0.180 3.2 2.8 16 2.3
13 r. internal carotid artery 0.180 5.7 4.3 16 6
14 r. external carotid artery 0.050 5.0 4.5 14 2
15 aortic arch B 0.040 21.4 20.8 14
16 l. common carotid artery 0.140 12.0 6.0 10 15
17 l. internal carotid artery 0.180 5.3 4.1 14 6
18 l. external carotid artery 0.050 4.7 4.3 14 2
19 thoracic aorta A 0.060 20.0 18.9 10
20 l. subclavian artery A 0.040 11.0 8.5 12
21 l. vertebral artery 0.150 3.7 2.8 16 5, 5
22 l. subcl. B + axill. + brach. 0.430 8.1 4.7 10
23 l. radial artery 0.240 3.5 2.8 16 2.3, 2
24 l. ulnar artery A 0.070 4.3 4.3 16
25 l. interosseous artery 0.079 1.8 1.8 16 0.14, 2
26 l. ulnar artery B 0.180 4.1 3.7 16 2.3, 2
27 thoracic aorta B 0.110 16.5 12.9 10 54
28 abdominal aorta A 0.060 12.2 12.2 10
29 celiac artery 0.040 7.8 6.9 12
30 hepatic artery 0.070 5.4 4.4 12 3.3
31 gastric artery 0.080 3.2 3.0 12 2.2
32 splenic artery 0.070 4.2 3.9 12 5.2
33 superior mesenteric artery 0.060 7.9 7.1 12 13
75
Chapter 3
34 abdominal aorta B 0.020 11.5 11.8 10
35 l. renal artery 0.040 5.2 5.2 10 10.7
36 abdominal aorta C 0.020 11.8 11.0 10
37 r. renal artery 0.040 5.2 5.2 12 10.7
38 abdominal aorta D 0.110 11.6 7.0 10
39 inferior mesenteric artery 0.050 4.7 3.2 12 1.8
40 abdominal aorta E 0.020 10.8 6.1 10
41 r. common iliac artery 0.060 7.9 4.0 16
42 l. common iliac artery 0.060 7.9 4.0 16
43 l. external iliac artery 0.150 6.4 3.7 16
44 l. internal iliac artery 0.050 4.0 2.8 16 1.5
45 l. femoral artery 0.443 5.2 2.3 30
46 l. deep femoral artery 0.126 4.0 3.7 30 1.5
47 l. posterior tibial artery 0.321 3.1 2.8 30 2.5
48 l. anterior tibial artery 0.343 2.6 2.3 30 2.5
49 r. external iliac artery 0.144 6.4 3.7 30
50 r. internal iliac artery 0.050 4.0 2.8 30 2.5
51 r. femoral artery 0.450 5.2 2.3 30
52 r. deep femoral artery 0.130 4.0 3.7 30 2.1
53 r. posterior tibial artery 0.330 3.1 2.8 30 2.5
54 r. anterior tibial artery 0.350 2.6 2.3 30 2.2
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Table A3: Geometrical and mechanical properties of venous segments, based on Müller
and Toro [30].
tube name [-] l [m] dprox [mm] ddist [mm] k [-]
55 vena cava superior 0.035 16.0 16.0 10
56 r. brachiocephalic vein 0.040 11.3 11.3 10
57 r. internal carotid vein 0.025 5.0 5.0 10
58 r. external carotid vein 0.025 5.0 5.0 10
59 r. subclavian vein A 0.030 11.3 11.3 10
60 r. vertebral vein 0.110 3.2 3.2 10
61 r. subclavian vein B 0.030 10.4 10.4 10
62 r. subclavian vein C 0.270 10.4 10.4 10
63 r. radial vein 0.406 4.0 4.0 10
64 r. ulnar vein A 0.100 4.0 4.0 10
65 r. interosseous vein 0.070 2.0 2.0 10
66 r. ulnar vein B 0.306 4.0 4.0 10
67 l. brachiocephalic vein 0.075 10.9 10.9 10
68 l. internal carotid vein 0.025 5.0 5.0 10
69 l. external carotid vein 0.025 5.0 5.0 10
70 l. subclavian vein A 0.030 11.2 11.2 10
71 l. vertebral vein 0.110 3.2 3.2 10
72 l. subclavian vein B 0.030 10.4 10.4 10
73 l. subclavian vein C 0.270 10.4 10.4 10
74 l. radial vein 0.406 4.0 4.0 10
75 l. ulnar vein A 0.100 4.0 4.0 10
76 l. interosseous vein 0.070 2.0 2.0 10
77 l. ulnar vein B 0.306 4.0 4.0 10
78 vena cava inferior 0.020 15.2 15.2 10
79 celiac vein 0.040 9.8 9.8 10
80 gastric vein 0.068 9.8 9.8 10
81 hepatic vein 0.068 9.8 9.8 10
82 splenic vein 0.068 9.8 9.8 10
83 superior mesenteric vein 0.068 9.8 9.8 10
84 vena cava inferior B 0.015 15.2 15.2 10
85 l. renal vein 0.032 5.0 5.0 10
86 r.renal vein 0.032 5.0 5.0 10
87 vena cava inferior C 0.015 15.2 15.2 10
88 vena cava inferior D 0.125 15.2 15.2 10
89 inferior mesenteric vein 0.060 9.0 9.0 10
90 vena cava inferior E 0.080 15.2 15.2 10
91 r. common iliac vein A 0.038 11.6 11.6 10
92 r. common iliac vein B 0.020 11.6 11.6 10
93 r. inner iliac vein 0.050 3.0 3.0 10
94 r. external iliac vein 0.144 6.0 5.0 10
95 r. deep femoral vein 0.126 7.0 7.0 10
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96 r. femoral vein 0.254 7.0 7.0 10
97 r. posterior tibial vein 0.173 3.0 3.0 10
98 r. anterior tibial vein 0.173 3.0 3.0 10
99 l. common iliac vein A 0.038 11.6 11.6 10
100 l. common iliac vein B 0.020 11.6 11.6 10
101 l. inner iliac vein 0.050 3.0 3.0 10
102 l. external iliac vein 0.144 10.0 10.0 10
103 l. deep femoral vein 0.126 7.0 7.0 10
104 l. femoral vein 0.254 7.0 7.0 10
105 l. posterior tibial vein 0.173 3.0 3.0 10
106 l. anterior tibial vein 0.173 3.0 3.0 10
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[39] P. Reymond, F. Merenda, F. Perren, D. Rüfenacht, and N. Stergiopulos. Validation of a one-
dimensional model of the systemic arterial tree. American Journal of Physiology-Heart and
Circulatory Physiology, 297(1):H208–H222, 2009.
[40] P. Reymond, P. Crosetto, S. Deparis, A. Quarteroni, and N. Stergiopulos. Physiological simulation
of blood ϐlow in the aorta: comparison of hemodynamic indices as predicted by 3-D FSI, 3-D
rigid wall and 1-D models. Medical Engineering and Physics, 35(6):784–791, 2013.
[41] P. Segers, N. Stergiopulos, P. Verdonck, and R. Verhoeven. Assessment of distributed arterial
network models. Medical and Biological Engineering and Computing, 35(6):729–736, 1997.
[42] F. N. van de Vosse and N. Stergiopulos. Pulse wave propagation in the arterial tree. Annual Review
of Fluid Mechanics, 43(1):467–499, 2011.
[43] J. Walmsley, T. Arts, N. Derval, P. Bordachar, H. Cochet, S. Ploux, F. W. Prinzen, T. Delhaas, and
J. Lumens. Fast simulation of mechanical heterogeneity in the electrically asynchronous heart
using the multipatch module. PLOS Computational Biology, 11(7):e1004284, 2015.
[44] J. J. Wang and K. H. Parker. Wave propagation in a model of the arterial circulation. Journal of
biomechanics, 37(4):457–470, 2004.
[45] T. Weber, S. Wassertheurer, M. Rammer, A. Haiden, B. Hametner, and B. Eber. Wave reϐlections,
assessed with a novel method for pulse wave separation, are associated with end-organ damage
and clinical outcomes. Hypertension, 60(2):534–41, 2012.
[46] K. H. Wesseling, J. R. Jansen, J. J. Settels, and J. J. Schreuder. Computation of aortic ϐlow from
pressure in humans using a nonlinear, three-element model. Journal of Applied Physiology, 74
(5):2566–2573, 1993.
81
Chapter 3
[47] N.Westerhof, F. Bosman, C. J. De Vries, and A. Noordergraaf. Analog studies of the human systemic
arterial tree. Journal of Biomechanics, 2(2):121–143, 1969.
[48] N. Westerhof, N. Stergiopulos, M. I. Noble, and B. E. Westerhof. Wave intensity analysis. In
Snapshots of Hemodynamics, pages 185–193. Springer, 2019.
[49] B. Williams, G. Mancia, W. Spiering, E. Agabiti Rosei, M. Azizi, M. Burnier, D. L. Clement, A. Coca,
G. de Simone, A. Dominiczak, et al. 2018 ESC/ESH guidelines for the management of arterial
hypertension. European Heart Journal, 39(33):3021–3104, 2018.
82
4 Augmentation index is not a
proxy for wave reflection
magnitude: Mechanistic
analysis using a computational
model
The contents of this chapter are based on:
Maarten H.G. Heusinkveld,1 Tammo Delhaas,1 Joost Lumens,1 Wouter Huberts,1,2
Bart Spronck,3 Alun D. Hughes,4 Koen D. Reesink1
Augmentation index is not a proxy for wave reϐlection magnitude: Mechanis-
tic analysis using a computational model. Journal of Applied Physiology (2019)
127(2):491–500
1Department of Biomedical Engineering, CARIM School for Cardiovascular Diseases, Maastricht
University, Maastricht, The Netherlands.
2Department of Biomedical Engineering, EindhovenUniversity of Technology, Eindhoven, TheNether-
lands.
3Department of Biomedical Engineering, Yale University, New Haven, United States.
4Institute of Cardiovascular Sciences, University College London, London, United Kingdom.
Chapter 4
4.1 Abstract
The augmentation index (AIx) is deemed to capture the deleterious effect on left
ventricular (LV) work of increased wave reϐlection associated with stiffer arteries.
However, its validity as a proxy forwave reϐlectionmagnitude has been questioned.
We hypothesised that, in addition to increased wave reϐlection due to increased
pulse wave velocity, LV myocardial shortening velocity inϐluences AIx.
Using a computational model of the circulation, we investigated the isolated and
combined inϐluences of myocardial shortening velocity vs,LV and arterial stiffness
on AIx. Aortic blood pressure waveforms were characterised using AIx and the
reϐlected wave pressure amplitude (pˆbw, obtained using wave separation analysis).
Our reference simulation (normal vs,LV and arterial stiffness) was characterised
by an AIx of 21%. A realistic reduction in vs,LV caused AIx to increase from 21 to
42%. An arterial stiffness increase, characterised by a relevant 1.0 m s–1 increase
in carotid-femoral pulse wave velocity, caused AIx to increase from 21 to 41%.
Combining the reduced vs,LV and increased arterial stiffness resulted in an AIx of
54%. In a multi-step parametric analysis, both vs,LV and arterial stiffness were
about equal determinants of AIx, whereas pˆbw was only determined by arterial
stiffness. Furthermore, the relation between increased AIx and LV stroke work
was only for about 50% explained by an increase in arterial stiffness, the other
factor being vs,LV . The pˆbw, on the other hand, related less ambiguously to LV stroke
work.
We conclude that the AIx reϐlects both cardiac and vascular properties and
should not be considered an exclusively vascular parameter.
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4.2 Introduction
TčĊ augmentation index (AIx) is deϐined as the late systolic boost in the aorticpressure waveform divided by pulse pressure, and is often expressed as apercentage [27] (Fig. 4.1). Pressure waveform augmentation is commonly
assumed to result from the superposition of a reϐlected wave originating from
a (discrete) reϐlection site in the periphery onto the incoming pressure wave
generated by the heart [27]. With increased arterial stiffness, the reϐlected wave
will propagate with increased velocity, causing the augmentation to occur earlier
in systole with a consequent increase in AIx [27]. AIx is considered a vascular
parameter intended to quantify the deleterious effect of systolic wave reϐlection
on cardiac workload, which is associated with adverse cardiovascular outcomes
[12].
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Figure 4.1: Overview of characteristics and indices extracted from the simulated aortic
pressurewaveform (left pane) and aortic ϐlowwaveform (right pane). Left: Aug-
mentation index (AIx), calculated as a percentage-fraction using augmentation
pressure (pa) and pulse pressure (ppulse). AIx’ was calculated as the percentage-
ratio using augmentation pressure (pa) and incident pressure (pinc). Time-to-
inϐlection (ti) is deϐined as the time interval between foot and the inϐlection
point at inϐlection pressure pi. Right pane: Left ventricular ejection duration
(tej), the time interval during which blood is ejected into the aorta.
An advantage of AIx is its non-dimensionality requiring neither calibration of
blood pressure nor measurement of blood ϐlow velocity [19]. Blood pressure
waveforms can be obtained using noninvasive tonometry at the location of the
carotid- or radial arteries, or by oscillometric blood pressure recordings at bra-
chial level [18, 20]. Subsequently, AIx can be estimated from a synthesised central
pressure waveform derived from a reconstruction algorithm, applied to the tono-
metric or oscillometric waveforms. The accuracy of noninvasive AIx estimation
by tonometry and oscillometry was evaluated by Chen et al. [8] and Horvath et al.
[18], ϐinding a good correlation between catheter- and noninvasive AIx. Further-
more, Wilkinson et al. [45] and Savage et al. [34] reported good inter-observer
reproducibility of AIx as measured by tonometry.
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The comprehensive meta-analysis of Baksi et al. [5] described AIx to drastically
increase with age, despite only a small advance in time of arrival of the reϐlected
wave. Considering the often used paradigm in clinical studies that AIx is a proxy
for wave reϐlection magnitude [12, 19], one would expect similar proportions in
the correlation between on the one hand age, and on the other hand AIx and wave
arrival time, respectively.
Mechanistically, during systole the blood pressure waveform is the result of the
instantaneous interaction between heart and arterial system. This is illustrated by
the fact that aortic and left ventricular pressure patterns are in phase and closely
related during LV ejection, when assuming normal aortic valve function [9, 43].
Moreover, acute changes in arterial load are directly reϐlected in the time-course of
ventricular and aortic pressures [21]. However, the potential inϐluence of cardiac
contractile properties on the AIx is rarely considered in clinical-epidemiological
studies. Though a few clinical studies reported an association between systolic
augmentation and LV diastolic dysfunction [41], the direct linkage between AIx
and cardiac contractile function is difϐicult to determine, since AIx is likely to be
confounded by other factors such as heart rate, body height and mean arterial
pressure [12, 35, 37]. To overcome this issue, physics and physiology-based
models of the cardiovascular system may be employed to evaluate the effect of
isolated changes of cardiac- and vascular properties on AIx.
The purpose of the present study is to assess the effect of changes in LV con-
tractility and arterial stiffness on AIx utilising the CircAdapt computational model
of the circulation (www.circadapt.org) [22, 40]. This closed-loop model was
chosen because of its realistic cardiac mechanics model, with sarcomere length
coupled to myoϐibre stress. Furthermore, it contains a vascular model simulating
arterial and venous pressure and ϐlow wave haemodynamics. We 1) modulated
LV contractile properties by varying sarcomere shortening velocity (vs,LV) in the
model, and 2) modulated arterial stiffness by varying the vessel stiffness para-
meter (k). Both vs,LV and k are physiologically relevant parameters, since decreases
in vs,LV and increases in k have been associated with ageing [1, 14, 16]. We com-
pared AIx to alternative indices of wave reϐlection derived using established wave
separation (WS) analysis [31, 32]. Finally, we evaluated the relation between AIx
and cardiac workload with respect to variations in LV shortening velocity and
arterial stiffness.
4.3 Methods
4.3.1 The CircAdapt model
We used the CircAdapt computational model, a closed-loop model of the four-
chambered heart and circulation, to simulate cardiac mechanics and haemody-
namics [22, 40].
CircAdapt consists of a limited number of modules representing cardiac walls,
valves, arteries and veins as well as the systemic and pulmonary vascular beds.
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The modules directly relevant for the present study are highlighted in Fig. 4.2.
Brieϐly, CircAdapt’s contraction model constitutes of a modiϐied Hill model, de-
(Eq. 2)
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Figure 4.2: Overview of the primary relevant modules of the CircAdapt model. We dis-
tinguish two modules; the module underlying mechanics of myocardial tis-
sue (CARDIAC) and the module underlying wave propagation in the vascular
tree (VASCULAR). The sarcomere model consists of a contractile (si) element
with length Lsi and a series-elastic (se) element with length Lse, in parallel
with parallel-elastic element (pe) with sarcomere length Ls according to the
model of Hill, which assumes a force-velocity relation as shown. Blood ves-
sels are characterised by a stiffness coefϐicient (k), intraluminal-, external- and
transmural pressure (pintra, pext and ptrans, respectively) and cross-sectional area
(A). A vessel segment with a given length (l) connects a proximal node to a
distal node. Peripheral vascular beds are modeled using an arterio-venous
impedance model. Abbreviations: RA: right atrium, RV: right ventricle, LA: left
atrium, LV: left ventricle. The model simulation code can be downloaded at
https://github.com/Mheu1991/.
scribing the sarcomere mechanics (Fig. 4.2). The sarcomere model contains a
contractile element with length Lsi, arranged in series to a series-elastic element
with length Lse, which in term are arranged parallel to a passive-elastic element
with length Ls (Fig. 4.2). The contractile and series-elastic elements describe the
additional stress generation due to muscle activation, whereas the passive-elastic
element describes passive muscle behaviour (Fig. 4.2). Moreover, the length of the
series-elastic element can be interpreted as the elastic deformation of the myosin
heads in response to load [22]. Total sarcomere length is deϐined as the sum of
the length of the contractile element and series element, i.e. Ls = Lsi + Lse. The
rate of shortening of the contractile element (dLsi/dt) is given by
dLsi
dt
= vs,LV[
 
Lse − Lse,iso

/Lse,iso] , (4.1)
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with vs,LV LV sarcomere shortening velocity, assumed 7 µm s
–1 [13] and Lse,iso the
length of the series elastic element at the onset of isovolumetric contraction [22].
In the model, vs,LV scales dLsi/dt . A phenomenological mechanical activation para-
meter C is calculated as a function of Ls, Lsi and time [22, 40]. Actively generated
myoϐibre stress is determined using the mechanical activation, multiplied by the
sarcomere extension from reference (i.e. C
 
Lsi − Lsi,ref)

[40]. To obtain cavity
pressures and volumes, CircAdapt uses the one-ϐibre model of Arts et al. [2] that
allows for separation of the contribution of cardiac geometry and myoϐibre stress
to cardiac cavity pressure, assuming myoϐibre stress to be homogeneously dis-
tributed within the myocardial wall. Furthermore, the heart is enclosed by the
pericardium, modelled as a compliant sac [29] (Fig. 4.2).
CircAdapt enables simulation of pressure and ϐlow waves in arteries and veins.
We implemented an arterial and venous tree describing the aorta and vena cava,
as well as the subclavian-, carotid-, brachial-, and femoral arteries and veins, re-
spectively. Transmural pressure (ptrans) and cross-sectional lumen area (A) are
related non–linearly, expressed by the constitutive law based on Arts et al. [4]
ptrans(A) = −pext + p0

(1+ b)

A
A0
1+ k/3−21+b − bA0
A

, (4.2)
with p0 a reference pressure, A0 a reference cross-sectional area, and k represents
the vessel stiffness coefϐicient, governing the non-linearity of the pressure-area
relation, and thereby material stiffness (Fig. 4.2) [4]. Additionally, parameter b
was incorporated to avoid collapse of the tube with negative transmural pressure.
Furthermore, pext represents a prescribed external pressure. For our reference
simulationwe chose k-values of 8 for the aorta and vena cava. For both the arteries
and veins we chose k-values of 14 for the subclavian, 16 for the carotid, 18 for the
brachial, and 20 for the femoral, describing elastic taper (i.e. the increase in vessel
wall stiffness towards the periphery [44]). Furthermore, estimations for A0 and
vessel length were based on human data given in Westerhof et al. [44]. Peripheral
vascular beds were modeled using an arterio-venous impedance model [3].
4.3.2 Simulation protocols
Departing from our reference (REF) situation as detailed above, we simulated
three additional scenarios:
• Reduced shortening velocity (vs,LV) of LV sarcomeres from 7 µm s
–1 to 3
µm s–1 (reduced shortening velocity; vs,LV ↓, Table 4.1). To characterise the
imposed change in vs,LV , we calculated peak systolic strain rate, because
peak systolic strain rate is considered a strong measure of LV contractility
[15].
• Increased stiffness of arteries by increasing stiffness parameter k (arterial
stiffening; k ↑, Table 4.1). Since themodelled arterial tree contains segments
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with different k-values, k-values of all segments were increased by addition
of a factor∆k. Here,∆k was set equal to 12 (i.e. kstiffening = kREF + 12). Ac-
cording to clinical standards, we quantiϐied arterial stiffness using pulse
wave velocity. We obtained pulse wave velocity from transit time and travel
distance. Transit time was calculated by identiϐication of the foots of the
carotid and femoral pressure waveforms. To identify the foot of the pres-
sure wave, we used the maximum of the 2nd-order derivative [10]. Travel
distance, on the other hand, was calculated as the path difference between
the combined length of the aortic to femoral artery segments and aortic to
carotid artery segments.
• The combined effect of a change in cardiac and vascular tissue properties
(combined; k ↑, vs,LV ↓, Table 4.1).
Additionally, to evaluate the dependence of AIx on LV shortening velocity and
arterial stiffness, we also performed parameter sweeps of vs,LV and∆k, varying LV
shortening velocity vs,LV from 2 to 10 µm s
–1 with 1 µm s–1 increments and∆k from
–2 to 14 with increments of 1. All simulations were performed in MATLAB 2015a
(The Mathworks, Natick, USA). In all simulations, mean arterial pressure and
cardiac output weremaintained at 92mmHg and 5.1 l min–1, respectively, through
changes of systemic vascular resistance and circulating blood volume, while heart
rate was kept constant at 72 beats min–1. Collapsible tube fraction b was kept at
0.02. Haemodynamics reached steady state prior to analyses. Theunderlying simu-
lation code and analysis scripts are available under the GNUGeneral Public License
v3.0 and can be downloaded from GitHub (https://github.com/Mheu1991).
4.3.3 Wave reflection indices extracted from simulations
Wave reϐlection indices were computed for simulated pressure and ϐlow velocity
waveforms of the aorta. To benchmark the relationships between simulated
cardiovascular alterations and AIx, we included wave reϐlection indices obtained
using wave separation (WS) analysis ([31], detailed below). While WS analysis
yields a wave reϐlection index expressed as a percentage-ratio, AIx expresses wave
reϐlection as a percentage-fraction using the expression in Fig. 4.1 [12]. Hence, we
also introduce the parameter AIx’, deϐined as a percentage-ratio of augmentation
pressure to incident pressure (i.e. pa/pinc · 100%). Furthermore, we calculated
time–to–inϐlection (ti, Fig. 4.1, right pane), deϐined as the time-interval between
the foot of the pressure waveform and inϐlection point [19]. Locations of foot
and inϐlection were identiϐied using the peak and zero-crossing of the 2nd-order
derivative of the pressure curve. We extracted LV ejection duration to evaluate
whether it was inϐluenced by our simulated changes in LV shortening velocity and
arterial stiffness. Using the 2nd-order derivative of the aortic valve ϐlow velocity,
LV ejection duration was calculated as the time-difference between the beginning-
and end of ejection (Fig. 4.1, right pane, vertical dashed lines).
The concept of WS analysis is based on solving the one-dimensional equations
of mass conservation andmomentum balance in elastic tubes [31]. InWS analysis,
89
Chapter 4
instantaneous changes in pressure and ϐlow velocity, representing wavefronts,
are calculated for the forward and backward directions using the water-hammer
equations:
dpfw = ρcdUfw , and (4.3)
dpbw = −ρcdUbw ,
where dpfw and dUbw denote forward or backward wavefronts of pressure and
ϐlow velocity, respectively, whereas ρ is the blood density (1050 kg m–3), and
c is the pulse wave velocity. The variables dpfw, dpbw, dUfw, dUbw and c were
determined as described by Parker [31]. Through calculation of forward and back-
ward pressures pfw and pbw, obtained by integration of separated instantaneous
pressure components, we derived wave reϐlection index pˆbw/pˆfw, deϐined as the
percentage-ratio between backward pressure wave amplitude (pˆbw) and forward
pressure wave amplitude (pˆfw).
4.3.4 Calculation of cardiac workload
To assess whether there is a relation between increased AIx and increased cardiac
external work, we assessed cardiac work load by calculation of LV stroke work
(Wstroke). The variableWstroke was calculated as the numerically integrated area
contained by the LV pressure (pLV)–volume (VLV) relation:
Wstroke =
∮
pLVdVLV . (4.4)
4.3.5 Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics for Windows, ver-
sion 24 (IBM Corp., Armonk, NY, USA). Linear regression analysis was performed
to examine the relationship between wave characteristics. P<0.05 was considered
statistically signiϐicant.
4.4 Results
4.4.1 Effects of reduced LV shortening velocity and increased
arterial stiffness on augmentation index
Fig. 4.3 and Table 4.1 contain an overview of pressure waveforms and derived
characteristics for the four simulated scenarios. Simulating vs,LV ↓ (red solid curve)
did not affect absolute pressure values (Table 4.1).
However, the inϐlection in the pressure waveform came earlier, (from 96 to 83
ms, Table 4.1) after the foot of the pressure waveform with a marked increase
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Figure 4.3: Aortic and left ventricular pressure curves for the four simulated scenarios.
Left pane: Overview of simulated left ventricular and aortic pressure wave-
forms for four simulated scenarios. Right pane: Closer look at the systolic
segment (t=100–450 ms) of the pressure waveforms (top) and their second or-
der derivatives (bottom). Right pane: Inϐlection points (black and red symbols,
respectively) are located by determining the zero-crossing of the second order
derivative of each simulated waveform.
in AIx (from 21 to 42%, Table 4.1). LV ejection duration was prolonged with
respect to the reference situation (from 238 to 274 ms, Table 4.1), and peak
systolic strain rate (PSSR)magnitude decreased (from –0.91 s–1 to –0.69 s–1, Table
4.1). Simulating k ↑ (Fig. 4.3, dashed black line), increased systolic pressure (127
to 162 mmHg) and decreased diastolic pressure (60 to 42 mmHg, Table 4.1).
The inϐlection occurred signiϐicantly earlier during systole (time-to-inϐlection
decreased from 96 to 69 ms) and AIx was markedly increased (21 to 41%, Table
4.1). The PSSR magnitude was only moderately decreased from –0.91 s–1 to –0.80
s–1 (Table 4.1). The combined effect of k ↑ and vs,LV ↓ resulted in a waveform
that can be considered an intermediate (Fig. 4.3, red dashed curve) curve of the
k ↑ and vs,LV ↓ curves, with an AIx increase from 21 to 54%. Ejection duration
increased to 309 ms and the inϐlection point occurred 60 ms after the foot of the
pressure waveform. Simulating k ↑ and vs,LV ↓ invoked the largest reduction in
PSSR magnitude, i.e. reducing from –0.91 s–1 to –0.64 s–1 (Table 4.1).
4.4.2 Effects on alternative measures of wave reflection
Fig. 4.4 contains a breakdown of simulated pressure waveforms into forward
(pfw) and backward (pbw) pressure wave components, using wave separation
(WS) analysis. Furthermore, separated pressure wave amplitudes, pˆfw and pˆbw
are indicated for the REF (Fig. 4.4, left pane), vs,LV ↓ (Fig. 4.4, centre pane) and
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Table 4.1: Inϐluence of LV shortening velocity and arterial stiffness on blood pressure in-
dices and reϐlection indices for four distinct simulated scenarios.
Simulation→
Metric ↓
Reference
(REF)
Reduced shortening velocity
(vs,LV ↓)
Arterial stiffening
(k ↑)
Combined
(vs,LV ↓, k ↑) Unit
psys 127 126 162 158 mmHg
pdia 60 63 42 42 mmHg
ppulse 66 63 120 116 mmHg
pmean 92 92 92 92 mmHg
AIx 21 42 41 54 %
AIx’ 27 72 70 120 %
pˆbw/pˆfw 76 74 76 76 %
pˆbw 28 26 51 48 mmHg
time-to-inϐlection 96 83 69 60 ms
ejection duration 238 274 285 309 ms
LV stroke work 1.04 0.98 1.18 1.10 J
PSSR –0.91 –0.69 –0.80 –0.64 s–1
The indices psys, pdia, ppulse and pmean are respectively systolic, diastolic, (systolic–diastolic)
and mean aortic blood pressure, and PSSR denotes peak systolic strain rate. Note that AIx’
and pˆbw/pˆfw are wave reϐlection indices that consider the ratio of backward and forward
pressure wave amplitudes, while AIx considers the fraction of augmentation pressure and
pulse pressure, respectively.
k ↑ (Fig. 4.4, right pane) simulations. Reducing LV shortening (vs,LV) caused pfw to
change in shape but not in amplitude as compared to the reference situation. On
the contrary, no clear difference was observed in the pbw waveform. As a result,
reϐlection index pˆbw/pˆfw virtually remained unchanged (76 and 74% respectively,
Table 4.1). Increased arterial stiffness (k ↑) resulted in an increase in backward
pressure wave amplitude (pˆbw) from 28 to 51 mmHg, whereas pˆbw/pˆfw remained
unchanged (76 for both REF and k ↑, Table 4.1). The latter is attributable to a
proportional increase in pˆfw and pˆbw (Fig. 4.5).
4.4.3 Parameter sweeps
Parameter sweeps of vs,LV and∆k provide more detailed insight into the relation-
ships between on the one hand the changes in cardiac and vascular properties and
on the other hand the indices AIx and pˆbw/pˆfw. Combined changes in cardiac and
vascular tissue properties seem to relate non-linearly to observed changes in AIx,
as is apparent in the contour plot of AIx as a function of vs,LV and∆k (Fig. 4.5, left
pane). Our simulation results indicate that AIx is monotonically increasing with
both higher arterial stiffness values and lower LV sarcomere shortening velocities.
For the simulations corresponding to the white regions (i.e. high vs,LV and low
k-values), no inϐlection point was present in the systolic phase of the aortic blood
pressure curve. The relation between AIx’ and changes in vs,LV and k was not
different, albeit that absolute values, expressing pressure wave augmentation as
the ratio between pressure above the inϐlection point on the curve to pressure
below the the inϐlection, ranged from 30 to 140% for all simulations (Fig. 4.5,
centre pane). Using wave separation, we did not ϐind distinctive differences in
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Figure 4.4: Wave separation analysis performed using pressure (p) and ϐlow velocity (U)
waveforms obtained from 1) the reference simulation, 2) the reduced shorten-
ing velocity simulation, and 3) the arterial stiffening simulation. Wave reϐlection
index pˆbw/pˆfw was calculated as percentage-ratio of backward pressure wave
amplitude (pˆbw) and forward pressure wave amplitude (pˆfw) using wave sep-
aration (WS) analysis. The simulated aortic blood pressure waveform can be
reconstructed by addition of separated pressure components (pfw and pbw). The
offset is determined by the pressure at t=0.
the ratio between backward and forward pressure amplitude pˆbw/pˆfw (range 72
to 76%, Fig. 4.5, right pane). This ϐinding was caused by almost proportional
increases in pˆfw and pˆbw.
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Figure 4.6: Relation between left ventricular stroke work (Wstroke) and wave reϐlection in-
dices, i.e. augmentation index (AIx) and backward pressure amplitude (pˆbw),
respectively. Each symbol represents a simulationwith a particular left ventricu-
lar sarcomere shortening velocity (vs,LV; indicated by symbol type) and imposed
arterial stiffness (∆k; indicated using symbol colour saturation). Upper pane:
Scatter plot indicating the relation between AIx and Wstroke. The dashed line
illustrates variation inWstroke values at an AIx value often found in elderly pa-
tients (see text). Lower pane: Scatter plot displaying the relation between pˆbw
as determined using wave separation andWstroke. Arrows indicate the direction
of changes in vs,LV and∆k for the simulations.
4.4.4 Relationship between AIx and left ventricular stroke
work
Fig. 4.6 (top panel) shows the relation between AIx andWstroke from simulations
with varying arterial stiffness (indicated by colour saturation coding) and LV
shortening (indicated by symbol type coding). Parameter sweeps revealed a large
scatter in the relation between AIx andWstroke (Fig. 4.6). At a ϐixed AIx of 40%,
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typically found in older subjects [25],Wstroke varies by as much as 25% (Fig. 4.6,
dashed line). On the other hand, scatter in the relation between pˆbw andWstroke
was smaller as compared to that in the relation between AIx andWstroke (≤11%
variation in Wstroke, for a given value of pˆbw), suggesting an increased cardiac
workload with increasing backward pressure wave amplitude (Fig. 4.6).
4.5 Discussion
To our knowledge, this is the ϐirst study to mechanistically study and discriminate
the inϐluence of LV contractile and arterial stiffness properties on the augmenta-
tion index. We compared our ϐindingswith alternativemeasures ofwave reϐlection
that were derived using wave separation analysis.
4.5.1 Key findings and interpretation
We found that the AIx is dependent on vascular as well as cardiac properties (Fig.
4.5). Moreover, increased AIx did not necessarily relate to increased LV workload
(Fig. 4.6), which goes against the commonly used concept of increased LVworkload
by increased LV afterload as caused by earlier systolic wave reϐlections.
We explain the observed cardiac impact on AIx as follows. Given a constant
stroke volume, a decreased myocardial shortening velocity will decrease LV volu-
metric rate (LV dV/dt) in early systole, causing a greater portion of stroke volume
to be expelled during late systole. Therefore, the pressure increase prior to the
inϐlection point will be relatively smaller than the pressure increase after the
inϐlection point, which leads to an increased AIx. This assumes that the timing of
the inϐlection point is primarily determined by the complex arterial impedance,
which is in line with current thinking [5].
The AIx is calculated from an aortic blood pressure waveform, whereas wave
separation analysis uses, in addition to blood pressure, ϐlow (velocity) information
and takes into account aortic impedance [31]. This may explain why backward
pressure amplitude in our study is a better correlate of wave reϐlection, while AIx
characterises rather the interactive inϐluence of heart and blood vessels on the
blood pressure.
Haemodynamic interaction between blood vessels and heart has been reported
in patients as judged from changes in peak systolic strain rate in response to
an imposed afterload change [7]. Additionally, previous experimental papers
suggest that acute changes in LV myocyte external load (i.e. arterial impedance)
impacts myocardial shortening [21, 33], corroborating that cardiac properties by
themselves and/or in response to vascular changes inϐluence AIx.
Taken together, theAIxmaybe an integrativemarker of concurrent degenerative
processes leading to increased arterial stiffness and reduced myocardial shorten-
ing velocity. Clearly, such reinterpretation of AIx requires further corroboration
from clinical studies using independent cardiac and vascular measurements. As
discussed in the meta-analysis of van der Waaij et al. [39], the number of clinical
96
Augmentation index
studies reporting effects of chronic changes in arterial stiffness on LV function is
limited.
4.5.2 Choice of model parameters
Clearly, AIx will likely be determined by multiple factors, especially in humans.
For our modelling study, we intentionally selected only one cardiac (vs,LV) and one
vascular (k) parameter with demonstrated linkages to tissue properties (myocar-
dial shortening velocity and arterial stiffness exponent). The simulated changes
in vs,LV and k were by no means intended to model the clinical-epidemiological
proϐiles of heart failure or vascular ageing.
The imposed reduction in LV shortening velocity (vs,LV ↓) signiϐicantly changed
the peak systolic strain rate from –0.91 s–1 for the reference simulation to –0.69 s–1
(i.e. a reduction in magnitude of 24%). This decrease in peak systolic strain rate is
physiologically plausible as based on reference data reported in Dalen et al. [11].
In previous work, we conducted a local sensitivity analysis assessing how changes
in cardiac CircAdapt model parameters affect aortic augmentation index [17]. In
this analysis, testing four candidate cardiac parameters, we found vs,LV to be the
most important cardiac determinant of augmentation indexwhichmotivated us to
select this model parameter in our analysis. We chose to reduce vs,LV based on rat
experimental data reporting force-velocity relations in papillarymuscle [1]. These
data showed a linear decrease in peak muscle shortening velocity of≈ 50%with
increasing age (i.e. 100 to 1000 days). Moreover, in isolated human ventricular
myocytes, a reduction in shortening velocity with age was also observed [16]. The
arterial stiffening simulation (k ↑) corresponded to a relevant carotid-to-femoral
pulse wave velocity increase from 6.6 m s–1 to 7.6 m s–1.
4.5.3 Alternative metrics in relation to wave reflection
magnitude
Augmentation index expressed as a percentage-ratio (i.e. the parameter AIx’)
showed the same dependency on vascular and cardiac properties as was found
for the regular AIx. In contrast to AIx and AIx’, the ratio of backward and forward
pressure wave amplitude calculated by means of wave separation analysis re-
mained relatively unaffected for all simulations (Fig. 4.5). This was caused by a
proportional increase in forward pressure wave amplitude with increased arterial
stiffness. Such increased forward pressure wave amplitude with age was also
observed in men and women in the Framingham Heart Study and was associated
with age-related stiffening of central arteries [38]. Our simulations did show a
clear pattern between arterial stiffness and backward wave amplitude (pˆbw) as de-
termined using wave separation analysis. Moreover, the pattern was independent
of LV sarcomere shortening velocity (Fig. 4.7).
Potential implications of increased backward wave amplitude with respect to
cardiovascular risk were reported by Weber et al. [42]. Two key ϐindings of their
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Figure 4.7: Effect of changes in sarcomere shortening velocity vs,LV and vessel stiffness
(k) on backward pressure amplitude (pˆbw) assessed using wave separation
(WS) analysis. The distinct simulated scenarios are highlighted by the dots and
squares as indicated. Each grid point corresponds to a single simulation.
study were that 1) backward wave amplitude was the most consistent predictor
of a composite cardiovascular end point, including mortality, in a group of 725
patients undergoing coronary angiography, and 2) the predictive value of AIx and
augmentation pressure was inferior to that of backward wave amplitude [42].
The present study supports their ϐindings and extends the explanation towards
cardiac inϐluences.
One should take caution when interpreting our simulated scenarios as emulat-
ors of human ageing and, hence, to expect an increased reϐlection magnitude as
has been reported by Segers et al. [36] in the ageing population. Several aspects
regarding cardio-vascular structure and function (e.g. cardiac mass and vascular
segment diameters) that reportedly change with age have been kept constant
throughout our simulations. Previously, Maksuti et al. [24] and Pagoulatou and
Stergiopulos [28] performed simulation studies focussing on changes in arterial
haemodynamics during physiological ageing, whereas Willemet et al. [46] intro-
duced a method to generate virtual cohorts consisting of arterial haemodynamics
models, with varying population characteristics including age. Future studies on
the evolution of AIx and otherwave reϐlection indicesmay consider thesemethods
as a take-off point.
Simulations revealed a linear association between ejection duration and aug-
mentation index. Based on the simulations obtained in our multi-step parametric
analysis, an increase in ejection duration of 20 ms caused AIx to increase with
9-percentage points (i.e. indicated by an unstandardised B of 0.43 %/ms, 95%
conϐidence interval=[0.40, 0.45] %/ms, P<0.001). In the study of Sharman et al.
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[37], a similar association between ejection duration and augmentation index of
10 percentage point per 20 ms of increase in ejection duration was found. In our
model, this association is explained by a decrease in LV early-systolic volumetric
rate with constant stroke volume, causing a signiϐicant portion of the LV stroke
volume to be expelled after the inϐlection point (see above).
4.5.4 Cardiac workload
In the present study, we quantiϐied cardiac workload by calculating left ventricular
stroke work. Increasing arterial stiffness caused left ventricular stroke work to
increase (+13%). Left ventricular stroke work slightly decreased (–6%) for the
simulation with reduced left ventricular shortening velocity (Table 4.1). While
AIx is derived from arterial measurements, using it to quantify cardiac workload
appears to be erroneous, as cardiac contractility plays a role as well. Results imply
that backward pressure amplitude —rather than depending solely on arterial
stiffness in these simulations— to be more indicative of cardiac workload than
AIx.
4.5.5 Previous clinical studies on ventriculo-arterial
interaction
Below, two examples of clinical studies investigating aspects of ventriculo-arterial
interaction are discussed. Bell et al. [6] reported that during systole the proximal
aorta elongates, imposing a higher stretch-related workload on the LV. During
diastole, the amount of elastic recoil energy is positively associatedwith increased
early diastolic LV ϐilling, suggesting that elastic recoil of the proximal aorta may
beneϐit LV diastolic function through mechanical ventriculo-arterial coupling.
In their analyses on the relations between aortic and LV measures, statistical
correction of the (potential) confounding effect of wave reϐlections was performed
using AIx. Given the present results, adjusting for AIx as a proxy of wave reϐlection
may lead to over or undercorrection for the cardiac inϐluence.
Palombo et al. [30] investigated the treatment effects of a calcium-channel block-
er on LV structure (e.g. LV mass) and function (e.g. LV stroke work) indices as well
as central (aortic) haemodynamics indices. Findings from the study included that
the ratio of backward pressure amplitude and forward pressure amplitude was
equal between hypertensive patients and normotensive controls, while backward
pressure amplitude and LV stroke work were signiϐicantly higher for the hyper-
tensive patient group. These ϐindings corroborate our simulation ϐindings that
pˆbw best reϐlects the impact of backward wave reϐlection with increased arterial
stiffness on LV workload.
4.5.6 Limitations
When interpreting our results, one has to realise that the data presented were not
based on patient measurements but come from computer simulations. Although
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wedid not ϐit ourmodel to patient data, the order ofmagnitude of theAIx compares
well with human studies. In our reference simulation, AIx was found to be equal
to 21%, which is in accordance with the range of values reported by Hughes et al.
[19] in 65 healthy individuals (44±14 years) and by Savage et al. [34] in 188
patients (56±15 years) with chronic renal failure. Imposing either reduced LV
shortening velocity or increased arterial stiffness caused AIx to increase to 41 and
42%, respectively. This is equivalent to the AIx measured in subjects between 70
and 80 years of age [26].
The following aspects regardingmodel assumptions and choiceswarrant discus-
sion: The CircAdapt model used in this study describes a highly simpliϐied cardiac
geometry, relating myoϐibre stress and strain by single values. This approach was
shown to be valid under the assumption that myoϐibre stress is homogeneously
distributed [2]. A previous study utilising the CircAdapt model obtained phys-
iologically realistic LV strain patterns as compared to global LV strain patterns
obtained from MR-tagging [23]. Therefore, we believe CircAdapt’s contraction
model is appropriate for our study’s purpose.
Furthermore, thewave propagationmodel we used neglects non-linear convective
acceleration (i.e. we assume linear wave behaviour), thereby introducing small
modelling error in pressure and ϐlow waveforms. However, the implication of
such error to derived haemodynamic indices is negligible in our study, since all
the wave reϐlection indices we derived also assume linear wave behaviour.
We simulated arterial stiffening by increasing material stiffness parameter
k (Eq. 4.2). Mean arterial pressure (i.e. p0) was assumed to remain constant.
As such, systolic blood pressure increased, whereas diastolic blood pressure
decreased, which may not be representative for patients for which diastolic blood
pressure is increased as well, e.g. due to increased peripheral resistance. To
assess the implication of keeping mean arterial pressure constant on our ϐindings,
we repeated the reference, reduced shortening velocity, arterial stiffening and
combined simulations with p0 kept at 102 mmHg and 112 mmHg, respectively.
With respect to changes (∆) in augmentation index and backward pressure wave
amplitude relative to the reference situation (i.e. the [vs,LV ↓ −REF], [k ↑ −REF],
and [vs,LV ↓, k ↑ −REF] differences), we found only a minor inϐluence of increasing
p0 (i.e.∆AIx≤ 8% and∆pˆbw ≤ 5 mmHg, respectively).
We believe our model-based ϐindings require further conϐirmation in clinical
studies. Such a study could be a case-control design with isolated systolic hyper-
tension and normotensive patient groups. Measurements in these studies should
include speckle-tracking echocardiography to characterise LV contractile function
[11], pulse wave analysis to characterise augmentation index [12], wave separ-
ation analysis [31] to characterise wave reϐlection behaviour, as well as stroke
volume and blood pressure measurements to estimate cardiac workload.
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4.6 Conclusion
We conclude that the AIx reϐlects both cardiac and vascular properties, and hence
should not be considered a vascular parameter. Furthermore, an increase in
AIx does not necessarily relate to increased stroke work. Hence, we believe AIx
should be abandoned as a proxy for increased wave reϐlection magnitude due to
an arterial stiffness increase.
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Chapter 7
7.1 Abstract
Quantiϐication of the uncertainty in constitutive model predictions describing
arterial wall mechanics is vital towards non-invasive assessment of vascular drug
therapies.
Therefore, we perform uncertainty quantiϐication to determine uncertainty
in mechanical characteristics describing the vessel wall response upon loading.
Furthermore, a global variance-based sensitivity analysis is performed to pinpoint
measurements that are most rewarding to be measured more precisely.
We used previously published carotid diameter-pressure and intima-media
thickness (IMT) data (measured in triplicate), and Holzapfel-Gasser-Ogden mod-
els. A virtual data set containing 5000 diastolic and systolic diameter-pressure
points, and IMT values was generated by adding measurement error to the av-
erage of the measured data. The model was ϐitted to single-exponential curves
calculated from the data, obtaining distributions of constitutive parameters and
constituent load bearing parameters.
Additionally, we 1) simulated vascular drug treatment to assess the relevance
of model uncertainty and 2) evaluated how increasing the number of measure-
ment repetitions inϐluences model uncertainty. We found substantial uncertainty
in constitutive parameters. Simulating vascular drug treatment predicted a 6-
percentage point reduction in collagen load bearing (Lcoll), approximately 50% of
its uncertainty.
Sensitivity analysis indicated that the uncertainty in Lcoll was primarily caused
by noise in distension and IMT measurements. Spread in Lcoll could be decreased
by 50%when increasing the number of measurement repetitions from 3 to 10.
Model uncertainty, notably that in Lcoll, could conceal effects of vascular drug
therapy. However, this uncertainty could be reduced by increasing the number of
measurement repetitions of distension and wall thickness measurements used
for model parametrisation.
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7.2 Introduction
AėęĊėĎĆđ stiffening is a major determinant of hypertension and vice versa[19]. Treatment options for arterial stiffening can roughly be dividedinto two categories: 1) prescribing drugs that lower blood pressure and
consequently reverse the arterial structural remodelling that occurs with hyper-
tension, or 2) prescribing drugs that directly affect the arterial wall structure [42].
The second category includes cross-link breaking drugs that target the arterial
collagen network [20, 48]. These type of drugs aim to break down the advanced
glycation end-products (AGE) that form cross-links between collagen molecules
[6, 20, 23]. The desired mechanical effect of such drug therapies is to reverse
pressure load bearing from a stiff, collagen dominated phenotype to a less stiff,
elastin dominated phenotype; resulting in a decrease in material stiffness [27, 48].
In vivo assessment of the performance of vascular drugs has proven to be cum-
bersome [7]. Arterial stiffness is typically quantiϐied bymeasuring carotid-femoral
pulse wave velocity, or by local assessment of arterial distensibility [20, 48]. A
limitation of these indices is their blood pressure dependence, for which an incre-
mental change in these indices could occur solely from a change in blood pressure
[38]. In addition, arterial stiffness measurements as such do not yield insight
into the effect of a drug at microstructural level, nor do they resolve whether the
load-bearing phenotype is collagen or elastin dominated.
A potential solution to this problem lies in the use of computer models that
simulate stress-strain behaviour of arteries using physical constitutive relations
[15]. In such models, it might be possible to analyse the individual contribution
of both elastin and collagen to the overall mechanical response of the vessel
wall. Ex vivo studies on human carotid arteries, performed in the laboratory,
reported good agreement between constitutive model computations and biaxial
tensile tests [35, 36]. If such models could be parametrised using non-invasive
measurements in patients, they could be used to evaluate the mechanics of the
vessel wall patient-speciϐically. Several studies have attempted to use in vivo data
to parametrise constitutivemodels of the arterialwall, as reviewed in Spronck et al.
[37]. Typically, diameter, pressure, and intima-media thickness measurements
at the carotid artery are used to ϐit such models [37]. Generally, noise in those
measurements will hamper patient-speciϐic evaluation of arterial wall mechanics.
In this study, we aim to 1) assess how measurement uncertainty propagates
into uncertainty of mechanical characteristics, estimated using a model of arterial
wall mechanics and 2) pinpoint the measurements responsible for the largest
spread in mechanical characteristics through sensitivity.
Uncertainty quantiϐication and sensitivity analysis are considered indispens-
able tools to ensure credibility of computer model-based predictions [26]. We
explicitly focus on two types of mechanical characteristics: 1) constitutive pa-
rameters, describing the mechanical properties of collagen and elastin; and 2)
constituent load-bearing parameters, describing to which extent the blood pres-
sure load is borne per constituent. The latter parameters are considered outcome
parameters, obtained by evaluating the model using the best-ϐit set of constitutive
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parameters (Fig. 7.1, left panel). For these purposes, a large set of virtual pres-
sure (P), diameter (D), and intima-media thickness (IMT) measurements will be
generated by sampling the measurement distributions of previously published P ,
D and IMT measurements in healthy volunteers [13].
For each D–P sample, we will obtain continuous D–P curves over the diastolic-
systolic pressure range, using the single-exponential function described earlier
[24, 11]. Holzapfel-Gasser-Ogden constitutive models will be ϐitted to these data
[15], and uncertainty quantiϐication will be used to quantify the spread in the
estimated mechanical characteristics, given the measurement noise (Fig. 7.1, left
panel). A sensitivity analysis will be performed to determine how noise in the
individualmeasured variables propagates into uncertainty in the model-predicted
mechanical characteristics. The relevance of the model output uncertainty mag-
nitude, which results from uncertainty in the model parameters, will be assessed
by simulating the effect of AGE-breaker treatment on changes in collagen load
bearing behaviour in our model (Fig. 7.1, right panel).
7.3 Methods
7.3.1 Constitutive model definition
To identify mechanical characteristics of the carotid artery wall, we used the
Holzapfel-Gasser-Ogden constitutive model describing passive carotid artery wall
mechanics [15]. This model was chosen on the one hand for its low number of
parameters, and on the other hand for its feasibility in identifying mechanical
characteristics when ϐitted to clinically obtained distensibility data [37]. Here, we
will give a brief description of the model. For more details we refer to Appendix
7.A1.
In the model, the carotid artery is considered to be a thick-walled incompress-
ible tubular structure composed of a mixture of two components: 1) elastin,
assumed mechanically isotropic, and 2) collagen ϐibres, assumed mechanically
orthotropic. Collagen was modelled by two families of ϐibres that are helically
oriented at an angle of +β0 and −β0 with respect to the circumferential direction
(Fig. 7.2). Elastin and collagen were assumed to operate in parallel. Furthermore,
we assumed that there is only deformation along the principal axes, i.e. no shear.
The mechanical response of the constituents can be described using a strain en-
ergy function (SEF). The SEFs of the constituents combined provide a relationship
between stress and strain, and comprise a way of formulating constitutive be-
haviour of hyperelastic materials [18]. The SEF used for elastin (Welast) is given
by
Welast = celast(I1 − 3) , (7.1)
with I1 the ϐirst invariant of the Green-Lagrange strain tensor, given by I1 =
λ2r r +λ
2
θθ
+λ2zz , with λ the stretch in the radial (r) direction, circumferential (θ)
direction, and axial (z) direction, respectively. The parameter celast is a constitutive
(stiffness) parameter for elastin.
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Figure 7.1: Outline of the current study, involving 1) uncertainty quantiϐication (UQ) and
sensitivity analysis (SA) of a constitutive model of arterial wall mechanics
(methodology, left) and 2) assessment of the relevance of the model output
uncertainty when evaluating the effects of vascular drug treatment (clinical ap-
plication, right). Left: Group-averaged measured variables were obtained from
a previous study, measuring twelve healthy subjects. The effect of measurement
uncertainty on measured variables was included by perturbing group-averaged
variables based on their measurement uncertainty. Within the margins of mea-
surement uncertainty, we generated a data set composed of 5000 samples
containing measured variables. Here, the measured variables are Dd: diastolic
diameter;∆D: distension; Pd and Pp: diastolic and pulse pressure, respectively;
IMT: intima-media thickness. Holzapfel-Gasser-Ogden models were ϐitted to
single-exponential diameter-pressure curves, determined for each sample of the
generated data set. This yielded initial (INIT) realisations of mechanical char-
acteristics, consisting of constitutive parameters and constituent load-bearing
parameters, that were subsequently used for uncertainty quantiϐication and
sensitivity analysis. The constitutive parameters are celast: elastin stiffness para-
meter; k1 and k2: collagen stress-scaling and stress-curve shape parameters,
respectively. The parameter Ri indicates the unstressed vessel inner radius and
is an auxiliary model parameter. The load-bearing parameter Lcoll indicates the
collagen load bearing as a percentage of the blood pressure (BP) load. Right:
Assessing the relevance of uncertainty in load-bearing parameters by simulat-
ing advanced glycation end-product (AGE) breaker treatment using the model.
We simulated AGE-breaker treatment by reducing parameters k1 and k2 equally
with respect to their INIT best-ϐit values.
The SEF used for collagen (Wcoll) is given by
Wcoll =
k1
k2

exp

k2
 
λ2fibre − 1
2− 1 , (7.2)
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Figure 7.2: Overview of unstressed (top) and stressed (bottom) conϐigurations of an artery.
Top: P: internal pressure, Fz : reduced axial force, R: unstressed radius, Ri:
unstressed inner radius, Ro: unstressed outer radius, α: opening angle, L: un-
stressed vessel length. In the unstressed conϐiguration, we consider two families
of helically orientated collagen ϐibres, with an angle ±β0 with respect to the
circumferential direction. Bottom: r: stressed radius, ri: stressed inner ra-
dius, ro: stressed outer radius, Aw: cross-sectional wall area in the stressed
conϐiguration, l: stressed vessel length, λzz : axial pre-stretch.
where k1 as well as k2 are constitutive parameters and λfibre denotes ϐibre stretch,
given by λfibre =
q
cos2(β0)λ2θθ + sin
2(β0)λ2zz . This collagen SEF should only con-
tribute when the ϐibres are extended (while collagen ϐibres cannot sustain com-
pression; Holzapfel et al. [15]). The positive luminal arterial pressure used in all
our simulations ensures that such condition is always met.
For incompressiblematerials, the local stress-strain behaviour can be calculated
using the derivatives of the SEFs:
σn = −Ph +λn ∂Welast
∂ λn
+λn
∂Wcoll
∂ λn
, (7.3)
with σn the Cauchy stress. The subscript n is r r for the radial direction, θθ for
the circumferential direction and zz for the axial direction. The pressure Ph is the
local hydrostatic pressure within the wall.
InWelast andWcoll, the following parameters thus characterise the constitutive
behaviour of elastin and collagen:
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• celast: stiffness parameter of elastin, units of Pa.
• k1: stress scaling parameter of collagen, units of Pa.
• k2: collagen stress-curve shape parameter, dimensionless.
Elastin acts physiologically as the predominant load bearer for low pressure
loads, whereas collagen, which is modelled as an unstressed ϐibrous material for
low pressure, starts bearing load at higher pressures [14, 27, 32, 45]. The ϐitted
parameters should result in a relation that mimics this behaviour. To quantify
collagen loadbearing, we estimated Lcoll, being the pressure loadborne by collagen
as a percentage of the total blood pressure load (see Appendix 7.A1.4).
Based on literature reports on excised human and animal carotid arteries, we
assumed that the artery is subjected to an initial axial pre-stretch (λzz , Fig. 7.2) of
1.20 [37]. The helix angle of the two families of collagen ϐibres in our model was
assumed to be ±35.3◦ in the unstressed conϐiguration (Fig. 7.2) [1]. This angle
was chosen from an analytical solution that for a thin-walled, ϐibre-reinforced tube
results in a constant reduced axial force (Fz) over the cardiac cycle (dFz/dP = 0
N
Pa ) [1, 18, 41, 44, 46]. Here, Fz is deϐined as the force applied in the axial direction
additional to that generated by the pressure on the closed ends of the vessel [14].
Furthermore, in an earlier study ϐitting a thick-walled two-ϐibre material model to
experimental data from coronary arteries, an optimal ϐibre angle of 36◦ was found
[43]. Cross-sectional wall area (Aw, Fig. 7.2) was calculated from the diastolic
outer diameter of the carotid (Dd) as well as IMT, using the relation given by
Aw = pi

1
4
D2d −

1
2
Dd − IMT
2
. (7.4)
To map from a cut, stress-free conϐiguration of an artery, to an unloaded intact
conϐiguration, to a loaded conϐiguration, we deϐine two additional parameters (Fig.
7.2, [16, 18, 37]): the opening angle (α) and the unstressed inner vessel radius
(Ri). The value for αwas taken from literature (100
◦, [37]). The parameter Ri was
ϐitted using the constitutive model ϐitting routine (see below).
Residual stresses are accounted for by using the parameters λzz , α and Ri to
deϐine the stretches in the loaded conϐiguration with respect to the stress-free
conϐiguration, as described in Appendix 7.A1. To obtain D–P and Fz–P relations,
the following boundary value problem was considered. Assuming axisymmetry
and neglecting torsion, acceleration forces, body forces and axial extension, the
relevant components of the radial momentum balance are given by
∂ σr r
∂ r
+
σr r −σθθ
r
= 0 . (7.5)
Applying the boundary conditionsσr r(ri) = −P andσr r(ro) = 0, with ri the vessel
inner radius and ro the vessel outer radius, the expression for lumen pressure is
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given by
P =
∫ ro
ri
σθθ −σr r
r
dr . (7.6)
Reduced axial force is given by
Fz = pi
∫ ro
ri
(2σzz −σr r −σθθ )rdr . (7.7)
7.3.2 Parametrisation
Clinical measurements
The measurement protocol and data used in the present study are elaborated by
Holtackers et al. [13]. Brieϐly, twelve apparently healthy volunteers (22±3 years, 6
male) were recruited. The study was approved by themedical ethics committee of
Maastricht University Medical Centre (Maastricht, The Netherlands) and written
consent was obtained from all participants prior to enrolment.
Ultrasound (US) B-mode recordings were performed at the right common ca-
rotid artery (CCA) in the anterolateral plane, and obtained in triplicate. Diastolic
blood pressure (Pd) and pulse pressure (Pp) were measured three times during
the US imaging protocol using an oscillometric device (Omron 705IT; Omron
Healthcare Europe, Hoofddorp, The Netherlands).
The US recordings were analysed to determine right CCA cyclic distension (i.e.
diastolic-systolic diameter change,∆D) and diastolic diameter (Dd). Because the
echo tracking tool used (RFQAS; Esaote, Maastricht, The Netherlands) utilises the
media-adventitia echoes of near and farwalls, we assumed themeasured diameter
signal over time to reϐlect the CCA outer diameter [37]. Furthermore, we obtained
IMT at Pd using an automated software tool that reported good agreement with
manual IMT methods [47].
Generation of data set for constitutive modelling
For the present analysis, we obtained an initial data set consisting of group-
averaged values for Pd, Pp, Dd, ∆D, and IMT (Fig. 7.1, left panel). Subsequently,
uncertainties in themeasured variableswere accounted for by generatingmultiple
samples within the uncertainty ranges of each measured metric. We assumed
Gaussian distributed uncertainty domains for each measured variable Mi inM,
given by
Mi = M¯i ± 1.96SDintra,MipNrep , (7.8)
see also Table 7.1.
Each sample consisted of a vector M containing the following variables: M =
[Pd, Pp,Dd,∆D, IMT]. Here, M¯i represents the average measured value of variable
Mi and SDintra,Mi represents the corresponding intra-subject standard deviation
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Table 7.1: Overview of average values, intra-subject SDs and uncertainty domains per
measured variable.
Data of twelve subjects
Parameter Unit Mean Intra-subject SD Uncertainty domain
Pd mmHg 72 3±0 [69 ; 75]
Pp mmHg 58 3±1 [54 ; 62]
Dd mm 6±37 0±22 [6.12 ; 6.62]
∆D mm 0±789 0±035 [0.750 ; 0.829]
IMT µm 539 40 [494 ; 584]
Intima-media thickness (IMT) was obtained at Pd. Intra-subject SD was determined using
the method described in Bland and Altman [3]. The uncertainty domains of the measured
variables were calculated using their respective mean and intra-subject SD values, see Eq.
7.8.
(i.e. indicating measurement error [3]). In our data set, measurements were
performed in triplicate (i.e. Nrep = 3) [13]. Samples were generated within the
uncertainty domains of the measured variables, using Sobol’s low discrepancy
series, implemented in theMATLAB Statistics andMachine Learning Toolbox func-
tion sobolset (MATLAB R2015a; The MathWorks, Natick, MA, USA) [34]. This
sampling method samples the uncertainty domains uniformly and was chosen as
a ”worst case scenario”. To ensure adequate convergence of mechanical character-
istics distributions, we generated 5000 samples. Systolic blood pressure (Ps) was
calculated as Ps = Pd + Pp; systolic diameter (Ds) was calculated as Ds = Dd +∆D.
The distributions of Dd, Ds, Pd, and Ps as well as IMT are shown in Fig. 7.3. The
greater amount of scattering of systolic D and P data points compared to diastolic
data points is caused by the fact that systolic blood pressure is deϐined as the sum
of diastolic and pulse pressure.
As diastolic and pulse pressure were assumed to be independent, their sum
(systolic blood pressure) will have a larger spread than diastolic blood pressure
alone. The larger spread in systolic diameter than in diastolic diameter has the
same origin, as systolic diameter is deϐined as the sum of diastolic diameter and
distension.
For each sample in the data set, the following single-exponential function was
parametrised to obtain continuous D–P relations:
P(D) = Pd exp

γ

D2
D2d
− 1

. (7.9)
Here, D is a continuous variable describing vessel diameter and γ is a dimen-
sionless non-linearity factor, which is calculated from systolic and diastolic blood
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Figure 7.3: Density plots displaying the distributions of the 5000 computer-generated
samples for diastolic and systolic blood pressure and diameter (left), as well
as intima-media thickness (right). Density of diastolic pressure and diameter
as well as intima-media thickness samples is high. The greater amount of
scattering of systolic diameter and pressure samples arises from the fact that
systolic blood pressure is deϐined as the sum of diastolic and pulse pressure,
assumed independent. Similarly systolic diameter is deϐined as the sum of
diastolic diameter and distension, also assumed independent.
pressures and diameters as described by Meinders and Hoeks [24]:
γ=
log

Ps
Pd

D2s
D2d
− 1 . (7.10)
Model fitting procedure
The constitutive model was ϐitted to the single-exponential curve, obtained for
each sampleM of the data set. Model ϐitting was performed by variation of model
parameters celast, k1, k2, and Ri (Fig. 7.1, left panel). Lower and upper bounds of
all ϐitted parameters are given in Table 7.2.
Table 7.2: Complete overview of lower and upper parameter bounds used for ϐitting the
diameter-pressure data.
Parameter Unit Lower bound Upper bound
celast kPa 1 400
k1 kPa 0.1 · 10−3 400
k2 - 0 100
Ri m 0.5 · 10−3 10 · 10−3
For each sample in the data set, we assumed the single-exponential curve to be
valid within the range P ∈ {Pd,sample − 15mmHg, Ps,sample + 15mmHg}
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[11, 24]. In Fig. 7.3 (left), the distribution of Pd,sample vs. Ps,sample is displayed.
Fitting was performed using the trust-region reϐlective algorithm [25], imple-
mented in the MATLAB Optimization Toolbox function lsqnonlin and was initi-
ated from10 random start points in the parameter space using theMATLABGlobal
Optimization Toolbox function MultiStart. The same 10 start points were used
for ϐitting all samples. Throughout model ϐitting, we aimed to minimise the sum
of squared differences between measured pressure from the single-exponential
curve Pj and modelled Pmod, j :
εP =
1
nP
1
P2p
nP∑
j=1
(Pj − Pmod, j)2 , (7.11)
where, for each sample, nP is the number of ϐitting points and Pp is the pulse
pressure.
As a physiological constraint, Fz was forced to remain constant at a target value
deϐined Fz,target, with varying pressure. This assumption was based on experi-
mental work performed by Van Loon [44] andWeizsäcker et al. [46], observing
axial force to be nearly insensitive to changes in pressure for arteries inϐlated
at their in vivo axial pre-stretch. We enforced this constraint by minimising the
following expression:
εFz =
1
nP
1
F2z,target
nP∑
j=1
(Fz, j − Fz,target)2 , (7.12)
where Fz,target was assumed to be equal to 0.5 N. This valuewas based on a study by
Patel et al. [28] in excised, vertically suspended canine arteries that were extended
by hanging weights from the bottom end of the artery. For the carotid artery to
restore its in vivo length, a weight of 54 g was required, corresponding to an Fz of
0.5 N. The two weighted errors εP and εFz are combined into the weighted total
sum of squares (εT):
εT = wPεP +wFzεFz , (7.13)
wherewP andwFz are non-dimensional weighting factors. Here, we chosewP = 10
andwFz = 1. The εP termwas given a higher importance than the εFz term, because
of absence of Fz measurements in our study and uncertainty in the assumed
target value for Fz . The ϐitting error describing goodness-of-ϐit is expressed as a
normalised root mean square error (ERMS,P and ERMS,Fz ):
ERMS,P = 100% · pεP , and (7.14)
ERMS,Fz = 100% ·pεFz . (7.15)
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7.3.3 Simulations and analysis
Initial constitutive parameter estimation
The constitutive model was ϐitted to all 5000 samples of the generated data set
using the procedure explained in the previous section. This yielded 5000 initial
constitutive model realisations (i.e. termed INIT).
Uncertainty quantification and sensitivity analysis
All constitutive model realisations together yield insight in the distribution of
the mechanical characteristics that results from the presence of measurement
uncertainty. This distribution of mechanical characteristics was therefore used
to quantify the uncertainty in constitutive parameters (i.e. the ϐitted parameters
celast, k1, and k2), as well as collagen load bearing parameters, (i.e. the outcome
parameter Lcoll at various blood pressure levels, Fig. 7.1, left panel). We used
kernel density estimation (KDE) to visualise the distributions of constitutive
parameters and load bearing parameters. KDE estimates the probability density
function, which in this context implies the probability density of ϐinding a certain
value of a constitutive parameter or load bearing value [33]. Furthermore, we
quantiϐied spread in parameters using the median and the 25th to 75th percentile
conϐidence interval (PCI25→75). Calculating the PCI25→75 comes at hand when
assessing spread of skewed distributions.
Sensitivity analysis (SA) was subsequently used to apportion uncertainty in the
model-predicted mechanical characteristics to uncertainty in speciϐic measured
variables, or their interactions [17]. A global variance-based SA was performed
using regression-based adaptive generalised polynomial chaos expansion (agPCE),
as detailed in Quicken et al. [29]. The agPCEmethod captures the relation between
mechanical characteristics (X i) and measured variables (Mi) by means of an
adaptively constructed ϐinite polynomial expansion fagPCE:
X i = f
X i (M)≈ f X iagPCE(M) . (7.16)
Here, X contains the mechanical characteristics, i.e. X = [celast, k1, k2, Lcoll]. Fur-
thermore,M= [M1,M2, ...,MNvars] = [Pd, Pp,Dd,∆D, IMT], and Nvars is the number
of measured variables. Such a polynomial expansion provides ameta-model of the
mechanical characteristics estimationmethod. After constructing themeta-model,
the value of the leave-one-out cross-validation coefϐicient (Q2) was computed.
Coefϐicient Q2, ranging between a value of 0 and 1 is a quality measure of the
meta-model, indicating its predictive properties [40]. Throughout this study we
assumedQ2 > 0.99 to indicate an appropriate meta-model.
From the meta-model, the variance of a mechanical characteristic (a meas-
ure of its uncertainty) can be computed. The following sensitivity metrics were
computed:
• Main sensitivity indices. The main sensitivity index (Si) of measured vari-
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able Mi represents the expected reduction in uncertainty of the mechanical
characteristic if Mi were known exactly. Assessment of Si determines which
measured variables are most rewarding to be measured more accurately to
reduce model output uncertainty (i.e. parameter prioritisation) [31].
• Total sensitivity indices. The total sensitivity index (ST) of Mi represents
the expected uncertainty in themechanical characteristic that would remain
if all other measured variables except Mi were known exactly. Assessment
of ST determineswhichmeasured variables could potentially be ϐixedwithin
their uncertainty domain (i.e. parameter ϐixing) [31].
The contribution of each measured variable to total uncertainty in estimating
mechanical characteristics can be illustrated as the segments of a disc (Fig. 7.1).
Total uncertainty may be apportioned to single measured variables but, may
also arise from interaction between measured variables (Fig. 7.1). Moreover,
signiϐicant interaction effects are indicated by large differences between total
sensitivity indices and main sensitivity indices [39].
Simulating the effect of AGE-breaker vascular drugs
AGE-breaker treatment was simulated using the INIT realisations as take-off
points (Fig. 7.1, right panel). We explicitly assumed that a reduction in cross-link
density can be represented in the model by reducing parameters k1 and k2. The
rationale of reducing k1 and k2 is based on previous work measuring the stress-
strain response of collagen tissue atmultiple levels of cross-linking [8, 21]. In their
work it was observed that a decrease in cross-link density results in 1) a decrease
in ϐibre stiffness at low amounts of strain and 2) a decrease in the non-linearity
of the ϐibre stress-strain response [8, 21]. In our analysis, k1 and k2 were equally
reduced by 40% of their initial best-ϐit value yielding the k1 ↓, k2 ↓ realisations
(Fig. 7.1, right panel). All other constitutive model parameters were assumed to
remain unchanged.
7.4 Results
7.4.1 Representative example of a fitted constitutive model
A representative example of a model-based D–P and Fz − P relationship, obtained
bymodel-ϐitting a samplewithin the virtual data set is depicted in Fig. 7.4. Thebest-
ϐit constitutive parameters for this representative sample were celast = 40.1kPa,
k1 = 6.9kPa and k2 = 8.5. Collagen load bearing (Lcoll) increased monotonically
with blood pressure from 0.6% at diastolic blood pressure (Pd), to 10.2% at mean
arterial pressure (Pm), up to 25.0% at systolic blood pressure (Ps), respectively.
The slope of the plotted curves (dD/dP) is a measure of vascular compliance. Low
vascular compliance corresponds to high vascular stiffness and vice versa.
175
Chapter 7
pressure [mmHg]
40 60 80 100 120 140 160
d
ia
m
e
te
r
[m
m
]
5.6
5.8
6
6.2
6.4
6.6
6.8
7
D-P relation
model fit
systolic/diastolic 
points
pressure [mmHg]
40 60 80 100 120 140 160
0
0.5
1
1.5
F
z,target
a
x
ia
l
fo
rc
e
[N
]
Figure 7.4: Representative example of the model-predicted diameter-pressure (D–P) curve
and the reduced axial force-pressure (Fz–P) curve (dashed lines) as well as the
group-averaged data ϐitted upon (solid lines). The difference betweenmeasured
and model-predicted pressure was minimised over the pressure ϐitting range
(i.e. Pd−15mmHg to Ps+15mmHg), whereas reduced axial forcewas ϐitted to an
assumed target value of 0.5 N (Fz,target, respectively). Values of ϐitted parameters
were celast = 40.1kPa, k1 = 6.9kPa and k2 = 8.5. Fit errors, describing the
goodness-of-ϐit were ERMS,P = 0.020% and ERMS,Fz = 16%, respectively.
The model ϐit (dashed lines, Fig. 7.4) shows sigmoidal D–P behaviour over a
40 to 160 mmHg pressure range, suggesting low compliance for the lower part of
pressure range followed by higher compliance in the physiological pressure range
and again lower compliance for the upper part of the pressure range. Furthermore,
there is some deviation between the model-based Fz − P curve and the assumed
(pressure-independent) target value of 0.5 N (Fig. 7.4).
7.4.2 Uncertainty quantification and sensitivity analysis
The distributions of the ϐitted constitutive parameters are shown in Fig. 7.5.
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Figure 7.5: Kernel density estimates (KDE) describing the distributions of ϐitted constitu-
tive parameters (celast, k1, and k2). Distributions of parameters were quantiϐied
using the median and the 25th to 75th percentile conϐidence interval (PCI25→75),
respectively.
Best-ϐit parameter values for elastin stiffness (celast) were 47.4 [44.8; 50.0] kPa
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(median [PCI25→75]). For collagen parameters, best-ϐit parameter values were 2.1
[0.8;5.9]) kPa for k1, and 8.8 [7.9;9.5]) for k2, respectively.
In Fig. 7.6, distributions of collagen load bearing parameters (Lcoll) are given at
three blood pressure levels (Pd, Pm, and Ps, respectively).
L
coll
 [%]
D
e
n
s
it
y
 e
s
ti
m
a
te
 [
1
/%
]
INIT  
k1i,k2i 
median [PCI
25g75
]: 1.5 [0.6 ; 4.5]% 
median [PCI
25g75
]: 0.8 [0.3 ; 2.5]% 
Lcoll
 [%] Lcoll
 [%]
-10 0 10 20 30 40 50
0
2
4
6
8
10
0 5 10 15 20
0
0.2
0.4
0.6
0.8
0 5 10 15 20 25 30
0
0.1
0.2
0.3
0.4
at mean arterial pressure, Pm at systolic blood pressure, Psat diastolic blood pressure, Pd x10-2
INIT  
k1i,k2i 
median [PCI
25g75
]: 3.1 [1.2 ; 8.2]% 
median [PCI
25g75
]: 1.7 [0.6 ; 5.0]% 
INIT  
k1i,k2i 
median [PCI
25g75
]: 16.7 [12.7 ; 24.0]% 
median [PCI
25g75
]: 10.8 [7.2 ; 17.6]% 
Figure 7.6: Kernel density estimates (KDEs) describing the distribution of collagen load
bearing characteristic (Lcoll). Black line: KDE for initial constitutive model
realisations (INIT). Red dashed line: KDEs for model with decreased k1 and
k2 (k1 ↓, k2 ↓). KDEs were calculated at three blood pressure levels; diastolic
blood pressure (Pd), mean arterial pressure (Pm) and systolic blood pressure
(Ps). Distributions of parameters were quantiϐied using the median and the 25
th
to 75th percentile conϐidence interval (PCI25→75), respectively.
Note that Lcoll = 0% indicates that blood pressure load is fully borne by elastin,
whereas Lcoll = 100% indicates that blood pressure load is fully borne by collagen.
For the initial constitutive model realisations (INIT), we found Lcoll equal to 1.5%
at Pd, 3.1% at Pm, and 16.7% at Ps (medians, respectively). As shown in Fig. 7.6,
the 25th to 75th percentile conϐidence interval for Lcoll at Pd as well as Ps were large
([0.6;4.5]% and [12.7;24.0]%, respectively), indicating large uncertainty in model
predictions of constituent load bearing.
A full overview of main and total sensitivity indices is given in Tables 7.3 and
7.4.
Table 7.3: Main (Si) and total (ST) sensitivity indices for constitutive parameters celast, k1
and k2.
Constitutive parameter:
celast k1 k2
Measured variable Symbol Si ST Si ST Si ST
Diastolic blood pressure Pd 0.012 0.014 0.00060 0.0011 0.052 0.056
Pulse pressure Pp 0.0018 0.021 0.027 0.041 0.10 0.12
Diastolic diameter Dd 0.0060 0.036 0.033 0.047 0.29 0.32
Distension ∆D 0.62 0.67 0.90 0.93 0.50 0.54
Intima-media thickness IMT 0.31 0.31 0.0083 0.015 0.00083 0.00083
Sensitivity indices larger than 0.10 are indicated in bold. The coefϐicientQ2, indicating the
accuracy of the meta-model, was 0.997, 0.998 and 0.998 for celast, k1 and k2, respectively
In general, distension and IMT were most rewarding to be measured more
reliably. For the constitutive parameters celast and k1, this is illustrated by main
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Table 7.4: Main (Si) and total (ST) sensitivity indices for collagen load bearing parameters
(Lcoll) at three blood pressure levels; diastolic- mean- and systolic blood pressure
(i.e. Pd, Pm and Ps, respectively.)
Load bearing parameter:
Lcoll at Pd Lcoll at Pm Lcoll at Ps
Measured variable Symbol Si ST Si ST Si ST
Diastolic blood pressure Pd 0.00043 0.00098 0.00073 0.0016 0.0019 0.0027
Pulse pressure Pp 0.021 0.035 0.023 0.035 0.052 0.054
Diastolic diameter Dd 0.036 0.058 0.041 0.059 0.064 0.067
Distension ∆D 0.90 0.94 0.90 0.93 0.87 0.88
Intima-media thickness IMT 0.0028 0.0049 0.0031 0.0046 0.0031 0.0048
Sensitivity indices larger than 0.10 are indicated in bold. The coefϐicientQ2, indicating the
accuracy of the meta-model, was 0.993, 0.995 and 0.999 for diastolic (Pd), mean (Pm) and
systolic blood pressure (Ps), respectively
sensitivity indices (Si) between 0.62 and 0.90 for distension and 0.31 for IMT
(Table 7.3).
For collagen parameter k2, distension and diastolic diameter are most inϐlu-
ential (Table 7.3). Moreover, pulse pressure has some inϐluence, indicated by an
Si of 0.10 (Table 7.3). For collagen load bearing (Lcoll), distension was the most
important measured variable, indicated by Si between 0.87 and 0.90 (Table 7.4).
The main sensitivity indices of the other measured variables were smaller than
0.06, indicating low inϐluence (Table 7.4).
Reducing uncertainty of blood pressure measurements appears of negligible im-
portance in reducing uncertainty in estimating celast, k1, and Lcoll, indicated by an
Si < 0.06 (Table 7.3). Moreover, total sensitivity indices (ST) for diastolic blood
pressure and pulse pressure were smaller than 0.12, suggesting these variables
could be ϐixed in their uncertainty domain.
For all measured variables, differences between main and total sensitivity indices
were minor, i.e. ST − Si was smaller than 0.10 (Tables 7.3 and 7.4). This indicates
that the contribution of interaction terms betweenmeasured variables to the total
variance was negligible [31].
7.4.3 Model-based assessment of vascular drug therapies
Fig. 7.7 shows the effect of AGE-breaker treatment (simulated by k1 ↓, k2 ↓) on the
model-predicted D–P curve, as well as on area compliance (CA).
Here, the average D–P curves, originating on the one hand from the initial best-ϐit
constitutive parameters (INIT, black line), and on the other hand following reduc-
tion of k1 and k2 (k1 ↓, k2 ↓, red dashed line) are shown. Moreover, CA is shown in
the right panel for all INIT realisations (black circles), and the k1 ↓, k2 ↓ realisa-
tions (red circles). Area compliance was calculated using CA = (As −Ad)/(Ps − Pd),
with As = pi (Dd +∆D)
2 /4 and Ad = piD2d/4, respectively. Simulating k1 ↓, k2 ↓
caused a left-upward shift of the group-averaged D–P curve, as well as a 40% in-
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Figure 7.7: Left panel: Reducing collagen parameters k1 and k2 with 40% (i.e. k1 ↓, k2 ↓),
caused a left-upward shift in the average diameter-pressure (D–P) relation.
Tangent lines (dotted lines) from the diastolic D–P point to the systolic D–P
point indicate area compliance. Right panel: Simulating k1 ↓, k2 ↓ caused area
compliance (CA) to increase from 0.15 mm
2 mmHg–1 to 0.21 mm2 mmHg–1,
respectively. For each INIT and k1 ↓, k2 ↓ realisation, area compliance was
calculated using CA = (As − Ad)/ (Ps − Pd), with As = pi (Dd +∆D)2 /4 and Ad =
piD2d/4, respectively.
crease in CA (Fig. 7.7). In Fig. 7.6, distributions of Lcoll for the k1 ↓, k2 ↓ realisations
(red dashed curves) are shown. We found Lcoll to equal 0.8 [0.3;2.5]% at Pd, 1.7
[0.6;5.0]% at Pm, and 10.8 [7.2;17.6]% at Ps (median [PCI25→75]). As compared to
the INIT realisations, spread in Lcoll was lower for k1 ↓, k2 ↓ realisations (Fig. 7.6).
7.5 Discussion
Computational models of arterial wall mechanics could be valuable for predicting
effects of vascular drug therapies on individual arterial wall constituents. The
aim of this study was 1) to quantify how measurement noise propagates into
uncertainty of the model predictions, and 2) to pinpoint the measurements re-
sponsible for the largest spread inmechanical characteristics. The relevance of the
model output uncertainty was assessed by simulating the effects of vascular drug
treatment on constituent load bearing. To our knowledge, this is the ϐirst study to
perform rigorous uncertainty quantiϐication and sensitivity analysis, assessing
the inϐluence of measurement noise in clinical arterial pressure and diameter
measurements on constitutive model predictions.
The present study demonstrates that the clinically usefulness of estimating
mechanical characteristics of the carotid artery using a constitutive model is ham-
pered by measurement uncertainty. Using sensitivity analysis, we pinpointed that
the majority of uncertainty in mechanical characteristics is caused by uncertainty
in measurements of distension and IMT.
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7.5.1 Model fitting and parameter estimation
Model ϐitting was performed on single-exponential diameter-pressure curves
calculated from diastolic and systolic diameters and pressures. The assumption of
a markedly exponential diameter-pressure curve in the physiological (i.e. diastolic
to systolic) pressure range was reported in earlier works by Hayashi et al. [11]
and Meinders and Hoeks [24]. At a wider pressure range (i.e. 40 to 160 mmHg),
a representative constitutive model realisation suggested sigmoidal diameter-
pressure behaviour (Fig. 7.4). Such sigmoidal behaviour was also observed in in
vitro studies, performing inϐlation tests on human aortic segments and rat carotid
arteries [9, 22].
In the present study, best-ϐit constitutive parameter values for elastin stiffness
(i.e. 47.4 [44.8;50.0] kPa) were in agreement to those found for cadaveric carotid
arteries, reporting values between 20 and 60 kPa [30, 35]. Moreover, values
for collagen parameter k2 were well within ranges found in earlier studies [30,
35]. We found a large spread for constitutive parameter k1, governing collagen
stiffness, i.e. median [PCI25→75] of 2.1 [0.8;5.9] kPa. Previous in vitro studies
found k1 values ranging from 2.9 kPa to 99.9 kPa, respectively [35]. Therefore,
our ϐindings for k1 are on the low end to those found in the aforementioned
studies. It has been pointed out that appropriate choices of both k1 and k2 ensure
collagen to virtually not bear load at very low amounts of stretch (i.e. at sub-
physiological pressure loads), whereas it will become the dominant load bearer
at high amounts of stretch [15]. In the present study, and in in vivo studies per se,
diameter and pressuremeasurements at these very low pressures are unavailable,
making robust estimation of model parameters (particularly k1) cumbersome, as
illustrated by our ϐindings.
7.5.2 Sensitivity analysis
Sensitivity analysis indicated that the most important contributors to uncertainty
in celast are both the variables measured by ultrasound (i.e. distension and IMT),
whereas uncertainty in collagen parameter k1 was primarily caused by measure-
ment uncertainty of distension. Although ourmodel-based approach still requires
blood pressure to be measured, improving the precision of distension and wall
thickness measurements clearly appears to be most rewarding.
Recent technological advances in vascular imaging, including plane wave ul-
trasound and image-reconstruction algorithms, could reduce the measurement
noise of a single ultrasound measurement [2]. More practically, uncertainty in
mechanical characteristics could be reduced by increasing the number of repeated
measurements (Nrep, Eq. 7.8).
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7.5.3 Decreasing measurement uncertainty by increasing the
number of repeated measurements
We evaluated to which extent increasing Nrep, for all measured variables displayed
in Table 7.1, inϐluenced uncertainty in collagen load bearing parameters. Results
indicate that increasing the number of repeated measurements from 3 to 10
decreases the spread in Lcoll by≈ 50% (i.e. reducing the 25th to 75th percentile
conϐidence interval at systolic blood pressure from [12.7;24.0]% to [14.0;19.9]%,
Table 7.5).
Table 7.5: The effect of increasing the number of repeated clinical measurements (Nrep) on
collagen load bearing parameters (Lcoll) as predicted using the initial constitutive
model realisations
Lcoll at Pd Lcoll at Pm Lcoll at Ps
Nrep median [%] PCI25→75 [%] median [%] PCI25→75 [%] median [%] PCI25→75 [%]
3 1.5 [0.6;4.5] 3.1 [1.2;8.2] 16.7 [12.7;24.0]
5 1.5 [0.7;3.5] 3.0 [1.4;6.7] 16.5 [13.2;21.8]
10 1.5 [0.9;2.7] 3.0 [1.8;5.3] 16.5 [14.0;19.9]
PCI25→75: 25th to 75th percentile conϐidence interval, Pd: diastolic blood pressure, Pm: mean
blood pressure, and Ps: systolic blood pressure.
Based on the results of our sensitivity analysis, increasing the number repetitions
of ultrasound measurements appears most rewarding in reducing uncertainty in
collagen load bearing parameters.
7.5.4 Model-based assessment of vascular drug therapies
AGE-breaking vascular drug therapy was simulated by changing constitutive
model parameters governing collagen behaviour (i.e. parameters k1 and k2). We
chose to reduce collagen stress scaling parameter k1, as well as collagen stress-
curve shape parameter k2 by 40% of their initial best-ϐit values. Consequently,
the modelled collagen becomes incrementally less stiff at low amounts of strain,
but will also stiffen ‘later’ (i.e. at higher amounts of strain), compared to when the
initial parameters would be used (Fig. 7.6). This shift in stress-strain behaviour
with decreasing cross-link densities was measured also in collagenous tissue such
as the pericardium [8, 21]. Reducing constitutive parameters k1 and k2 by 40%,
resulted in amodel-predicted area compliance increase from0.15mm2 mmHg–1 to
0.21 mm2 mmHg–1 (Fig. 7.7). This observed 40% increase in area compliance is in
agreementwith in vitromeasurements performed in rat carotid arteries, following
AGE-breaker treatment [48]. Furthermore, collagen load bearing is reduced, with
the load transferred to elastin instead (Fig. 7.7). The median reduction of collagen
load bearing was 1%, 2%, and 6% at diastolic, mean and systolic blood pressures
(Fig. 7.5 and 7.6). However, the reduction in collagen load bearing was exceeded
by the initial spread in collagen load bearing (Fig. 7.5). This is illustrated by the
reduction in collagen load bearing at systolic blood pressure (6%, respectively, Fig.
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7.6), which is much smaller compared to the 25th to 75th percentile conϐidence
interval ranging between 12.7% and 24.0%, respectively (Fig. 7.6). In other words,
measurement of the beneϐit of a cross-link breaker on arterial compliance may be
easily concealed by uncertainties in the estimation of the effects, given the impact
of noise on model output.
7.5.5 Limitations
Unfortunately, no actual distensibility measurements, acquired before and during
AGE-breaker treatment were available in this study. Consequently, we had to
resort to simulating AGE-breaker treatment using our constitutive model. This
was achieved by changing constitutive parameters governing collagen behaviour,
reproducing results from an earlier AGE-breaker intervention study [48].
The one-layered Holzapfel-Gasser-Ogden model we used – neglecting active
smooth muscle response and containing only three parameters to characterise
elastin and collagen behaviour – was chosen as a pragmatic simpliϐication of the
actual arterial biomechanical behaviour. Furthermore, our model neglects the
dispersion of collagen ϐibre orientation in the adventitia [10]. We are aware that
more elaboratemodels exist describing the inϐluence of collagen cross-links on the
stress-strain behaviour of an arterymore directly. For example, in thework of Sáez
et al. [30], a cross-linking degree parameter was introduced which includes cross-
links behaviour between the main collagen ϐibres. However, using such a model
requires estimating one extra model parameter. To ensure unique parameter
values, this would require more clinical data to be measured, which might not be
possible in in vivo situations. Of note, parameter values in the current study were
highly similar, indicated by the fact that the best-ϐit constitutive parameter values
—for each of the 10 random starting points—were highly similar.
In our model, not all combinations of celast, k1, and k2 yield physiological be-
haviour. However, the adjustment (ϐitting) of these parameters ensures that
eventually their combination does yield physiological behaviour. The parameter
celast can be physiologically interpreted as the stiffness of the arterial elastin. All
ϐitted values for this parameter ranged from 35 to 55 kPa, which corresponds to
previous literature [35]. For k1 and k2, no separate interpretation can be made in
terms of physiology. Nevertheless, the ϐitted combinations of k1 and k2 yielded
physiologically realistic mechanical behaviour which, given that the elastin model
was plausibly parametrised, corresponds to realistic collagen behaviour.
The global variance-based sensitivity analysis method used, distinguishes from
more commonly used local methods by taking into account the entire distribu-
tion of measured variables, being model free, and assessing interaction between
measured variables [5, 29, 40]. However, it assumes on the one hand statistical
independence betweenmeasured variables and on the other hand that variance is
an adequate metric for model uncertainty. The latter assumption becomes ques-
tionable for skewed distributions of parameters, i.e. as present in the distributions
of parameters k1 and Lcoll at Pd and Pm, respectively (Fig. 7.5 and 7.6). A solution
to this problem could be to use moment-independent sensitivity methods instead
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[5]. To this end, Borgonovo [4] evaluated an alternative sensitivity metric that,
instead of being computed using the variance of the model uncertainty distribu-
tion, considers this distribution as a whole. In their paper, it was concluded that
sensitivity indices of both methods 1) show discrepancies between inϐluential
measured variables, but 2) agree in distinguishing non-inϐluential from inϐluential
measured variables [4]. Based on these ϐindings, we believe that utilising the
variance-based sensitivity analysis as proposed by Quicken et al. [29] in this study
is justiϐied.
7.5.6 Conclusion
This study shows that in vivo assessment of arterial wall mechanics using a con-
stitutive model is hampered by large model uncertainty. We quantiϐied model
uncertainty in constitutive parameters (i.e. celast, k1, and k2, respectively), and
collagen load bearing parameters, at various blood pressures (Lcoll). Our simu-
lation of vascular drug therapy suggested a reduction of collagen load bearing
of 6-percentage points, at systolic blood pressure. This reduction is 3 to 4 times
lower compared to its uncertainty. Therefore, model output uncertainty could
conceal potential effects of vascular drugs. Sensitivity analysis revealed that es-
timation of mechanical characteristics would beneϐit most from increasing the
precision of measurements of arterial diameter, distension, and wall thickness.
Whereas the potential for improving the precision of e.g. a single ultrasound
measure is practically limited, the effective precision of ultrasoundmeasurements
could be improved by increasing the number of repeated measurements.
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7.A1 Appendix: Constitutive model
7.A1.1 Constitutive relations
Under the assumption that 1) elastin and collagen act in parallel in terms of
mechanical load-bearing; 2) the vessel wall is incompresible, and 3) deforma-
tion occurs only along the principal axes, the constituent-speciϐic strain energy
functions (Eq. 7.1 and 7.2) were cast into a relation describing local Cauchy stress:
σn = −Ph +λn ∂Welast
∂ λn
+λn
∂Wcoll
∂ λn
, (7.A1)
The subscript n is r r for the radial direction, θθ for the circumferential direction
and zz for the axial direction. This results in the following expressions for σr r ,
σθθ and σzz :
σr r = −Ph + 2λ2r r celast , (7.A2)
σθθ = −Ph + 2λ2θθ celast + 4k1λ2θθ (λ2fibre − 1) cos2(β0)

exp

k2
 
λ2fibre − 1
2
, and
(7.A3)
σzz = −Ph + 2λ2zzcelast + 4k1λ2zz(λ2fibre − 1) sin2(β0)

exp

k2
 
λ2fibre − 1
2
,
(7.A4)
with Ph the local hydrostatic pressure within the wall, λfibre the ϐibre stretch given
by λfibre =
q
cos2(β0)λ2θθ + sin
2(β0)λ2zz , β0 the ϐibre helix angle, celast the constitu-
tive (stiffness) parameter of elastin, and k1 and k2 stiffness parameters of collagen,
respectively.
7.A1.2 Constitutive framework
Wedistinguished between the unstressed and stressed states of an artery (Fig. 7.2).
Under the assumption of an incompressible wall tissue, a mapping of coordinates
(r,θ , z) of the deformed, stressed conϐiguration to coordinates (R,Θ, Z) of the
unstressed conϐiguration is given by:
r(R) =
√√√
r2o −
R2o − R2
λzzkα
, θ = kαΘ , and z =
l
L
Z , (7.A5)
where Ro and ro are the outer radii of respectively the unstressed and stressed
conϐiguration. The parameter kα is deϐined as kα =
2pi
2pi−α , with α the opening
angle (Fig. 7.2). L and l are vessel length of the unstressed and stressed conϐigur-
ation deϐining the initial pre-stretch of an artery λzz . The principal stretch ratios
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(λr r ,λθθ ,λzz) with respect to the unstressed conϐiguration are:
λr r =
R
rkαλzz
, λθθ =
kαr
R
, and λzz =
l
L
. (7.A6)
Inner and outer radii (ri and ro, respectively) in the stressed conϐiguration can be
written as follows:
ri =
λθθRi
kα
and ro =
√√Aw
pi
+ r2i , (7.A7)
where Aw is the cross-sectional wall area in the stressed conϐiguration (Fig. 7.2).
In practice, Aw can be determined by measuring IMT and vessel diameter using
ultrasonography [12]. We furthermore assumed λzz = 1.20, α= 100◦, and β0 =
35.3◦.
7.A1.3 Balance equations
Conservation of momentum is given by
∇ ·σ = 0 , (7.A8)
with ∇ the spatial gradient operator. Assuming axisymmetry and neglecting
torsion, acceleration forces, body forces and axial extension, Eq. 7.A8 reduces to
∂ σr r
∂ r
+
σr r −σθθ
r
= 0 . (7.A9)
Applying the boundary conditions σr r(ri) = −P and σr r(ro) = 0, the expression
for lumen pressure (P) is given by
P =
∫ ro
ri
σθθ −σr r
r
dr . (7.A10)
Reduced axial force is given by
Fz = pi
∫ ro
ri
(2σzz −σr r −σθθ )rdr . (7.A11)
7.A1.4 Calculating collagen load bearing parameters
We calculated collagen load bearing (Lcoll) at three blood pressure levels; diastolic,
mean and systolic blood pressure (i.e. Pd, Pm, and Ps, respectively). Mean blood
pressure (Pm) was calculated as
1
3 Ps +
2
3 Pd. Using Eq. 7.A2, the expression for Lcoll
is given by
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Lcoll =
∫ ro
ri
τθθ ,coll
σθθ −σr r dr

P∈{Pd,Pm,Ps}
· 100% , (7.A12)
with τθθ ,coll the circumferential stress borne by collagen, given by
τθθ ,coll = λθθ
∂Wcoll
∂ λθθ
. (7.A13)
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8 General discussion
Chapter 8
8.1 Executive summary
Iē this thesis, we focussed on developing a computational modelling platformto assess heart-vessel interaction in humans.
We ϐirst performed a meta-analysis of clinical studies to explore a conceptual
chain-of-events describing how increases in arterial stiffness lead to increases in
systolic blood pressure with consequent left ventricular mass increases. Based
on the ϐindings as well as the limitations drawn from our meta-analysis, we then
turned our attention to developing computational models and applying them
to speciϐic research questions. We developed a computational modelling plat-
form describing the heart and vasculature, consisting on the one hand of a well
characterised and validated whole-heart model, and on the other hand a newly
developed vascular module describing wave transmission in blood vessels. This
platform was subsequently used to assess the validity of augmentation index, a
metric that is hypothesised to capture the deleterious effect of increased wave
reϐlection, and earlier arrival of wave reϐlections on left ventricular (LV) work.
Parallel to using computational models for hypothesis-testing, we were in-
terested in using our platforms for patient-speciϐic applications. A caveat of
patient-speciϐic modelling is missing data. To beneϐit patient-speciϐic modelling,
we evaluated the role of incorporating physical-physiological adaptation rules
into models to reduce the amount of clinical data needed to render these models
patient-speciϐic.
Following model development and assessment steps, we employed models in
twouse-cases concerningpatient-speciϐicmodelling: i) characterisingLV (diastolic-
) function, which is highly relevant in heart failure with preserved ejection frac-
tion (HFpEF) and ii) constitutive interpretation of arterial stiffness measurement,
which is key to treatment monitoring.
8.2 Left ventricular mass, arterial stiffness and
systolic blood pressure: Exploring the
‘Bermuda Triangle’
As a ϐirst step, we performed a meta-analysis to assess clinical evidence describ-
ing changes in indices of cardiac- and vascular structure and function following
intervention, i.e. conventional antihypertensive treatment, bariatric surgery or
lifestyle interventions. Pooled analysis of clinical data suggested a signiϐicant
association between treatment-induced changes in arterial stiffness (assessed by
pulse wave velocity (PWV)) on changes in LV mass (assessed by LV mass index
(LVMI)). This association was characterised by a 6.9 g m–2 decrease in LVMI per 1
m s–1 decrease in PWV (Chapter 2).
Haider et al. [23] established that in subjects with LV hypertrophy (LVH) an
LV mass increase of 50 g m–1 (i.e. LV mass indexed by body height) increases the
relative risk of cardiovascular disease by approximately two-fold. Studies included
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in our review reported PWV changes of approximately 1 to 3 m s–1, whereas LVMI
changes were approximately to 2 to 35 g m–2 (Chapter 2). Our ϐindings thus
corroborate that arterial stiffness may be a major player in the above described
chain-of-events leading to LV hypertrophy.
In the proposed chain-of-events, it is expected that systolic blood pressure is im-
portant as well, because increased arterial stiffness has been described as a cause
and consequence of increased systolic blood pressure [12, 30, 56]. Furthermore,
increased LV mass may result from independent mechanisms including increased
arterial stiffness (e.g. through earlier arrival of pulse wave reϐlections) as well
as increased systolic blood pressure (e.g. through decreased aortic compliance)
[8, 24, 42].
Unfortunately, we were unable to uncover sequential relations in this chain
using our data extracted from clinical intervention studies. The editorial com-
mentary on our review article used the term ‘Bermuda Triangle’ [59] as analogy
to express the obscure mutual relations between arterial stiffness, systolic blood
pressure, and LV mass. Interestingly, the authors [59] do justice to their analogy
by glossing over the essential difference between diastolic blood pressure and
systolic blood pressure. Mechanistically, systolic (i.e. ‘peak’) blood pressure de-
termines peak wall stress and, therefore, is a known trigger for LV hypertrophy
[19, 22, 51].
Based on our ϐindings from Chapter 2, four key issues related to the interpret-
ation of corresponding clinical data and studies may be identiϐied:
• First, the number of follow-up visits throughout intervention was insufϐi-
cient to infer sequential relations between LV mass and the various haemo-
dynamic indices reported. Meta-analyses of clinical studies appear unsuited
to establish causality [1].
• Second, not all data we hoped to ϐind was reported: studies that related left
ventricular diastolic function to (changes) in arterial stiffness were scarce.
• Third, data on arterial stiffness changes were limited to reporting functional
indices, (e.g. distensibility or pulse wave velocity), and did not consider
constitutive/structural properties.
• Fourth, the clinical characterisation of e.g. LV mass and PWV contains mea-
surement noise, which inϐluences the associations found.
8.3 Applications
In this section, we place the ϐindings from our model application studies in a
broader perspective. We structure this discussion on the applications as follows:
1) cardiac, 2) vascular, and 3) heart-vessel interaction applications. Future re-
search directions are discussed for each category separately.
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8.3.1 Model-based estimation of left ventricular diastolic
function indices: Towards non-invasive cardiac
catheterisation
We developed a non-invasive computational approach to obtain markers of LV
diastolic abnormalities consisting of the metrics LV end-diastolic pressure (ped)
and compliance (Ced) (Chapter 6). We tested our model-estimations against
data obtained by means of LV pressure-conductance catheterisation, and found
reasonable agreement between model and measurement.
The patient population studied inChapter 6 (n=39)was homogeneous, contain-
ing too few patients with HFpEF according to current guidelines [43]. Therefore,
it was not possible to examine whether and how ped and Ced differ between HFpEF
and control subjects, nor could we compare our model estimates against com-
mon echocardiographic indices, such as E/e’, that are currently being used to
distinguish between normal and elevated ped [43]. Exploitation of an existing
case-control study including echocardiography andblood pressuremeasurements,
such as the Queen of Hearts study [11], would help in judging the ‘face value’ of
model-based ped and Ced.
As a next step, a randomised controlled trial (RCT) is needed to prove the added
value of ped and Ced in classifying HFpEF or diastolic dysfunction. Previously,
Zonnebeld et al. [64] proposed an RCT design to assess the added value of compu-
tational model predictions to optimise vascular access surgery in haemodialysis
patients. Their study design consisted of routine, and routine complemented with
model-prediction arms. Such a design would be realistic to test our approach.
Further development may include considering measurements of both baseline
and Valsalva in our model-ϐitting scheme. Such approach, effectively doubling
the amount of data available for model-ϐitting could improve model-estimations.
Regarding modelling aspects herein, integration of this data requires mimicking
Valsalva circumstances in CircAdapt. Unpublished numerical work, in which we
were engaged previously, indicated feasibility of simulating Valsalva using our Circ-
Adapt model. Simulated LV pressure and volume signals during Valsalva showed
typical responses as compared to measured ones. Integration of haemodynamic
measurements acquired during Valsalva in our model-based approach, demands
strict adherence to a standardised Valsalva protocol (e.g. in terms of intra-oral
pressure and straining duration, Chapter 6).
8.3.2 Expanded view of vascular haemodynamics and wall
mechanics: Towards in silico assessment of the
performance of novel drug therapies
Vascular haemodynamics and wall mechanics were studied using models with
varying levels of (anatomical) detail. Our vascular module (Chapter 3) describes
pressure-ϐlow wave transmission in extensive arterial and venous networks. Al-
though our model’s numerical implementation differs from those used in the
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existing wave propagation modelling literature [6, 34, 41, 50], we found good
agreement between our model’s pressure and ϐlow waveforms and those of a
previously validated pulse wave propagation model [6, 34], i.e. relative errors in
pressure and ϐlow waveforms≤ 5.6%.
The constitutivemodelwe used (Chapter 7), assuming a single-layeredmixture
of elastin and collagen, provides three-dimensional stresses and strains of these
microstructural wall components. Constitutive parameter estimation using our
model was feasible, and estimated constitutive parameters were in agreement
with those reported in literature [53].
We introduced a vascular adaptation model (Chapter 5) to facilitate person-
alisation of vascular networks for use in patient-speciϐic modelling applications.
Our vascular adaptationmodel adequately predicted arterial radius andwall thick-
ness as concluded from our test-case in which we compared model-estimated
arterial geometries with those measured using ultrasound and MRI in healthy
young volunteers (bias±2SD of difference equal to 0.2±2.6 mm, and –140±557
µm, respectively).
Observed changes in aortic (systolic) blood pressure with ageing are attributed
to changes in aortic compliance or wave reϐlections [5, 40, 44]. Models describ-
ing vascular wave transmission could be used to apportion LV mass changes to
changes in compliance or wave reϐlections. Previous studies simulated arterial
haemodynamics in virtual patient cohorts, e.g. to study changes in the aortic pres-
sure pulse during ageing, or to assess the validity of metrics deemed a proxy for
arterial stiffness [46, 60, 61]. To create large numbers of virtual haemodynamic
models that represent virtual patients, perturbations of vascular segment geo-
metries were imposed based on population-average values [60, 61]. To facilitate
research using virtual patient cohorts, the basic concept of our vascular adapt-
ation model may aid physiological parametrisation of subject-speciϐic vascular
trees.
In our analysis testing the applicability of incorporating vascular adaptation
in haemodynamic models (Chapter 3), discrepancies between model-estimated
geometries andmeasureddatamay result from limitations in themodel of vascular
adaptation. Our model is formulated based on the hypothesis of a homeostatic
feedback mechanism that triggers changes in vascular geometry [31, 37, 39, 63].
Basedon experimental data, weproposed a vascular adaptationmodel inwhichwe
assumed complete normalisation of wall (shear) stresses to homeostatic values.
It has been suggested that the assumption of wall shear stress normalisation
may become invalid for speciϐic patients or patient groups in which the adaptive
capacity of blood vessels is compromised (e.g. in diabetes or end-stage renal
disease [7, 10, 15]). As consequence, applying the concept of adaptation may
be inapplicable in some cases. One way to deal with issues of applicability is to
estimate the adaptive capacity of blood vessels on beforehand, for instance using
existing non-invasive tests such as ϐlow-mediated dilation (FMD), because FMD-
scores have been shown in arterio-venous ϐistula creation studies to correlate
with blood vessels’ ability to remodel [3, 45].
In our vascular module, we used a mathematical relation (i.e. referred to as
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‘tube law’) for solving for pressures and ϐlows, that relates blood pressure and
vessel area. This tube law mimics the elastic behaviour of the vascular wall as
observed in experiments by modelling an incremental increase in vessel stiffness
for an incremental increase in pressure (Fig. 8.1). For the physiological pressure
range (approximately 50 to 180 mmHg, Fig. 8.1), choosing appropriate stiffness
values (i.e. k-values, Fig. 8.1) for the tube law resulted in excellent agreement with
pressure-radius experiments of human arteries. For pressure loads below 50
mmHg or above 180 mmHg, deviations between tube law (coloured curves) and
experiment (black curves) are observed, which limits our tube law’s application
to (sub-)physiological pressure ranges.
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Figure 8.1: Estimated pressure-radius curves using tube law (coloured curves) drawn
over previously measured data of human arteries (black solid, dashed and
dotted curves, respectively). Measured data were taken from ex vivo inϐlation
experiments on human arteries [25].
Ex vivo inϐlation experiments of human and animal arteries over awide pressure
range (e.g. 0 to 200 mmHg) clearly indicated S-shaped (‘sigmoidal’) pressure-area
relations [18, 36]. Such behaviour cannot be captured using our tube law (Fig.
8.1), but requires more elaborate mathematical functions [36], or a constitutive
model description of a blood vessel’s behaviour [27].
For some applications, consideration of microstructural properties of the arte-
rial wall in wave transmission models may be necessary, because the vessel wall
microstructure inϐluences pressure-ϐlow waves propagation [2].
For example, much research has been conducted in the ϐield of drug develop-
ment to reverse ageing-related stiffening of arteries [16, 33, 58]. Drugs that were
developed include arterial wall collagen cross-link breakers (e.g. alagebrium chlor-
ide) that aim to reduce arterial stiffness by cleaving cross-links, thereby reducing
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vessel wall material stiffness. These drugs showed beneϐicial effects on compli-
ance in rats [62]. Since cross-link breakers reportedly affect large artery stiffness,
that of small arteries, but also cardiac mass [17, 55, 62] the question, yet again,
arises which local compliance or distributed effects of wave propagation play in
their reported beneϐicial effect.
Based on the work performed in the thesis (Chapters 3, 5 and 7), creating an
interface of on the one hand personalised constituent-based models of arterial
wall mechanics and on the other hand our vascular module may serve as starting
point for studies assessing effectivity of such novel vascular drugs.
Because signiϐicant uncertainty in model-estimates of collagen load-bearing
was found, primarily due to measurement error in ultrasound data (Chapter
7), we speculated on methods to improve estimation of model predictions [54].
Holtackers et al. [28], demonstrated that local carotid artery distensibility sig-
niϐicantly changed when young healthy volunteers were measured under two
different (standardised) head positions. This ϐinding may be exploited to effect-
ively double the amount of mechanical information that can be employed for
model ϐitting, by performing measurements at two head positions. Incorporating
measurements, acquired at two axial stretch levels (‘in vivo biaxial testing’), could
thus in future serve as a utility to reduce the uncertainty in constitutive property
estimation [49].
8.3.3 Simulating heart-vessel interaction: Blood pressure
characteristics, left ventricular hypertrophy, and left
ventricular diastolic function
We extended the existing CircAdapt whole-heart model [57] with a vascular mod-
ule and investigated heart-vessel interaction by calculating on the one hand wave
intensity tracings, and on the other hand augmentation index (AIx) (Chapters 3
and 4). We found that wave intensity tracings, as derived from our model simula-
tions of local pressure and ϐlow velocity corresponded to clinical measurements
[29]. As such, we concluded that our model is suited for studying mechanical
linkage between cardiac mechanics and vascular haemodynamics at the level of
wave reϐlections. The advantage of a model of heart-vessel interaction is that it
can provide noise-free and controllable study conditions. These characteristics
are desirable when performing mechanistic studies, because measurement noise
limits determination of wave transit delays, which are about 1 to 20 milliseconds
[26, 48].
Patient-studies showed that concentric left ventricular remodelling and LVH
are common ϐindings in hypertension [13, 20]. Therefore, consideration of LV
afterload in relation to LV structure and function (i.e. heart-vessel interaction)
appears to be important for research on treating LVH. Whereas ϐindings from
Chapter 2 offer insight in correlates of left ventricular hypertrophy, it does not
elucidate the mechanism leading to left ventricular hypertrophy.
We justiϐied using our circulatory model for heart-vessel interaction hypothesis
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testing, based on successful model validation and illustration of its applicability
in clinically relevant use-cases (Chapters 3 and 4). In a preliminary study, we
expanded the circulatory model with a model describing cardiac adaptation [4].
We then simulated the effect of stiffer arteries in ourmodel. Computer simulations
of haemodynamics were obtained under a reference normotensive (REF) state
and a chronic hypertensive (HYP). Comparing left ventricular mass and pulse
wave velocity before and after adaptation to a systemic hypertensive situation,
we found a REF–HYP change (∆) in LVMI of –23 g m–2, as well as a difference
in PWV of –2.2 m s–1. Interestingly, the model-predicted increase of LV mass in
hypertension ϐinding ϐits well with the association between ∆LVMI and ∆PWV as
extracted from clinical intervention studies (Fig. 8.2).
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Figure 8.2: Change in pulse wave velocity (∆PWV) and left ventricular mass index (∆LVMI)
values in clinical studies (circles) and simulation (diamond). Closed circles:
antihypertensive drug therapy studies. Open circles: other types of intervention
studies, e.g. bariatric surgery. Diamond: Simulated relation between ∆PWV
and ∆LVMI obtained by subtraction of systemic hypertension simulation (HYP)
values from the reference simulation (REF) values.
Future modelling work should aim for mechanistic hypothesis-testing of the
effect of earlier arrival of pulsewave reϐlections (e.g. usingwave intensity analysis)
or evaluation of interactive metrics (e.g. AIx) on LV relaxation. Directly related
to this aim is the role of wave reϐlections in diastolic dysfunction [9, 21, 47, 52].
Studies suggested that earlier arrival of wave reϐlection during the ejection phase
would require the cardiac tissue to generate more tension to overcome the in-
creased afterload [8, 21]. Increased tension in the LV sarcomeres is known to affect
muscle relaxation, which will impair LV ϐilling (i.e. diastolic function). Research on
the role of arterial load aspects in the development of LV diastolic dysfunction is
clinically relevant, because LV diastolic dysfunction is a precursor of heart failure,
speciϐically HFpEF [32, 35, 38].
Before we can in silico investigate LV relaxation and the role of arterial load
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aspects, as described above, we ϐirst need to address a limitation of our current
model. The physiological validity of the whole-heart model [57] that was used
in our full circulatory model was limited by the sarcomere contraction model,
containing only a phenomenological description of cardiac muscle contraction
and relaxation [57]. Recently, the MechChem sarcomere model was proposed,
describing mechanical-chemical interactions in cardiac sarcomeres [14]. The
MechChemmodel does take into consideration tension-dependent relaxation, as
governed by intracellular calcium concentration [14]. The MechChemmodel is
currently being interfaced to the existing CircAdapt heart modules, which paves
the way for studies investigating e.g. the inϐluence of arterial wave reϐlections on
LV relaxation.
8.4 Multi-scale modelling perspective and clinical
relevance
In Section 8.3, we have discussed the model developments and applications that
have been presented, distinguishing between cardiac, vascular and interaction
aspects. Together, the model-based approaches may be combined into a multi-
scale modelling platform, to study cardiovascular (patho-)physiology from e.g.
changes in wall-constituent properties of blood vessels to their impact on the
contractile function of cardiac muscle (Fig. 8.3).
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Figure 8.3: Status of development of a multi-scale modelling platform, suited to investigate
in silico the indicated hypothesised causative pathways.
The hypothesised causative pathways as indicated in Fig. 8.3 are clinically rel-
evant, because the general population becomes increasingly older. As a result,
more patients will likely present with age-related arteriosclerosis (i.e. stiffened
arteries) and LV remodelling and/or diastolic dysfunction, affecting medical treat-
ment decisions. Therefore, increased mechanistic insight into cardio-vascular
ageing, including well-tested indices that capture functional impairment beyond
that expected to come with age, is needed to achieve personalised and sustainable
health management.
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8.5 General conclusions
In this thesis, we developed, characterised and assessed computational models
consisting of networks of applied physical-physiological relations. The models
have shown to be helpful in understanding measurable haemodynamic measures
as well as enabling estimation of non-measurable properties. As such we have
contributed to the integrative interpretation of data which nowadays is at the clini-
cian’s disposal. Furthermore, the presented model-components may be combined
to form a multi-scale platform to further investigate and characterise pathological
heart-vessel interaction in the context of an ageing general population. Ultimately,
the developing model platform may serve as a ‘digital twin’ of the cardiovascular
system of a human, for example to assess cardiac effects of vascular drugs.  
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Summary
OĚė cardiovascular system enables transportation of dissolved gases, hor-mones and other substances to support metabolism, growth, and repair.The system consists of an actively contracting heart, which ejects blood
into conducting pulmonary and systemic blood vessels. Usually, the heart’s left
ventricle and the large arteries are coupled in such a way that the volume and
rate of the ejected blood match the impedance of the receiving arteries. This
coupling is inϐluenced by changes in cardiac and arterial structure and function,
which are interrelated through haemodynamic interactions. Therefore, measur-
able haemodynamic features are of (clinical-epidemiological) interest as markers
of cardiovascular health. However, because such markers reϐlect changes ‘in-
between’ the interacting heart and arteries, their interpretation may be tricky.
We hypothesised that an integrative description of cardiac and vascular physiol-
ogymay be better suited tomechanistically explain the interrelationships between
cardiac and vascular structure and function. The development and application
of a computational modelling platform to assess heart-vessel interaction is the
subject of this thesis.
As a ϐirst step in the development of our computational modelling platform,
we performed a meta-analysis of clinical literature on heart-vessel interaction
through treatment-induced changes in arterial properties on the one hand and left
ventricular (LV) structure on the other hand (Chapter 2). Through meta-analysis,
we found that a decrease in arterial stiffness is associated with a reduction in LV
mass. Unfortunately, it was not possible to infer any causal relationships between
arterial stiffness, blood pressure and LV structure.
To infer causality in heart-vessel interaction, we turned our attention to compu-
tational models describing circulatory physiology (Chapter 3) and extended the
existing CircAdapt model, a well-characterised whole-heart model, with a new
transmission line (TL) model that also allows for an accurate examination of wave
transmission and reϐlections in blood vessels. The governing equations of the TL
model originate from those derived in the 1880s, describing signal transduction
along telegraph wires. We ϐirst veriϐied the numerical framework of the TL model
by benchmarking against a previously validated pulse wave propagation model.
The results showed good agreement regarding pressure and ϐlow waveforms (i.e.
relative errors ≤2.9% for pressure, and ≤5.6% for ϐlow). Subsequently, the per-
formanceof the combinedCircAdapt–TLmodelwas tested in ause-case, simulating
carotid arterywave intensity proϐiles during normotensive aswell as hypertensive
conditions. The results of this use-case indicate that the domain of applicability
of CircAdapt is extended for detailed studies on heart-vessel interaction if the TL
model is included.
In Chapter 4, we applied the CircAdapt–TL model to scrutinise the validity
of the augmentation index (AIx) as a vascular index of increased pulse wave
reϐlections in a stiffer arterial tree. The AIx quantiϐies a deemed augmentation
(i.e. as signalled by an inϐlection point) of a pressure waveform relative to its
peak-to-peak amplitude. In population studies, the AIx increased with age, which
is usually interpreted to result from an increase in pulse wave reϐlections with
the age-related stiffening of arteries. We hypothesised that cardiac properties are
likely to inϐluence pressure augmentation as well because they too determine the
time-course of the arterial pressure waveform. We simulated the isolated and
combined inϐluences of myocardial shortening velocity and arterial stiffness on
AIx and indeed found that the AIx may depend as much on cardiac as on vascular
properties, which goes against the common interpretation of the index.
In the above, our use of models focussed on evaluating hypotheses. A more
advanced application would be to predict patient-speciϐic haemodynamic changes
and features, which adds the challenge of model personalisation.
Chapter 5 is the ϐirst chapter concerning personalisation of computational
models. In our previous simulation studies, we prescribed generic vessel geomet-
ries for the modelled arterial and veins. Source data describing these geometries
came from a collection of independent literature sources. As such, different parts
of the modelled vascular tree are based on data from different subjects, differing
in age, sex, BMI and other characteristics. Models containing generic descriptions
of the human vasculature often appear insufϐicient for patient-speciϐic predictions.
Unfortunately, complete characterisations of blood vessel geometries and proper-
ties are usually not available or even attainable in practice. Chapter 5 presents an
adaptationmodel to complement sparse data on arterial radius andwall thickness,
utilising rules for the response towall stress and shear stress. To test our approach,
we acquired vascularMRI and ultrasound data sets of arterial wall thicknesses and
radii of central and arm segments in ten healthy subjects. Comparison between
adaptation model-predicted and measured geometries demonstrated small dif-
ferences (bias±2SD of difference equal to 0.2±2.6 mm for arterial radius, and
−140±557 µm for wall thickness, respectively). We believe that our methodology
is suitable to complete sparse data sets in patient-speciϐic applications.
The subsequent twochapters employedmodel-basedapproaches for thepatient-
speciϐic characterisation of LV or arterial properties, respectively. In Chapter 6,
we used the CircAdapt–TL model to non-invasively estimate LV end-diastolic pres-
sure (ped) and compliance (Ced) from routine measurements of brachial artery
blood pressure and echocardiographic recordings. We found reasonable agree-
ment between our non-invasive estimates of ped and Ced and those measured by
an invasive catheter.
To improve mechanistic interpretation of clinical arterial stiffness data, inverse
modelling approaches may be used to estimate tissue properties from measured
vessel geometric anddynamic elastic properties. InChapter7, weutilised a consti-
tutive model of carotid artery mechanics, describing the stress-strain behaviours
of arterial collagen and elastin. As a prerequisite, we performed extensive un-
certainty quantiϐication and sensitivity analysis to investigate how measurement
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errors propagate into estimation errors. We were able to substantiate that the
signiϐicant uncertainty with a single set of carotid artery ultrasound and pressure
data points can be reduced by increasing the number of repeated acquisitions of
cyclic diameter (i.e. distension) and of wall thickness (i.e. intima-media thickness).
This thesis concludes with a general discussion (Chapter 8), in which we
provide an overall perspective of how the above model developments and per-
sonalisation approaches may be further integrated. We envision the role of our
developing computational models to facilitate 1) detailed haemodynamic studies,
2) patient-speciϐic estimation of non-measurable characteristics, and 3) in silico
evaluation of disease progression and treatment scenarios.
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Valorisation addendum
TĔcombat cardiovascular disease andenablepatients at risk to age in ahealth-ier way, roughly two strategies can be distinguished. The ϐirst strategyconsists of the identiϐication of the cellular mechanisms responsible for
cardiovascular disease followed by the development of new drugs acting on these
cellularmechanisms to halt or even regress the disease (‘the biologist’s approach’).
The second strategy consists of the earlier detection of cardiac and vascular prob-
lems by developing diagnostic technologies that characterise the mechanical
performance of the heart and vessels (‘the engineer’s approach’).
This thesis advocates the use of computational models that embody human
cardiovascular physiology to achieve better characterisation of heart failure and
arterial stiffness mechanisms. Ideally, computational models are so realistic that
they can be regarded as ‘digital twins’ of actual patients. The path towards such
a digital twin comprises of both model development steps (Chapters 3 and 5)
as well as model corroboration steps (Chapters 4, 6, and 7), in which the utility
of the model is put to the test. Although an ultra-realistic digital twin of human
cardiovascular physiology is not available yet, we contribute substantially to the
development of a digital twin. It is therefore of no surprise that the present
thesis readily contains signiϐicant valorisation potential: First, valorisation of the
knowledge obtained in this research may advance society and the academic ϐield
as primary target groups. The second valorisation aspect represents economic
exploration by transferring knowledge into new products or services through
business development.
Below, I provide a discussion on both valorisation aspects.
Target groups
Pathological changes to the heart and blood vessels impact local cardiac and vascu-
lar tissue properties and inϐluence their function. In patients, this harmful process
can progress silently for years but will eventually become apparent. Therefore,
assessment of tissue properties can beneϐit timely diagnosis of pathologies pre-
cluding cardiovascular disease. However, clinically applicable measurements
alone are often insufϐicient to assess tissue properties. The combination of mecha-
nistic computationalmodelswith awell-selected set of clinicalmeasurementsmay
allow for estimation of tissue properties, using an inverse approach, in which the
model is ‘tuned’ to the measurements. In this thesis, we showed that an inverse
approach to routine data has real potential in detecting diastolic dysfunction, a
precursor of heart failure (Chapter 6).
Currently, assessment of left ventricular ϐilling pressure in patients relies on
a clinical algorithm that is based on three echocardiographic indices. Such an
algorithm can discriminate between (four) grades of diastolic dysfunction (i.e.
with increasing severity; no-, grade I-, grade II- and grade III diastolic dysfunction)
[1], each of them reϐlecting a category of ϐilling pressure, ranging from low to
elevated [2]. However, in the absence of one echocardiographic index and con-
ϐlicting results of the remaining two indices, the clinical algorithm contains a grey
zone in which ϐilling pressure is classiϐied as indeterminate. The model-based
method introduced in Chapter 6, −providing actual estimations of ϐilling pres-
sure and diastolic compliance− could be used alongside or concurrently with the
existing clinical algorithm. Such methodology comes at hand when confronted
with patients in which the clinical algorithm cannot determine ϐilling pressure.
An inverse method may also be used for characterisation of vascular wall tissue.
For this purpose, we did not use the circulatory computational model, but rather
a more detailed model describing local arterial wall mechanics that incorporated
distinct features of collagen and elastin. The method allows identiϐication of the
wall constituent that contributes the most to the increase in stiffness of a patient’s
arteries. As such, these models may be of use in the design of new vascular drugs
(Chapter 7).
Parallel to providing personalised estimates, the developed computational
models are useful for hypothesis testing. InChapter 4, ourmodel study challenges
a widespread interpretive model in which augmentation index is deemed and
promoted as an index for arterial properties. Already, an increasing number
of human studies show that augmentation index might also be inϐluenced by
ventricular function and thus cannot serve as a distinct marker of arterial stiffness
or wave reϐlection magnitude. Our study provided yet another important piece of
evidence that the augmentation index does not solely reϐlect arterial stiffness.
While the research version of the circulatory computational model we used is
implemented in a scientiϐic programming environment (MATLAB, TheMathworks,
Natick, USA), a stripped-down version of the model is also available on-line as a
user-friendly ‘CircAdapt simulator’. This simulator is actively used for teaching
cardiovascular physiology in the (bio-)medical curricula at Maastricht University
and many other universities. Currently, the simulator is capable of describing a
catalogue of cardiac pathologies, including cardiogenic shock, pulmonary arterial
hypertension, and valvular defects. Integration of the vascular module (Chapter
3) that models pressure and ϐlow phenomena in the systemic arterial and venous
circulations, further extends this catalogue. The present work paves the way for
simulation-based education with even more (vascular) types of pathology. Ex-
amples of pathologies as well as their recommended clinical assessment methods
include, e.g. 1) arterial stiffening; quantiϐiable using carotid-to-femoral pulse wave
velocity, and 2) peripheral arterial disease; assessable using the brachial-ankle
index, respectively.
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Utilisation of knowledge for the development of
products or businesses
First, the circulatory computational model is of interest to medical device and
(health) technology companies. For example, Samsung and Apple have shown
interest in developing wearables (e.g. smartwatches) to be used for continuous
measurement of the arterial pulse waveform. Samsung’s approach uses a smart-
watch to measure the photoplethysmogram (PPG) at the location of the radial
artery [3]. Speciϐic features of the wrist-measured PPG waveform are hypothes-
ised to be indicative of vascular conditions such as arteriosclerosis, but also of
psychological conditions, including mental stress. Both arteriosclerosis and men-
tal stress are known risk factors of cardiovascular disease [4]. Information from
continuous monitoring of arteriosclerosis and mental stress could thus be used to
identify patients at risk of cardiovascular disease. Computational models like ours
are very well suited to (pre-)test and select sets of PPG features that are sensitive
for (changes in) arterial and mental health.
Second, the developed methodologies for determining on the one hand left
ventricular diastolic indices and on the other hand, arterial wall constituent prop-
erties are already well-suited to be integrated as separate cardiac- or vascular
workϐlows in ultrasound machines. When selecting either of the workϐlows, the
corresponding computational model should be initiated, for example as a third-
party application, and the user should be guided to perform the measurements
that are required to complete or augment the analysis. These computationalmodel
approaches to the interpretation of echocardiographic-, and blood pressure data
are of interest to companies, such as Microlife Corporation, IMEC, Pie Medical
Imaging, and Philips Medical Systems. Partnerships with these companies can be
beneϐicial in two ways. First, third-party integration projects will generate rev-
enue for the Department of Biomedical Engineering, which can be allocated to the
hiring of staff or investments in computational resources. Second, partnerships
could also include setting up new research and development projects, thereby
providing opportunities to further develop our algorithms (e.g. using machine
learning methods based on large clinical data sets).
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1990.
Als laatste wil ik mijn familie bedanken. Lieve mama, papa en Lena, jullie waren
zo belangrijk de afgelopen jaren.
218
About the author
Curriculum vitae
MĆĆėęĊē Heusinkveld was born on 28 March 1991 in Sittard, the Nether-lands. From 2003 to 2009, he attended atheneum (pre-university edu-cation) at Trevianum Scholengroep in Sittard. He started his academic
education in September 2009 at Eindhoven University of Technology (TU/e). Dur-
ing his undergraduate studies, Maarten performed a six-month internship at the
Department of Biomedical Engineering, Maastricht University (UM). InMaastricht,
he discovered that his principal interest lies in the interface between engineering
and clinical research. After obtaining his Bachelor’s degree in August 2012, he en-
rolled in theMasterMedical Engineering (TU/e in collaborationwith UM, 09-2012
to 03-2015). His Master’s program included an international internship at the
Laboratory of Biorheology and Medical Ultrasonics of the Centre de Recherche du
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